Cancer metabolism: a therapeutic perspective
Key Points The metabolic ecology of tumours enables component cells to generate ATP, maintain redox balance, and undertake biosynthesis, which in turn support tumour progression Tumours share features of complex ecosystems, with cancer cells inducing nutrient enrichment; however, the requirement for...
Uložené v:
| Vydané v: | Nature reviews. Clinical oncology Ročník 14; číslo 1; s. 11 - 31 |
|---|---|
| Hlavní autori: | , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
Nature Publishing Group UK
01.01.2017
Nature Publishing Group |
| Predmet: | |
| ISSN: | 1759-4774, 1759-4782 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Key Points
The metabolic ecology of tumours enables component cells to generate ATP, maintain redox balance, and undertake biosynthesis, which in turn support tumour progression
Tumours share features of complex ecosystems, with cancer cells inducing nutrient enrichment; however, the requirement for a tight nutrient balance might be a vulnerability of tumours that can be exploited therapeutically
Compared with their normal counterparts, tumour cells require higher rates of catabolite uptake, transfer, and utilization; hence, catabolite-deprivation might be a selective and effective anticancer treatment strategy
Targeting glycolysis and mitochondrial metabolism with drug combinations holds promise as another strategy to disrupt the diverse metabolic compartments within tumours
Measuring glucose, lactate, pyruvate, β-hydroxybutyrate, and glutamine levels in different tumour compartments and their intercompartmental transfer is needed in clinical trials that examine the efficacy of drugs targeting tumour metabolism
Normal tissues frequently have activation of metabolic pathways that are upregulated in cancer and, therefore, dose-limiting toxicity is a challenge in the development of drugs targeting these pathways
Metabolic reprogramming to support tumour growth is a near universal characteristic of cancer, and thus targeting cancer metabolism has been, and continues to be, a focus for drug-development efforts. In this Review, the authors describe the various metabolic alterations and vulnerabilities of tumours that are potentially important targets for anticancer agents, highlighting both the challenges and opportunities.
Awareness that the metabolic phenotype of cells within tumours is heterogeneous — and distinct from that of their normal counterparts — is growing. In general, tumour cells metabolize glucose, lactate, pyruvate, hydroxybutyrate, acetate, glutamine, and fatty acids at much higher rates than their nontumour equivalents; however, the metabolic ecology of tumours is complex because they contain multiple metabolic compartments, which are linked by the transfer of these catabolites. This metabolic variability and flexibility enables tumour cells to generate ATP as an energy source, while maintaining the reduction–oxidation (redox) balance and committing resources to biosynthesis — processes that are essential for cell survival, growth, and proliferation. Importantly, experimental evidence indicates that metabolic coupling between cell populations with different, complementary metabolic profiles can induce cancer progression. Thus, targeting the metabolic differences between tumour and normal cells holds promise as a novel anticancer strategy. In this Review, we discuss how cancer cells reprogramme their metabolism and that of other cells within the tumour microenvironment in order to survive and propagate, thus driving disease progression; in particular, we highlight potential metabolic vulnerabilities that might be targeted therapeutically. |
|---|---|
| AbstractList | Awareness that the metabolic phenotype of cells within tumours is heterogeneous - and distinct from that of their normal counterparts - is growing. In general, tumour cells metabolize glucose, lactate, pyruvate, hydroxybutyrate, acetate, glutamine, and fatty acids at much higher rates than their nontumour equivalents; however, the metabolic ecology of tumours is complex because they contain multiple metabolic compartments, which are linked by the transfer of these catabolites. This metabolic variability and flexibility enables tumour cells to generate ATP as an energy source, while maintaining the reduction-oxidation (redox) balance and committing resources to biosynthesis - processes that are essential for cell survival, growth, and proliferation. Importantly, experimental evidence indicates that metabolic coupling between cell populations with different, complementary metabolic profiles can induce cancer progression. Thus, targeting the metabolic differences between tumour and normal cells holds promise as a novel anticancer strategy. In this Review, we discuss how cancer cells reprogramme their metabolism and that of other cells within the tumour microenvironment in order to survive and propagate, thus driving disease progression; in particular, we highlight potential metabolic vulnerabilities that might be targeted therapeutically. Key Points The metabolic ecology of tumours enables component cells to generate ATP, maintain redox balance, and undertake biosynthesis, which in turn support tumour progression Tumours share features of complex ecosystems, with cancer cells inducing nutrient enrichment; however, the requirement for a tight nutrient balance might be a vulnerability of tumours that can be exploited therapeutically Compared with their normal counterparts, tumour cells require higher rates of catabolite uptake, transfer, and utilization; hence, catabolite-deprivation might be a selective and effective anticancer treatment strategy Targeting glycolysis and mitochondrial metabolism with drug combinations holds promise as another strategy to disrupt the diverse metabolic compartments within tumours Measuring glucose, lactate, pyruvate, β-hydroxybutyrate, and glutamine levels in different tumour compartments and their intercompartmental transfer is needed in clinical trials that examine the efficacy of drugs targeting tumour metabolism Normal tissues frequently have activation of metabolic pathways that are upregulated in cancer and, therefore, dose-limiting toxicity is a challenge in the development of drugs targeting these pathways Metabolic reprogramming to support tumour growth is a near universal characteristic of cancer, and thus targeting cancer metabolism has been, and continues to be, a focus for drug-development efforts. In this Review, the authors describe the various metabolic alterations and vulnerabilities of tumours that are potentially important targets for anticancer agents, highlighting both the challenges and opportunities. Awareness that the metabolic phenotype of cells within tumours is heterogeneous — and distinct from that of their normal counterparts — is growing. In general, tumour cells metabolize glucose, lactate, pyruvate, hydroxybutyrate, acetate, glutamine, and fatty acids at much higher rates than their nontumour equivalents; however, the metabolic ecology of tumours is complex because they contain multiple metabolic compartments, which are linked by the transfer of these catabolites. This metabolic variability and flexibility enables tumour cells to generate ATP as an energy source, while maintaining the reduction–oxidation (redox) balance and committing resources to biosynthesis — processes that are essential for cell survival, growth, and proliferation. Importantly, experimental evidence indicates that metabolic coupling between cell populations with different, complementary metabolic profiles can induce cancer progression. Thus, targeting the metabolic differences between tumour and normal cells holds promise as a novel anticancer strategy. In this Review, we discuss how cancer cells reprogramme their metabolism and that of other cells within the tumour microenvironment in order to survive and propagate, thus driving disease progression; in particular, we highlight potential metabolic vulnerabilities that might be targeted therapeutically. |
| Audience | Academic |
| Author | Martinez-Outschoorn, Ubaldo E. Peiris-Pagés, Maria Pestell, Richard G. Lisanti, Michael P. Sotgia, Federica |
| Author_xml | – sequence: 1 givenname: Ubaldo E. surname: Martinez-Outschoorn fullname: Martinez-Outschoorn, Ubaldo E. organization: The Sidney Kimmel Cancer Center, Thomas Jefferson University – sequence: 2 givenname: Maria surname: Peiris-Pagés fullname: Peiris-Pagés, Maria organization: The Breast Cancer Now Manchester Research Unit, Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester – sequence: 3 givenname: Richard G. surname: Pestell fullname: Pestell, Richard G. organization: The Sidney Kimmel Cancer Center, Thomas Jefferson University – sequence: 4 givenname: Federica surname: Sotgia fullname: Sotgia, Federica email: fsotgia@gmail.com organization: The Breast Cancer Now Manchester Research Unit, Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, School of Environment and Life Sciences, University of Salford – sequence: 5 givenname: Michael P. surname: Lisanti fullname: Lisanti, Michael P. email: michaelp.lisanti@gmail.com organization: The Breast Cancer Now Manchester Research Unit, Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester, The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, Cancer Research UK Manchester Institute, University of Manchester |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27141887$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkl1rFDEUhoO02A_9Ad7IgiC9cNd8TZL1rixVC4Xe6HXIZE66KZnMmGQK_nszbLu0RS25OOHwvC_n6wQdxCECQu8IXhHM1OeYbPA1Z1cUE7ES-BU6JrJZL7lU9GD_l_wIneR8i7EQXLLX6IhKwolS8hh92phoIS16KKYdgs_9l4VZlC0kM8JUvF2MkPIItvg7eIMOnQkZ3t7HU_Tz68WPzffl1fW3y8351dIKQsvSGgWMM2V4hw20bC2UajGD1gHHHeBWMoa5UxZT54jjnLJWiK5zznTGNR07RWc73zENvybIRfc-WwjBRBimrIlqGiyprM28jFIhpBSYV_TDM_R2mFKsjVSKr1mzbupU99SNCaB9dENJxs6m-pxLjqmqWKVWf6Hq66D3tm7J-Zp_Ivj4SLAFE8o2D6FOeIj5Kfj-vsqp7aHTY_K9Sb_1w8oqIHeATUPOCZy2vpjZp5bggyZYz8eh98eh5-PQYm6NPFM-mP9PQ3eaXNl4A-nR0P4p-gNoes1l |
| CODEN | AJHYE6 |
| CitedBy_id | crossref_primary_10_1007_s00204_020_02838_8 crossref_primary_10_3390_ijms19123859 crossref_primary_10_1002_mrc_4925 crossref_primary_10_1080_15548627_2021_1909408 crossref_primary_10_3390_ijms232113172 crossref_primary_10_1016_j_bcp_2024_116422 crossref_primary_10_1158_1078_0432_CCR_22_2263 crossref_primary_10_1186_s12935_023_03027_0 crossref_primary_10_1016_j_bbcan_2016_11_002 crossref_primary_10_1002_adhm_202301853 crossref_primary_10_1111_cas_14246 crossref_primary_10_1177_0194599817746934 crossref_primary_10_1016_j_phrs_2020_104895 crossref_primary_10_1016_j_semcdb_2019_05_016 crossref_primary_10_3389_fonc_2023_1210130 crossref_primary_10_3389_fphar_2024_1431958 crossref_primary_10_1002_advs_201903483 crossref_primary_10_1111_cpr_70036 crossref_primary_10_1364_AO_500531 crossref_primary_10_1038_cr_2016_110 crossref_primary_10_1016_j_semcdb_2019_05_011 crossref_primary_10_1002_anie_202300379 crossref_primary_10_1016_j_cmet_2022_09_009 crossref_primary_10_3390_biomedicines11041076 crossref_primary_10_1007_s00726_021_03012_9 crossref_primary_10_1016_j_bbcan_2018_07_007 crossref_primary_10_1038_cr_2017_155 crossref_primary_10_1007_s13273_022_00300_7 crossref_primary_10_1186_s40880_018_0302_3 crossref_primary_10_1021_jacs_4c07624 crossref_primary_10_1038_s41598_021_03946_w crossref_primary_10_1016_j_biomaterials_2024_122705 crossref_primary_10_3389_fcell_2024_1506492 crossref_primary_10_1038_s41467_022_32101_w crossref_primary_10_1371_journal_pone_0232283 crossref_primary_10_1016_j_phrs_2023_106899 crossref_primary_10_1038_s41419_023_05599_1 crossref_primary_10_1016_j_ejmech_2019_03_053 crossref_primary_10_3892_ol_2019_10112 crossref_primary_10_1371_journal_pone_0245348 crossref_primary_10_3390_cancers11020223 crossref_primary_10_1002_adtp_202200179 crossref_primary_10_1016_j_cmet_2022_09_021 crossref_primary_10_1038_s41419_018_0802_8 crossref_primary_10_3389_fgene_2022_959170 crossref_primary_10_3389_fendo_2025_1530578 crossref_primary_10_1038_s41420_024_01910_x crossref_primary_10_1002_ange_201900387 crossref_primary_10_1007_s00018_018_2831_y crossref_primary_10_1007_s00216_020_02562_3 crossref_primary_10_1016_j_biochi_2021_08_004 crossref_primary_10_3390_ijms19041200 crossref_primary_10_5507_bp_2025_009 crossref_primary_10_1136_gutjnl_2017_315448 crossref_primary_10_7717_peerj_8288 crossref_primary_10_1002_adfm_201910335 crossref_primary_10_1088_1752_7163_ab0bee crossref_primary_10_1016_j_bbrc_2017_01_075 crossref_primary_10_1038_s41420_025_02535_4 crossref_primary_10_3389_fgene_2022_1022734 crossref_primary_10_1042_BSR20231400 crossref_primary_10_3390_cells8040293 crossref_primary_10_1002_1878_0261_70002 crossref_primary_10_1002_smll_201902945 crossref_primary_10_3389_fonc_2020_553045 crossref_primary_10_1002_advs_202406220 crossref_primary_10_1016_j_cej_2025_159871 crossref_primary_10_1126_sciimmunol_abc6373 crossref_primary_10_1007_s10911_020_09464_1 crossref_primary_10_1016_j_tcb_2017_11_006 crossref_primary_10_3389_fgene_2018_00427 crossref_primary_10_3390_cancers13030399 crossref_primary_10_1016_j_drup_2021_100790 crossref_primary_10_1016_j_jare_2024_09_005 crossref_primary_10_1016_j_bioactmat_2024_05_042 crossref_primary_10_1038_s41388_018_0384_z crossref_primary_10_1002_adma_202301099 crossref_primary_10_1016_j_drup_2021_100797 crossref_primary_10_1016_j_carbpol_2021_118018 crossref_primary_10_3389_fonc_2020_00722 crossref_primary_10_1038_nrclinonc_2016_108 crossref_primary_10_1093_cdn_nzaa131 crossref_primary_10_1111_bph_14808 crossref_primary_10_1111_cpr_13015 crossref_primary_10_1016_S1470_2045_20_30062_0 crossref_primary_10_1038_emm_2016_129 crossref_primary_10_3390_ijms22094382 crossref_primary_10_1038_s41420_024_01805_x crossref_primary_10_1038_srep45136 crossref_primary_10_18632_oncotarget_16523 crossref_primary_10_1097_PAI_0000000000001106 crossref_primary_10_1177_1010428317705033 crossref_primary_10_3390_app11031259 crossref_primary_10_1016_j_ccell_2019_10_007 crossref_primary_10_1016_j_canlet_2022_215814 crossref_primary_10_1002_ijc_30795 crossref_primary_10_1016_j_tranon_2025_102323 crossref_primary_10_1021_acs_nanolett_5c01811 crossref_primary_10_3389_fonc_2017_00105 crossref_primary_10_1074_jbc_TM117_000239 crossref_primary_10_3390_molecules23061396 crossref_primary_10_1111_febs_16032 crossref_primary_10_1016_j_bone_2020_115302 crossref_primary_10_1016_j_bcp_2022_114943 crossref_primary_10_1186_s12935_023_02908_8 crossref_primary_10_2147_IJN_S438164 crossref_primary_10_1016_j_ccr_2025_216746 crossref_primary_10_1016_j_neo_2018_12_003 crossref_primary_10_1038_s41556_025_01635_8 crossref_primary_10_1016_j_tranon_2024_102019 crossref_primary_10_1002_anie_202203843 crossref_primary_10_1016_j_ejmech_2019_03_003 crossref_primary_10_1134_S0026893322060188 crossref_primary_10_2174_0929867326666190416165004 crossref_primary_10_1016_j_aca_2023_341897 crossref_primary_10_1016_j_canlet_2024_216649 crossref_primary_10_1038_s41467_023_38360_5 crossref_primary_10_1186_s12915_019_0654_4 crossref_primary_10_3390_ijms22010055 crossref_primary_10_1038_s41419_022_05242_5 crossref_primary_10_1016_j_canlet_2024_216644 crossref_primary_10_1007_s11033_020_05669_z crossref_primary_10_1016_j_biocel_2024_106688 crossref_primary_10_1186_s40170_016_0163_7 crossref_primary_10_1186_s43556_023_00139_x crossref_primary_10_12688_f1000research_15635_1 crossref_primary_10_1158_0008_5472_CAN_22_3059 crossref_primary_10_12688_f1000research_15635_2 crossref_primary_10_1159_000540068 crossref_primary_10_3390_metabo9050081 crossref_primary_10_1038_s41598_025_88917_1 crossref_primary_10_3389_fphar_2022_879751 crossref_primary_10_3389_fonc_2021_745584 crossref_primary_10_1158_0008_5472_CAN_18_2110 crossref_primary_10_1002_adhm_202403019 crossref_primary_10_1016_j_canlet_2023_216138 crossref_primary_10_1007_s12272_019_01115_2 crossref_primary_10_3390_ph18010075 crossref_primary_10_1200_EDBK_390290 crossref_primary_10_1111_cas_14630 crossref_primary_10_3389_fimmu_2018_01697 crossref_primary_10_1016_j_celrep_2025_115487 crossref_primary_10_3390_cells11233719 crossref_primary_10_1371_journal_pone_0181243 crossref_primary_10_1007_s12026_024_09505_5 crossref_primary_10_3389_fonc_2025_1582116 crossref_primary_10_1002_cac2_12360 crossref_primary_10_1038_s41388_018_0582_8 crossref_primary_10_1371_journal_pone_0234613 crossref_primary_10_1016_j_molmet_2021_101272 crossref_primary_10_1038_s44318_024_00120_6 crossref_primary_10_1080_07328303_2025_2468188 crossref_primary_10_1186_s12943_021_01486_5 crossref_primary_10_1007_s11060_022_03964_2 crossref_primary_10_1038_s41392_022_01168_8 crossref_primary_10_1080_15384101_2018_1515551 crossref_primary_10_1111_cbdd_70054 crossref_primary_10_1016_j_matdes_2023_111750 crossref_primary_10_1186_s13046_025_03372_0 crossref_primary_10_1007_s10528_024_10733_5 crossref_primary_10_1186_s12964_023_01129_w crossref_primary_10_1002_cac2_12374 crossref_primary_10_1016_j_carbpol_2024_121889 crossref_primary_10_1016_j_bbcan_2016_12_004 crossref_primary_10_3389_fonc_2020_571384 crossref_primary_10_1038_s41392_025_02395_5 crossref_primary_10_3390_cancers15153775 crossref_primary_10_3390_ijms25147907 crossref_primary_10_1016_j_bioorg_2020_103652 crossref_primary_10_1186_s13046_022_02524_w crossref_primary_10_1016_j_clbc_2023_02_001 crossref_primary_10_1016_j_oraloncology_2022_106061 crossref_primary_10_3389_fonc_2022_942064 crossref_primary_10_1139_cjpp_2022_0260 crossref_primary_10_2147_IJN_S364840 crossref_primary_10_1155_2021_8872977 crossref_primary_10_1038_s41392_020_0168_0 crossref_primary_10_3389_fonc_2020_00317 crossref_primary_10_3390_cancers11050712 crossref_primary_10_1038_s41388_022_02497_2 crossref_primary_10_1039_C8CC01336E crossref_primary_10_3389_fonc_2022_923307 crossref_primary_10_1159_000523750 crossref_primary_10_3390_molecules28093671 crossref_primary_10_1002_cnr2_1945 crossref_primary_10_1016_j_cej_2024_153887 crossref_primary_10_1016_j_cllc_2022_07_010 crossref_primary_10_1038_s42004_023_00864_y crossref_primary_10_3390_cancers12092576 crossref_primary_10_1038_s41420_023_01463_5 crossref_primary_10_3390_ijms232112941 crossref_primary_10_15252_embr_202357339 crossref_primary_10_1186_s12967_023_04498_5 crossref_primary_10_3389_fonc_2021_740720 crossref_primary_10_1002_adhm_202102038 crossref_primary_10_3389_fimmu_2018_00353 crossref_primary_10_3389_fgene_2023_955466 crossref_primary_10_1158_1541_7786_MCR_22_0250 crossref_primary_10_1016_j_molmed_2017_09_001 crossref_primary_10_1007_s10863_019_09811_w crossref_primary_10_3390_pr9071170 crossref_primary_10_1080_01635581_2025_2557593 crossref_primary_10_1016_j_cmet_2018_10_014 crossref_primary_10_1158_1078_0432_CCR_23_2025 crossref_primary_10_3390_pharmaceutics13111785 crossref_primary_10_1002_INMD_20230059 crossref_primary_10_1016_j_chembiol_2020_03_002 crossref_primary_10_1016_j_nano_2021_102370 crossref_primary_10_1007_s13402_020_00545_1 crossref_primary_10_3389_fimmu_2023_1325360 crossref_primary_10_1002_imt2_68 crossref_primary_10_1007_s00726_021_03052_1 crossref_primary_10_1016_j_sbi_2022_102378 crossref_primary_10_1016_j_jmr_2023_107405 crossref_primary_10_3390_cells10051056 crossref_primary_10_1038_s12276_018_0070_9 crossref_primary_10_32604_oncologie_2022_025144 crossref_primary_10_1016_j_ccell_2025_02_004 crossref_primary_10_1097_GOX_0000000000004492 crossref_primary_10_1186_s12859_022_05093_z crossref_primary_10_1038_s41598_024_63891_2 crossref_primary_10_1016_j_canlet_2020_08_044 crossref_primary_10_1038_s41598_023_46426_z crossref_primary_10_1038_s41420_025_02670_y crossref_primary_10_1038_s41374_019_0296_8 crossref_primary_10_1002_2211_5463_12196 crossref_primary_10_1038_s41598_019_52814_1 crossref_primary_10_1186_s12935_024_03541_9 crossref_primary_10_3389_fcell_2021_641469 crossref_primary_10_3389_fphar_2024_1367981 crossref_primary_10_1016_j_bbcan_2017_08_004 crossref_primary_10_1007_s00044_019_02444_z crossref_primary_10_1038_s41392_024_01859_4 crossref_primary_10_3389_fonc_2018_00677 crossref_primary_10_3892_ijo_2017_4094 crossref_primary_10_1016_j_cytogfr_2019_12_002 crossref_primary_10_1016_j_xinn_2025_100805 crossref_primary_10_1016_j_ejphar_2025_177561 crossref_primary_10_1016_j_pbiomolbio_2023_05_004 crossref_primary_10_1007_s11033_022_07536_5 crossref_primary_10_1007_s13577_022_00702_8 crossref_primary_10_3390_ijms252011179 crossref_primary_10_1002_pro_3939 crossref_primary_10_1016_j_cmet_2018_05_012 crossref_primary_10_1038_nrclinonc_2017_1 crossref_primary_10_1007_s00262_023_03595_0 crossref_primary_10_1515_jnet_2019_0037 crossref_primary_10_1016_j_ejmech_2022_114312 crossref_primary_10_1189_jlb_4MR1116_476R crossref_primary_10_3389_fendo_2022_1069528 crossref_primary_10_1038_s41467_019_13950_4 crossref_primary_10_3892_ol_2021_12451 crossref_primary_10_7554_eLife_60917 crossref_primary_10_1016_j_cclet_2023_109420 crossref_primary_10_1038_s41598_025_95703_6 crossref_primary_10_1016_j_cej_2024_152295 crossref_primary_10_1038_s41388_022_02448_x crossref_primary_10_1002_mco2_431 crossref_primary_10_1002_advs_202101553 crossref_primary_10_1038_s43018_021_00184_x crossref_primary_10_1016_j_bioorg_2025_108697 crossref_primary_10_1126_science_aar2001 crossref_primary_10_1186_s13046_021_02207_y crossref_primary_10_1016_j_cellsig_2020_109718 crossref_primary_10_3389_fphar_2019_00709 crossref_primary_10_1159_000519784 crossref_primary_10_1186_s12951_022_01752_8 crossref_primary_10_1016_j_semcancer_2018_01_016 crossref_primary_10_3389_fphar_2023_1330910 crossref_primary_10_3389_fonc_2020_01010 crossref_primary_10_1002_nbm_4018 crossref_primary_10_2174_0929867327999200819123357 crossref_primary_10_3389_fonc_2021_644857 crossref_primary_10_3390_molecules24132483 crossref_primary_10_1016_j_jpba_2019_112797 crossref_primary_10_1007_s00432_022_04501_4 crossref_primary_10_1186_s12967_024_05843_y crossref_primary_10_3390_toxics11020182 crossref_primary_10_1002_advs_202404853 crossref_primary_10_2174_1381612826666200115095937 crossref_primary_10_1016_j_canlet_2019_03_029 crossref_primary_10_1155_2017_2545031 crossref_primary_10_1038_s41598_024_64602_7 crossref_primary_10_3389_fimmu_2018_01816 crossref_primary_10_3389_fcell_2019_00004 crossref_primary_10_1007_s00018_019_03398_6 crossref_primary_10_1016_j_jinorgbio_2024_112550 crossref_primary_10_3389_fimmu_2021_613492 crossref_primary_10_3390_metabo11080556 crossref_primary_10_1016_j_jconrel_2019_04_032 crossref_primary_10_1038_s42003_019_0666_1 crossref_primary_10_3389_fcell_2017_00027 crossref_primary_10_1007_s11864_022_00947_3 crossref_primary_10_1016_j_nut_2020_110748 crossref_primary_10_1038_s41598_022_13836_4 crossref_primary_10_1042_BCJ20170967 crossref_primary_10_1016_j_canlet_2024_216940 crossref_primary_10_1073_pnas_1704862114 crossref_primary_10_1080_14728222_2018_1498082 crossref_primary_10_1002_ptr_7990 crossref_primary_10_3390_biology5040040 crossref_primary_10_1158_0008_5472_CAN_22_2145 crossref_primary_10_3389_fcell_2022_798165 crossref_primary_10_1002_prp2_993 crossref_primary_10_1016_j_jbc_2022_102037 crossref_primary_10_1016_j_csbj_2020_09_023 crossref_primary_10_3389_fonc_2021_745209 crossref_primary_10_1016_j_ejphar_2019_04_051 crossref_primary_10_3390_ijms25052630 crossref_primary_10_1155_2018_2984247 crossref_primary_10_1186_s12951_024_02841_6 crossref_primary_10_1007_s12282_023_01516_8 crossref_primary_10_1016_j_ceca_2020_102241 crossref_primary_10_1111_cbdd_13026 crossref_primary_10_1016_j_colsurfb_2025_114844 crossref_primary_10_3389_fonc_2018_00452 crossref_primary_10_3390_cancers16173028 crossref_primary_10_1242_jcs_239277 crossref_primary_10_1002_adfm_201904268 crossref_primary_10_1111_bph_15239 crossref_primary_10_3390_cancers10010003 crossref_primary_10_3389_fonc_2016_00240 crossref_primary_10_35118_apjmbb_2025_033_3_12 crossref_primary_10_1007_s10555_019_09792_7 crossref_primary_10_1002_jcp_30303 crossref_primary_10_3389_fcell_2020_602668 crossref_primary_10_1007_s12257_022_0063_3 crossref_primary_10_1016_j_canlet_2025_217458 crossref_primary_10_1002_advs_202411980 crossref_primary_10_3389_fonc_2017_00040 crossref_primary_10_3390_cells14161288 crossref_primary_10_1158_1078_0432_CCR_17_3070 crossref_primary_10_1002_mc_23100 crossref_primary_10_1007_s00018_020_03637_1 crossref_primary_10_1038_s41419_024_07103_9 crossref_primary_10_3390_cancers12051119 crossref_primary_10_3390_cells11223599 crossref_primary_10_1002_adma_202207384 crossref_primary_10_3389_fphar_2024_1375993 crossref_primary_10_1245_s10434_023_13587_0 crossref_primary_10_1016_j_canlet_2020_05_007 crossref_primary_10_1038_s41419_019_1481_9 crossref_primary_10_1038_s41585_019_0263_6 crossref_primary_10_3390_genes13112111 crossref_primary_10_1016_j_bbcan_2018_05_002 crossref_primary_10_3390_nu15010003 crossref_primary_10_1002_mc_23349 crossref_primary_10_1038_srep38407 crossref_primary_10_3390_cancers17111881 crossref_primary_10_1002_jcla_23578 crossref_primary_10_1038_s41598_017_18484_7 crossref_primary_10_3390_ijms18091904 crossref_primary_10_1096_fj_202500198R crossref_primary_10_1002_cbdv_202000441 crossref_primary_10_1016_j_biopha_2025_118121 crossref_primary_10_1038_s41429_021_00438_x crossref_primary_10_1016_j_ejphar_2023_175655 crossref_primary_10_1007_s12274_024_6892_y crossref_primary_10_7555_JBR_34_20190037 crossref_primary_10_1016_j_ijbiomac_2022_09_162 crossref_primary_10_1016_j_jiec_2021_08_030 crossref_primary_10_3390_ijerph16040588 crossref_primary_10_1007_s11538_021_00914_3 crossref_primary_10_1007_s11596_019_2050_2 crossref_primary_10_3389_fonc_2022_983254 crossref_primary_10_1038_s41388_018_0469_8 crossref_primary_10_1002_advs_202307963 crossref_primary_10_1016_j_biopha_2023_115956 crossref_primary_10_3390_ijms22126587 crossref_primary_10_1186_s12935_023_02880_3 crossref_primary_10_1371_journal_pone_0240849 crossref_primary_10_1002_ntls_20210071 crossref_primary_10_1038_s41392_023_01320_y crossref_primary_10_1002_smll_202504264 crossref_primary_10_1186_s40364_024_00588_8 crossref_primary_10_1016_j_trecan_2025_04_004 crossref_primary_10_1371_journal_pone_0215246 crossref_primary_10_17816_clinutr101663 crossref_primary_10_1002_fsn3_70741 crossref_primary_10_1007_s00109_018_1659_0 crossref_primary_10_1038_s41556_017_0033_8 crossref_primary_10_1182_blood_2020007932 crossref_primary_10_3390_antiox12101818 crossref_primary_10_1186_s13550_018_0453_x crossref_primary_10_1002_mc_23379 crossref_primary_10_1016_j_preme_2024_100003 crossref_primary_10_1038_cr_2017_146 crossref_primary_10_3390_metabo14110604 crossref_primary_10_1080_14786419_2017_1343329 crossref_primary_10_3389_fcell_2021_667435 crossref_primary_10_1038_s41401_024_01287_8 crossref_primary_10_1016_j_eurpolymj_2024_112835 crossref_primary_10_1038_nrclinonc_2016_183 crossref_primary_10_3389_fonc_2018_00075 crossref_primary_10_1016_j_jep_2021_113813 crossref_primary_10_1016_j_devcel_2017_01_011 crossref_primary_10_1155_2020_5068268 crossref_primary_10_3390_ijms221910790 crossref_primary_10_1002_advs_202401738 crossref_primary_10_1002_adfm_202113028 crossref_primary_10_1016_j_jconrel_2019_07_029 crossref_primary_10_3390_ijms20081817 crossref_primary_10_1038_s41573_019_0032_5 crossref_primary_10_1002_adfm_202211869 crossref_primary_10_1038_s41477_018_0309_4 crossref_primary_10_1016_j_colsurfb_2024_114162 crossref_primary_10_1038_s41598_017_05595_4 crossref_primary_10_1016_j_bioactmat_2025_08_036 crossref_primary_10_2147_IJN_S436038 crossref_primary_10_1186_s10020_025_01125_5 crossref_primary_10_4252_wjsc_v12_i6_448 crossref_primary_10_1038_s41598_025_86052_5 crossref_primary_10_3390_ijms24065564 crossref_primary_10_1016_j_canlet_2022_215642 crossref_primary_10_1016_j_biopha_2024_116906 crossref_primary_10_1038_s41418_023_01240_y crossref_primary_10_1038_s41419_024_06592_y crossref_primary_10_1038_s41598_018_29708_9 crossref_primary_10_1111_his_13334 crossref_primary_10_1016_j_apsb_2023_07_011 crossref_primary_10_1038_s41419_020_03251_w crossref_primary_10_3892_ol_2024_14244 crossref_primary_10_1002_cncr_33870 crossref_primary_10_1186_s13045_023_01430_8 crossref_primary_10_1139_bcb_2018_0076 crossref_primary_10_3389_fonc_2020_00409 crossref_primary_10_3389_fnut_2023_1113228 crossref_primary_10_3390_ijms24108848 crossref_primary_10_1038_s41388_019_1151_5 crossref_primary_10_1080_01635581_2022_2076889 crossref_primary_10_1038_s41598_023_28576_2 crossref_primary_10_1016_j_bbadis_2020_165715 crossref_primary_10_1038_s41598_019_40512_x crossref_primary_10_1016_j_ccell_2020_12_003 crossref_primary_10_3389_fimmu_2024_1427200 crossref_primary_10_1007_s12672_025_02135_9 crossref_primary_10_3390_cancers13246278 crossref_primary_10_1002_1873_3468_12797 crossref_primary_10_1186_s12967_023_03978_y crossref_primary_10_1089_ars_2019_7947 crossref_primary_10_1016_j_semcancer_2025_03_006 crossref_primary_10_1016_j_ccr_2025_216889 crossref_primary_10_1158_0008_5472_CAN_24_1271 crossref_primary_10_1007_s11426_024_2316_4 crossref_primary_10_3389_fonc_2017_00216 crossref_primary_10_1016_j_bbadis_2020_165962 crossref_primary_10_1016_j_sajb_2024_04_003 crossref_primary_10_1016_j_cmet_2019_11_014 crossref_primary_10_1002_hbm_70103 crossref_primary_10_1016_j_intimp_2021_107461 crossref_primary_10_1016_j_bcp_2021_114537 crossref_primary_10_1021_acs_jproteome_4c00991 crossref_primary_10_1016_j_drup_2016_09_003 crossref_primary_10_1016_j_semcancer_2020_02_007 crossref_primary_10_1016_j_cca_2019_10_046 crossref_primary_10_1158_0008_5472_CAN_22_0959 crossref_primary_10_3390_cancers12040850 crossref_primary_10_1002_advs_202002021 crossref_primary_10_1002_cnr2_1417 crossref_primary_10_1186_s12964_024_01957_4 crossref_primary_10_3389_fimmu_2025_1512502 crossref_primary_10_1038_s41419_021_04028_5 crossref_primary_10_1074_jbc_RA119_011471 crossref_primary_10_1111_cpr_70122 crossref_primary_10_1016_j_ejbt_2019_10_001 crossref_primary_10_3389_fonc_2021_632364 crossref_primary_10_1016_j_ccr_2021_214360 crossref_primary_10_3389_fphar_2023_1252567 crossref_primary_10_1002_advs_202105126 crossref_primary_10_3390_cancers15204931 crossref_primary_10_1096_fj_201901237R crossref_primary_10_3390_ijms22179507 crossref_primary_10_3389_fonc_2023_1143798 crossref_primary_10_1007_s00259_019_04543_w crossref_primary_10_1002_1878_0261_12424 crossref_primary_10_1016_j_bmc_2018_02_044 crossref_primary_10_1038_s41419_023_05981_z crossref_primary_10_1016_j_carbpol_2017_06_027 crossref_primary_10_3892_ijo_2022_5309 crossref_primary_10_1016_j_canlet_2021_06_001 crossref_primary_10_1016_j_canlet_2021_07_046 crossref_primary_10_1111_jog_15709 crossref_primary_10_1016_j_lfs_2021_119950 crossref_primary_10_1038_s41598_017_00703_w crossref_primary_10_1007_s10637_025_01577_w crossref_primary_10_3390_cells10061393 crossref_primary_10_1002_adma_201904197 crossref_primary_10_1002_nbm_4935 crossref_primary_10_4155_fmc_2017_0082 crossref_primary_10_1158_0008_5472_CAN_21_1179 crossref_primary_10_3390_biomedicines9121927 crossref_primary_10_1038_s41598_024_80874_5 crossref_primary_10_3390_diagnostics12020394 crossref_primary_10_1016_j_cclet_2024_110351 crossref_primary_10_3389_fonc_2020_602498 crossref_primary_10_3389_fonc_2019_00315 crossref_primary_10_1016_j_intimp_2024_112433 crossref_primary_10_1016_j_talanta_2019_120557 crossref_primary_10_3390_antiox12071371 crossref_primary_10_1080_24701394_2018_1475478 crossref_primary_10_1111_jcmm_14875 crossref_primary_10_3390_cells9020380 crossref_primary_10_1186_s12885_017_3817_0 crossref_primary_10_1016_j_devcel_2024_06_022 crossref_primary_10_3389_fonc_2021_772263 crossref_primary_10_1002_cmdc_202300265 crossref_primary_10_1038_s41467_025_60798_y crossref_primary_10_1016_j_gene_2021_145796 crossref_primary_10_1002_1878_0261_12647 crossref_primary_10_1186_s12951_024_02585_3 crossref_primary_10_3389_fonc_2023_1154661 crossref_primary_10_3390_cells9061529 crossref_primary_10_1038_s41418_024_01323_4 crossref_primary_10_3389_fmolb_2023_1279645 crossref_primary_10_1007_s12032_023_02074_x crossref_primary_10_1158_0008_5472_CAN_19_1167 crossref_primary_10_1042_BCJ20170164 crossref_primary_10_3390_biom10081118 crossref_primary_10_1016_j_jcs_2019_04_009 crossref_primary_10_1016_j_semcancer_2019_07_016 crossref_primary_10_1111_cas_15279 crossref_primary_10_1186_s12885_018_4568_2 crossref_primary_10_1016_j_chempr_2023_12_019 crossref_primary_10_1002_jcsm_12703 crossref_primary_10_1080_07853890_2023_2242247 crossref_primary_10_1186_s12976_017_0066_5 crossref_primary_10_3390_biomedicines9121942 crossref_primary_10_1177_1010428320965284 crossref_primary_10_3389_fphar_2022_909755 crossref_primary_10_1038_s41467_020_18493_7 crossref_primary_10_1124_molpharm_120_000130 crossref_primary_10_1186_s12935_024_03374_6 crossref_primary_10_3389_fonc_2022_906494 crossref_primary_10_1038_s42003_022_03923_7 crossref_primary_10_1186_s13073_024_01410_8 crossref_primary_10_3389_fgene_2024_1475378 crossref_primary_10_3390_cancers13112605 crossref_primary_10_1016_j_jbc_2022_101858 crossref_primary_10_1186_s13046_025_03458_9 crossref_primary_10_1016_j_critrevonc_2024_104438 crossref_primary_10_1038_s41598_018_29692_0 crossref_primary_10_1016_j_cmet_2024_04_018 crossref_primary_10_1016_j_tibs_2019_01_001 crossref_primary_10_1038_s41598_018_19182_8 crossref_primary_10_1002_anie_201900387 crossref_primary_10_1016_j_semcancer_2018_09_008 crossref_primary_10_1002_ange_202203843 crossref_primary_10_1002_adfm_201803924 crossref_primary_10_15252_embr_201948183 crossref_primary_10_7717_peerj_12918 crossref_primary_10_1177_0194599817709224 crossref_primary_10_1186_s13046_018_0701_y crossref_primary_10_1016_j_beha_2023_101514 crossref_primary_10_1038_s41598_025_96004_8 crossref_primary_10_3389_fonc_2025_1545086 crossref_primary_10_1016_j_biotechadv_2018_01_007 crossref_primary_10_1016_j_ejmech_2020_112192 crossref_primary_10_1016_j_critrevonc_2023_104141 crossref_primary_10_3389_fonc_2021_619351 crossref_primary_10_1002_jcb_28757 crossref_primary_10_1002_cmdc_202500136 crossref_primary_10_1038_s41419_025_07516_0 crossref_primary_10_1186_s12885_025_14141_9 crossref_primary_10_1038_s41401_018_0014_x crossref_primary_10_1053_j_seminoncol_2017_09_001 crossref_primary_10_1186_s12943_024_02165_x crossref_primary_10_1088_2057_1739_aa5cd9 crossref_primary_10_1038_s41467_024_46776_w crossref_primary_10_3390_biom10081163 crossref_primary_10_1016_j_pharmthera_2017_10_018 crossref_primary_10_1111_febs_16195 crossref_primary_10_3390_ijms21197346 crossref_primary_10_1038_s41598_019_44361_6 crossref_primary_10_1210_er_2017_00211 crossref_primary_10_1002_cmdc_202400536 crossref_primary_10_1093_pcmedi_pby011 crossref_primary_10_1016_j_bbadis_2024_167164 crossref_primary_10_1111_febs_16191 crossref_primary_10_1016_j_molmet_2021_101389 crossref_primary_10_1038_s41598_018_22690_2 crossref_primary_10_1038_s41419_018_1279_1 crossref_primary_10_1038_s41467_021_23902_6 crossref_primary_10_1038_s41598_017_11025_2 crossref_primary_10_1039_D1QM00411E crossref_primary_10_1002_mco2_157 crossref_primary_10_1016_j_semcancer_2019_08_015 crossref_primary_10_1002_mas_21674 crossref_primary_10_1186_s13046_023_02940_6 crossref_primary_10_3389_fcell_2022_811075 crossref_primary_10_1186_s40170_024_00339_1 crossref_primary_10_3390_ijms20215414 crossref_primary_10_3390_jcm14061992 crossref_primary_10_1146_annurev_biochem_062917_011840 crossref_primary_10_3390_biomedicines11020475 crossref_primary_10_3389_fphar_2021_720886 crossref_primary_10_1002_ange_202300379 crossref_primary_10_1002_cam4_70252 crossref_primary_10_1016_j_actbio_2025_04_031 crossref_primary_10_1158_1078_0432_CCR_18_2297 crossref_primary_10_1186_s12935_021_01996_8 crossref_primary_10_3389_fonc_2018_00500 crossref_primary_10_3390_cancers15041070 crossref_primary_10_2174_0115734129317614240809053901 crossref_primary_10_3389_fonc_2021_676562 crossref_primary_10_3389_fonc_2020_01528 crossref_primary_10_1016_j_semcancer_2017_11_007 crossref_primary_10_1016_j_tcb_2018_01_010 crossref_primary_10_1134_S0006297923140018 crossref_primary_10_3390_molecules25204831 crossref_primary_10_1016_j_molimm_2020_06_029 crossref_primary_10_1186_s13073_023_01252_w crossref_primary_10_3389_fonc_2021_594200 crossref_primary_10_3390_cancers13050977 crossref_primary_10_3390_cancers13050978 crossref_primary_10_3390_nu15061514 crossref_primary_10_1016_j_matbio_2017_12_015 crossref_primary_10_3389_fcell_2021_684322 crossref_primary_10_1016_j_cellsig_2024_111239 crossref_primary_10_1016_j_bbcan_2020_188421 crossref_primary_10_1016_j_arcmed_2019_12_002 crossref_primary_10_1016_j_semradonc_2017_04_001 crossref_primary_10_1371_journal_pone_0233449 crossref_primary_10_3390_genes15050635 crossref_primary_10_1186_s13045_019_0778_6 crossref_primary_10_1152_physrev_00005_2024 crossref_primary_10_1038_s42003_024_06052_5 crossref_primary_10_1016_j_devcel_2020_02_019 crossref_primary_10_1016_j_mcp_2022_101862 crossref_primary_10_1016_j_bioorg_2023_106658 crossref_primary_10_1002_mc_23831 crossref_primary_10_3390_ijms232012143 crossref_primary_10_1158_0008_5472_CAN_23_1443 crossref_primary_10_3390_pharmaceutics15112610 crossref_primary_10_1002_jbio_201960210 crossref_primary_10_1007_s12272_019_01127_y crossref_primary_10_1007_s00421_017_3795_6 crossref_primary_10_1016_j_biochi_2024_01_018 crossref_primary_10_1186_s12943_020_01169_7 crossref_primary_10_1016_j_chembiol_2017_08_028 crossref_primary_10_3389_fimmu_2023_1225948 crossref_primary_10_3390_ijms21093363 crossref_primary_10_1002_advs_201800250 crossref_primary_10_1007_s13402_023_00801_0 crossref_primary_10_1016_j_talanta_2023_124600 crossref_primary_10_1186_s40164_025_00657_0 crossref_primary_10_1155_2021_5515692 crossref_primary_10_1016_j_fct_2016_08_006 crossref_primary_10_3390_biomedicines12010201 crossref_primary_10_1016_j_bioorg_2024_107164 crossref_primary_10_3389_fonc_2022_870721 crossref_primary_10_3390_cells8020089 crossref_primary_10_3390_antiox8050111 crossref_primary_10_1002_bies_201900008 crossref_primary_10_1097_HS9_0000000000000722 crossref_primary_10_3389_fonc_2020_01177 crossref_primary_10_1158_0008_5472_CAN_17_0165 crossref_primary_10_31083_j_fbl2703095 crossref_primary_10_1002_JLB_2A0419_117R crossref_primary_10_1002_med_21446 crossref_primary_10_1016_j_talanta_2020_121721 crossref_primary_10_1016_j_cmet_2021_04_002 crossref_primary_10_3892_ol_2019_10948 crossref_primary_10_1016_j_lfs_2018_07_008 crossref_primary_10_3390_biology14091109 crossref_primary_10_1007_s00432_025_06211_z crossref_primary_10_1002_ijc_34660 crossref_primary_10_15252_embj_2018100600 crossref_primary_10_3389_fonc_2021_698302 crossref_primary_10_3390_cancers13092171 crossref_primary_10_3390_ijms22158019 crossref_primary_10_3390_ijms26052322 crossref_primary_10_1186_s13045_022_01262_y crossref_primary_10_2147_CMAR_S258196 crossref_primary_10_1016_j_biochi_2020_09_014 crossref_primary_10_1126_scitranslmed_aau5758 crossref_primary_10_3389_fendo_2023_1272806 crossref_primary_10_1002_ctm2_588 crossref_primary_10_1038_s41420_021_00580_3 crossref_primary_10_3390_biomedicines8080270 crossref_primary_10_1016_j_nantod_2021_101200 crossref_primary_10_1016_j_yexcr_2020_111997 crossref_primary_10_1016_j_cytogfr_2021_02_001 crossref_primary_10_3389_fphar_2024_1509172 crossref_primary_10_1016_j_bioorg_2020_103943 crossref_primary_10_1016_j_prp_2022_154177 crossref_primary_10_3390_cancers15010107 crossref_primary_10_3390_metabo15040222 crossref_primary_10_1056_NEJMra1905136 crossref_primary_10_1016_j_molcel_2019_07_007 crossref_primary_10_1007_s12032_018_1214_4 crossref_primary_10_1038_s41392_024_01823_2 crossref_primary_10_3390_ijms23179985 crossref_primary_10_1016_j_clnu_2017_06_017 crossref_primary_10_1038_s41417_020_00279_0 crossref_primary_10_3748_wjg_v27_i39_6527 crossref_primary_10_1158_0008_5472_CAN_21_2778 crossref_primary_10_1136_jitc_2024_010008 crossref_primary_10_3390_ph14020133 crossref_primary_10_1007_s12038_020_00107_5 crossref_primary_10_1007_s12011_024_04331_0 crossref_primary_10_1002_cac2_12341 crossref_primary_10_1016_j_matdes_2022_110961 crossref_primary_10_1038_s41392_024_01954_6 crossref_primary_10_1007_s10593_018_2269_z crossref_primary_10_3389_fcell_2020_603837 crossref_primary_10_1016_j_cmet_2017_09_015 crossref_primary_10_3390_cancers13040762 crossref_primary_10_1007_s40259_017_0237_2 crossref_primary_10_1016_j_marenvres_2019_104844 crossref_primary_10_1016_j_isci_2023_108659 crossref_primary_10_1089_ars_2024_0741 crossref_primary_10_26453_otjhs_463786 crossref_primary_10_1016_j_canlet_2024_216841 crossref_primary_10_3390_nu9020121 crossref_primary_10_1038_s41540_025_00525_x crossref_primary_10_1016_j_jddst_2021_103022 crossref_primary_10_3390_cells8050401 crossref_primary_10_1016_j_canlet_2022_215586 crossref_primary_10_3390_cancers12020396 crossref_primary_10_3390_md19020079 crossref_primary_10_1016_j_aquatox_2019_02_014 crossref_primary_10_1016_j_tem_2023_01_003 crossref_primary_10_1002_advs_202309203 crossref_primary_10_1038_s41416_020_01113_y crossref_primary_10_1016_j_csbj_2023_01_044 crossref_primary_10_1007_s13238_017_0451_1 crossref_primary_10_1038_s41598_017_01230_4 crossref_primary_10_1038_celldisc_2017_34 crossref_primary_10_1021_jacs_1c11856 crossref_primary_10_1007_s00280_018_3635_3 crossref_primary_10_1002_lary_26489 crossref_primary_10_1016_j_ccell_2018_03_012 crossref_primary_10_1038_s41598_020_78620_8 crossref_primary_10_3390_cancers11040528 crossref_primary_10_1016_S0021_9258_17_49891_7 crossref_primary_10_1016_j_cmet_2020_10_012 crossref_primary_10_1038_s41580_018_0068_0 crossref_primary_10_1002_mdr2_70004 crossref_primary_10_1002_prp2_632 crossref_primary_10_3390_cells12182237 crossref_primary_10_62347_ZLOS1416 crossref_primary_10_1038_s41568_022_00459_0 crossref_primary_10_1016_j_actbio_2020_01_019 crossref_primary_10_1073_pnas_1808950116 crossref_primary_10_1089_ars_2021_0251 crossref_primary_10_1136_gutjnl_2018_318025 crossref_primary_10_2478_jtim_2022_0022 crossref_primary_10_1242_jcs_241463 crossref_primary_10_3389_fonc_2019_01099 crossref_primary_10_1080_07853890_2021_1937694 crossref_primary_10_3389_fphar_2023_1224828 crossref_primary_10_1016_j_semcancer_2022_07_004 crossref_primary_10_1002_1873_3468_13361 crossref_primary_10_3390_ijms19092502 crossref_primary_10_3389_fnut_2023_1091067 crossref_primary_10_1016_j_bmc_2019_02_055 crossref_primary_10_1002_mc_23455 crossref_primary_10_3390_cancers17172938 crossref_primary_10_3390_vaccines9121497 crossref_primary_10_3390_molecules27072276 crossref_primary_10_1053_j_seminoncol_2017_10_004 crossref_primary_10_1053_j_seminoncol_2017_10_003 crossref_primary_10_1186_s13059_020_02115_y crossref_primary_10_3390_md21090486 crossref_primary_10_1002_cam4_1748 crossref_primary_10_1053_j_seminoncol_2017_10_008 crossref_primary_10_3389_fphar_2022_851401 crossref_primary_10_1016_j_ijbiomac_2024_139273 crossref_primary_10_1155_ijfo_2256871 crossref_primary_10_1038_s41467_021_27329_x crossref_primary_10_1186_s12885_018_4443_1 crossref_primary_10_3390_ijms18112355 crossref_primary_10_1053_j_seminoncol_2017_10_002 crossref_primary_10_3389_fphar_2021_601626 crossref_primary_10_1053_j_seminoncol_2017_10_001 crossref_primary_10_3390_ijms21041266 crossref_primary_10_1016_j_biopha_2019_109791 crossref_primary_10_1016_j_copbio_2022_102739 crossref_primary_10_2174_0929867325666180426165001 crossref_primary_10_1002_wnan_1842 crossref_primary_10_1016_j_adcanc_2022_100065 crossref_primary_10_1038_s41392_020_00213_8 crossref_primary_10_1038_s41598_019_51526_w crossref_primary_10_1080_14728222_2020_1751819 crossref_primary_10_3390_vaccines4040046 crossref_primary_10_1002_advs_202100997 crossref_primary_10_1038_s41388_019_0974_4 crossref_primary_10_1002_advs_202409329 crossref_primary_10_1016_j_semcancer_2018_10_002 crossref_primary_10_1093_advances_nmaa174 crossref_primary_10_1016_j_apsb_2022_06_009 crossref_primary_10_1155_2022_2353115 crossref_primary_10_1371_journal_pcbi_1009841 crossref_primary_10_3390_antiox13060745 crossref_primary_10_1016_j_canlet_2024_217271 crossref_primary_10_3390_biom9030089 crossref_primary_10_1002_advs_202305662 crossref_primary_10_1038_s41590_020_00834_9 crossref_primary_10_3390_cancers12041005 crossref_primary_10_26508_lsa_202302547 crossref_primary_10_1016_j_heliyon_2024_e37592 crossref_primary_10_1007_s40618_018_0890_4 crossref_primary_10_3390_cancers15072144 crossref_primary_10_1016_j_biomaterials_2020_120193 crossref_primary_10_1002_lsm_23870 crossref_primary_10_1021_jacs_3c13165 crossref_primary_10_1002_bies_201600026 crossref_primary_10_54097_xb5npk11 crossref_primary_10_3390_cancers14215268 crossref_primary_10_1186_s12964_024_02018_6 crossref_primary_10_1186_s12964_023_01253_7 crossref_primary_10_1007_s11684_021_0866_1 crossref_primary_10_1002_biof_1799 crossref_primary_10_1038_s41467_020_16918_x crossref_primary_10_1016_j_ebiom_2018_12_026 crossref_primary_10_1124_pharmrev_121_000528 crossref_primary_10_1111_bjh_18968 crossref_primary_10_1038_s41598_019_46643_5 crossref_primary_10_3390_cancers12123798 crossref_primary_10_1016_j_wneu_2020_05_231 crossref_primary_10_1021_jacs_1c05103 crossref_primary_10_3389_fonc_2023_1207603 crossref_primary_10_1038_s44341_024_00007_x crossref_primary_10_1038_s41598_019_54709_7 crossref_primary_10_1038_s41419_024_06930_0 crossref_primary_10_3389_fonc_2024_1480074 crossref_primary_10_1002_cmdc_201600483 crossref_primary_10_7841_ksbbj_2023_38_4_236 crossref_primary_10_1016_j_jhep_2022_04_038 crossref_primary_10_1186_s12935_024_03261_0 crossref_primary_10_3389_fonc_2022_888276 crossref_primary_10_2174_0929867331666230714144851 crossref_primary_10_1007_s00432_021_03713_4 crossref_primary_10_3389_fonc_2021_700629 crossref_primary_10_3390_ijms25179593 crossref_primary_10_1002_adma_202505726 crossref_primary_10_1016_j_actbio_2023_10_001 crossref_primary_10_1038_s41557_020_0426_3 crossref_primary_10_3390_nu17132079 crossref_primary_10_1038_s41467_019_10374_y crossref_primary_10_3389_fonc_2019_01268 crossref_primary_10_3390_diagnostics13050861 crossref_primary_10_3389_fonc_2020_01197 crossref_primary_10_1016_j_semcdb_2019_05_021 crossref_primary_10_1038_s41388_022_02229_6 crossref_primary_10_1200_EDBK_238499 crossref_primary_10_3390_cancers12051267 crossref_primary_10_1016_j_chembiol_2019_06_005 crossref_primary_10_1002_agt2_443 crossref_primary_10_1016_j_ejmech_2018_09_043 crossref_primary_10_3390_ijms22115543 crossref_primary_10_1186_s13046_022_02367_5 crossref_primary_10_3389_fimmu_2025_1603032 crossref_primary_10_1186_s12935_020_01357_x crossref_primary_10_1186_s13045_022_01358_5 crossref_primary_10_1038_s43856_024_00471_5 crossref_primary_10_1016_j_fbio_2024_104370 crossref_primary_10_1002_ctm2_70045 crossref_primary_10_2174_0929867326666181213092652 crossref_primary_10_1016_j_carbpol_2022_120439 crossref_primary_10_1016_j_aohep_2020_03_005 crossref_primary_10_1186_s13046_024_03203_8 crossref_primary_10_1073_pnas_2315348121 crossref_primary_10_1016_j_bbcan_2023_188987 |
| Cites_doi | 10.1021/cb500683c 10.1158/1078-0432.CCR-14-2810 10.1016/j.ccr.2013.03.005 10.1038/nature08617 10.1016/j.phrs.2015.06.014 10.1016/j.oooo.2014.04.003 10.4161/cc.24092 10.1146/annurevbiochem060815014343 10.1016/j.biocel.2015.05.012 10.1158/0008-5472.CAN-05-1489 10.1371/journal.pgen.1000293 10.7150/ijbs.10190 10.2337/diacare.29.02.06.dc05-1558 10.1038/srep04927 10.1016/j.cmet.2015.06.009 10.1371/journal.pone.0075154 10.1023/A:1008336904585 10.1038/ng.3421 10.1038/327389a0 10.1056/NEJMoa1300874 10.1158/1535-7163.MCT-13-0870 10.1158/0008-5472.CAN-09-2994 10.1016/j.semcancer.2005.04.003 10.1073/pnas.0914433107 10.1056/NEJMc0806396 10.1172/JCI72873 10.1016/j.bbabio.2010.10.022 10.1038/ncb3124 10.1101/gad.1987211 10.2174/15680096113139990041 10.1126/science.1193497 10.1053/j.seminhematol.2015.03.002 10.1158/1078-0432.CCR-14-1209 10.1158/1078-0432.CCR-12-3629 10.1172/JCI67230 10.1038/nature11066 10.1097/MCO.0000000000000122 10.1530/ERC-14-0284 10.1126/science.aaa1299 10.1126/science.1218595 10.1016/j.cmet.2011.12.011 10.1038/35030019 10.1371/journal.pcbi.1002018 10.1158/0008-5472.CAN-12-1949 10.1158/0008-5472.CAN-08-4806 10.1016/B978-0-12-397927-8.00004-X 10.1126/science.1160809 10.1089/ars.2011.4243 10.1016/j.ccr.2012.11.020 10.1016/j.ccr.2012.09.020 10.2174/0929867043364711 10.1158/0008-5472.CAN-11-1457 10.1101/gad.16771811 10.1038/nm.2890 10.1038/onc.2008.108 10.1038/nm.3596 10.1016/j.cmet.2011.12.015 10.1038/onc.2011.51 10.1126/science.aaa1193 10.1172/JCI69600 10.1021/acs.jmedchem.5b00168 10.1016/0009-8981(88)90359-2 10.1016/j.cmet.2012.01.004 10.1126/scitranslmed.3007653 10.4161/cc.10.23.18151 10.1056/NEJM200511243532123 10.1016/j.cmet.2008.07.007 10.3389/fpsyg.2015.00027 10.1038/nrd4002 10.1126/science.1079368 10.1200/JCO.2005.02.0933 10.2174/138955712798868977 10.1038/nature07733 10.1126/science.aaa5004 10.1128/MCB.00440-07 10.1016/j.semcancer.2014.01.005 10.1172/JCI75836 10.1038/jcbfm.2011.149 10.1038/sj.bjc.6604554 10.4161/cc.9.17.12908 10.1016/j.copbio.2014.11.012 10.1084/jem.20120162 10.1073/pnas.1307237110 10.1016/j.pharmthera.2015.02.004 10.4161/cc.8.23.10238 10.1016/j.cell.2007.01.047 10.1158/1078-0432.CCR-13-2270 10.18632/oncotarget.5260 10.1038/nrc3262 10.1126/science.1249410 10.1126/science.1117728 10.1200/JCO.2003.03.034 10.1016/j.celrep.2015.02.006 10.1038/nature13110 10.1038/4441022a 10.1158/0008-5472.CAN-13-2034 10.1158/0008-5472.CAN-03-3294 10.1038/sj.onc.1208773 10.1158/0008-5472.CAN-09-2650 10.1016/j.ccell.2014.12.002 10.1128/MCB.01101-09 10.1016/j.bbrc.2003.11.136 10.1126/science.1260384 10.1038/srep00362 10.1056/NEJMoa1201735 10.4161/cc.20948 10.1126/science.aab1054 10.1038/msb.2013.65 10.1038/nature13236 10.1016/j.ccr.2011.10.015 10.18632/oncotarget.3174 10.1016/j.cell.2013.03.004 10.1038/ncb3039 10.1007/s00109-015-1307-x 10.1126/science.1234769 10.1038/nrd4145 10.1074/jbc.275.1.223 10.1016/j.cell.2012.01.035 10.1158/0008-5472.CAN-04-3640 10.1016/j.ccr.2014.05.004 10.1172/JCI69741 10.1126/science.1258026 10.1126/science.aaa9607 10.15252/embj.201490784 10.1038/nrm4007 10.1038/nature10350 10.2174/092986711795590101 10.1182/blood-2014-08-594408 10.1093/jnci/djj373 10.1158/1078-0432.CCR-14-1019 10.1016/j.cmet.2015.06.023 10.1158/1541-7786.MCR-15-0068 10.1111/pcmr.12000 10.1016/j.cell.2011.02.013 10.1042/BJ20120294 10.1186/1752-0509-4-58 10.1073/pnas.92.12.5510 10.1016/j.ccr.2007.04.001 10.1038/nrclinonc.2015.169 10.1158/0008-5472.CAN-12-2464 10.1146/annurev-pathol-011811-120856 10.1016/j.advenzreg.2010.09.010 10.18632/oncotarget.4159 10.2217/fon.10.11 10.1016/j.bcp.2009.12.003 10.1038/nature08530 10.18632/oncotarget.4479 10.1074/jbc.M301546200 10.1158/1078-0432.CCR-15-0420 10.1002/cphy.c130008 10.1073/pnas.1107553108 10.1016/j.cmet.2015.11.008 10.1038/nrclinonc.2014.51 10.1158/1940-6207.CAPR-11-0299 10.18632/oncotarget.3910 10.1016/j.cmet.2014.12.003 10.1038/nrc3064 10.1016/j.cmet.2014.09.018 10.1042/CS20060307 10.1038/nm.2492 10.1002/jcp.24346 10.1056/NEJM194806032382301 10.1182/blood-2014-04-567065 10.1056/NEJMoa1400029 10.1038/nature13490 10.1158/1535-7163.MCT-13-0097 10.1038/nature13611 10.4161/cc.9.17.12928 10.1042/BST20150051 10.1126/science.1060456 10.1126/science.1231677 10.1016/S1470-2045(15)00027-3 10.1016/j.cmet.2012.05.001 10.1016/0022-5193(67)90079-3 10.1126/science.1058079 10.1200/JCO.2011.41.4466 10.1126/science.aaa3872 10.1038/nature10602 10.1038/nrc3162 10.1038/ng.890 10.1126/science.aaa6204 10.1016/j.ccr.2005.09.008 10.1016/j.critrevonc.2014.08.002 10.1016/j.cell.2011.03.054 10.1038/nrmicro3155 10.1016/j.lfs.2012.10.025 10.1016/j.cmet.2015.05.014 10.1073/pnas.1212780110 10.1016/j.hoc.2012.02.002 10.1016/j.molcel.2010.06.022 10.1038/nrc3365 10.1016/j.ccr.2012.08.014 10.1074/jbc.M800102200 10.1038/onc.2009.358 10.1172/JCI67228 10.1053/j.gastro.2014.01.001 10.1016/j.molcel.2012.09.025 10.1517/14712598.2014.912270 10.1016/j.tips.2012.01.005 10.1158/2159-8290.CD-15-0507 10.1126/science.1236062 10.1038/nature10642 10.1038/bjc.2012.527 10.1038/ng0793-289 10.18632/oncotarget.3430 10.1073/pnas.1003428107 10.1016/j.celrep.2014.06.043 10.1042/bj3480607 10.1210/jc.2011-1754 10.1200/JCO.2009.26.7765 10.1186/s40170-015-0128-2 10.1007/s10549-011-1612-1 10.4103/0973-1482.55136 10.1016/j.tips.2014.11.004 10.1038/nature10189 10.1182/blood-2008-04-149443 10.1016/j.ccell.2014.10.003 10.1159/000076737 10.1016/j.cmet.2014.12.007 10.1038/msb.2011.56 10.1242/dmm.007724 10.1073/pnas.0700690104 |
| ContentType | Journal Article |
| Copyright | Springer Nature Limited 2016 COPYRIGHT 2017 Nature Publishing Group Copyright Nature Publishing Group Jan 2017 |
| Copyright_xml | – notice: Springer Nature Limited 2016 – notice: COPYRIGHT 2017 Nature Publishing Group – notice: Copyright Nature Publishing Group Jan 2017 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7T5 7TM 7TO 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1038/nrclinonc.2016.60 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & allied health premium. Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Oncogenes and Growth Factors Abstracts MEDLINE MEDLINE - Academic ProQuest Central Student |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1759-4782 |
| EndPage | 31 |
| ExternalDocumentID | 4279869791 A474028951 27141887 10_1038_nrclinonc_2016_60 |
| Genre | Journal Article Review |
| GroupedDBID | --- .XZ 0R~ 29M 39C 3V. 53G 70F 7RV 7X7 88E 8FI 8FJ AAEEF AARCD AAWTL AAWYQ AAYZH AAZLF ABAWZ ABJNI ABLJU ABUWG ACGFS ACPRK ADBBV AENEX AFKRA AFSHS AGAYW AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS ARMCB AXYYD BBNVY BENPR BHPHI BKEYQ BKKNO BPHCQ BVXVI CCPQU DB5 EBS EE. EJD EX3 EXGXG F5P FQGFK FSGXE FYUFA HCIFZ HMCUK HZ~ IAO IHR IHW INH INR ITC M1P M7P NAPCQ NNMJJ NXXTH O9- ODYON OVD PQQKQ PROAC PSQYO RNR RNT RNTTT SHXYY SIXXV SJN SNYQT SOJ TAOOD TBHMF TDRGL TEORI TSG UKHRP WOW AAYXX AFANA AFFHD AGSTI ALPWD ATHPR CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NFIDA NPM 7T5 7TM 7TO 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ H94 K9. LK8 PKEHL PQEST PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c612t-ca8e3438a4d0aeb39688b03ebfe40de0b73304f8c02ff1f4423b66ddffadaf5d3 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 1102 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000391344000004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1759-4774 |
| IngestDate | Thu Oct 02 17:14:57 EDT 2025 Sun Nov 09 04:46:29 EST 2025 Sat Nov 29 14:29:55 EST 2025 Tue Nov 11 10:21:18 EST 2025 Tue Nov 04 17:29:26 EST 2025 Thu May 22 20:55:12 EDT 2025 Thu Apr 03 07:03:40 EDT 2025 Sat Nov 29 06:26:55 EST 2025 Tue Nov 18 20:53:21 EST 2025 Fri Feb 21 02:37:40 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c612t-ca8e3438a4d0aeb39688b03ebfe40de0b73304f8c02ff1f4423b66ddffadaf5d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
| OpenAccessLink | http://usir.salford.ac.uk/id/eprint/39270/1/nrclinonc.2016.60.pdf |
| PMID | 27141887 |
| PQID | 1849359510 |
| PQPubID | 536303 |
| PageCount | 21 |
| ParticipantIDs | proquest_miscellaneous_1855072747 proquest_miscellaneous_1826677604 proquest_journals_1849359510 gale_infotracmisc_A474028951 gale_infotracacademiconefile_A474028951 gale_healthsolutions_A474028951 pubmed_primary_27141887 crossref_citationtrail_10_1038_nrclinonc_2016_60 crossref_primary_10_1038_nrclinonc_2016_60 springer_journals_10_1038_nrclinonc_2016_60 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-01-01 |
| PublicationDateYYYYMMDD | 2017-01-01 |
| PublicationDate_xml | – month: 01 year: 2017 text: 2017-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Nature reviews. Clinical oncology |
| PublicationTitleAbbrev | Nat Rev Clin Oncol |
| PublicationTitleAlternate | Nat Rev Clin Oncol |
| PublicationYear | 2017 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Hasmann, Schemainda (CR172) 2003; 63 Possemato (CR93) 2011; 476 Whitaker-Menezes (CR8) 2011; 10 Martinez-Outschoorn (CR196) 2010; 9 Halestrap (CR54) 2013; 3 Fathi, Wander, Faramand, Emadi (CR143) 2015; 52 Zhang (CR52) 2015; 10 Dwarakanath (CR27) 2009; 5 Wallace (CR14) 2012; 12 Carrer, Wellen (CR209) 2015; 34 Boroughs, DeBerardinis (CR18) 2015; 17 Pollak (CR126) 2014; 20 Bitner-Glindzicz (CR155) 2009; 360 Kordes (CR136) 2015; 16 Menendez (CR130) 2012; 11 CR153 Intlekofer (CR208) 2015; 22 Lo-Coco (CR123) 2013; 369 Vander Heiden, Cantley, Thompson (CR2) 2009; 324 Yun (CR175) 2015; 350 Luo (CR182) 2011; 145 Kennedy (CR44) 2013; 8 Cox, Bonner (CR4) 2001; 292 El-Mir (CR217) 2000; 275 Diers, Broniowska, Chang, Hogg (CR62) 2012; 444 Hanahan, Weinberg (CR12) 2011; 144 Asterholm, Mundy, Weng, Anderson, Scherer (CR166) 2012; 15 Papaldo (CR28) 2003; 21 Ley, Turnbaugh, Klein, Gordon (CR73) 2006; 444 Chiavarina (CR187) 2010; 9 Sriskanthadevan (CR111) 2015; 125 Sampath, Zabka, Misner, O'Brien, Dragovich (CR173) 2015; 151 Chen, Xu, Renko, Derwahl (CR132) 2012; 97 Amunts (CR148) 2014; 343 Ahn, Metallo (CR1) 2015; 3 Kruiswijk, Labuschagne, Vousden (CR77) 2015; 16 Jeon, Chandel, Hay (CR78) 2012; 485 Curry (CR114) 2013; 12 Bahrami, Morris, Pourgholami (CR160) 2012; 12 Kimura, Takabatake, Takahashi, Isaka (CR199) 2013; 73 Losman (CR205) 2013; 339 Wilson, Danenberg, Johnston, Lenz, Ladner (CR88) 2014; 11 Wells (CR178) 2015; 43 White (CR195) 2012; 12 Pavlides (CR226) 2012; 16 Sun (CR71) 2012; 18 Holubarsch (CR85) 2007; 113 Deep, Agarwal (CR21) 2013; 13 Morais-Santos (CR212) 2015; 6 Weinberg (CR39) 2010; 107 Lamb (CR122) 2015; 6 Funes (CR112) 2007; 104 Hirsch, Iliopoulos, Tsichlis, Struhl (CR128) 2009; 69 Wurm (CR115) 2011; 108 Sagan (CR144) 1967; 14 Kaelin, McKnight (CR202) 2013; 153 Peiris-Pages, Martinez-Outschoorn, Sotgia, Lisanti (CR210) 2015; 22 Chiarini, Evangelisti, McCubrey, Martelli (CR198) 2015; 36 Gallego-Ortega, Gomez del Pulgar, Valdes-Mora, Cebrian, Lacal (CR107) 2011; 51 Gehrke (CR116) 2015; 21 Fan (CR98) 2015; 10 Kanno (CR61) 1988; 173 Greber (CR146) 2015; 348 Martinez-Outschoorn (CR165) 2010; 9 Fan (CR100) 2014; 510 Polanski (CR53) 2014; 20 Valencia (CR192) 2014; 26 Rabinowitz, White (CR70) 2010; 330 Bowker, Majumdar, Veugelers, Johnson (CR127) 2006; 29 Stine, Walton, Altman, Hsieh, Dang (CR97) 2015; 5 Burgos (CR174) 2011; 18 Porstmann (CR66) 2008; 8 Owen, Doran, Halestrap (CR124) 2000; 348 Smolkova, Dvorak, Zelenka, Vitek, Jezek (CR207) 2015; 65 Bertolini, Sukhatme, Bouche (CR86) 2015; 12 Porporato (CR176) 2014; 8 Fiaschi (CR17) 2012; 72 Bauer, Hatzivassiliou, Zhao, Andreadis, Thompson (CR102) 2005; 24 Moazed, Noller (CR152) 1987; 327 Bailey, Wojtkowiak, Hashim, Gillies (CR58) 2012; 65 Vazquez, Liu, Zhou, Oltvai (CR162) 2010; 4 Dang (CR204) 2009; 462 Amunts, Brown, Toots, Scheres, Ramakrishnan (CR147) 2015; 348 Goodwin (CR9) 2014; 26 Ogawa, Washio, Takahashi, Echigo, Takahashi (CR42) 2014; 118 Pavlides (CR15) 2009; 8 Rohle (CR206) 2013; 340 Pardee (CR215) 2014; 20 Schug (CR69) 2015; 27 Semenza (CR185) 2013; 123 Carter (CR151) 2000; 407 Doherty, Cleveland (CR10) 2013; 123 Sena, Chandel (CR164) 2012; 48 Wilson (CR150) 2014; 12 Velasco-Hernandez, Hyrenius-Wittsten, Rehn, Bryder, Cammenga (CR186) 2014; 124 Maslowski (CR72) 2009; 461 Parks, Mazure, Counillon, Pouyssegur (CR79) 2013; 228 Metallo (CR33) 2011; 481 Fu (CR141) 2015; 22 Sayin (CR225) 2014; 6 Jara, Lopez-Munoz (CR218) 2015; 101 Ferreri (CR158) 2012; 30 Pieters (CR89) 2008; 112 Li, Simon (CR96) 2013; 19 Shlomi, Benyamini, Gottlieb, Sharan, Ruppin (CR163) 2011; 7 Salani (CR137) 2014; 21 Kamphorst (CR64) 2013; 110 Talekar, Boreddy, Singh, Amiji (CR189) 2014; 14 Doherty (CR49) 2014; 74 Brown (CR149) 2014; 346 Pietrocola, Galluzzi, San Pedro, Madeo, Kroemer (CR11) 2015; 21 Lamb (CR121) 2015; 6 Vazquez (CR117) 2013; 23 Feun, Kuo, Savaraj (CR220) 2015; 18 DeNicola (CR95) 2015; 47 Jain (CR101) 2012; 336 Cortes-Cros (CR24) 2013; 110 Chen, Wu, Tanaka, Zhang (CR190) 2014; 10 Duvel (CR67) 2010; 39 Zhang (CR180) 2007; 11 Zu, Guppy (CR5) 2004; 313 Fan (CR32) 2013; 9 Ascierto (CR90) 2005; 23 Clem (CR104) 2011; 30 Fogal (CR113) 2010; 30 Clem (CR211) 2013; 12 Birsoy (CR131) 2014; 508 Yang, Soga, Pollard (CR161) 2013; 123 Glazer (CR91) 2010; 28 Propper (CR139) 1999; 10 Michelakis, Webster, Mackey (CR140) 2008; 99 Flavin, Peluso, Nguyen, Loda (CR105) 2010; 6 Pelicano (CR125) 2003; 278 Pham (CR222) 2015; 21 Xiang (CR37) 2015; 125 Schlaepfer (CR83) 2015; 6 Britten (CR138) 2000; 6 Nisoli (CR170) 2003; 299 Goldin (CR26) 2008; 27 DeNicola (CR177) 2011; 475 Zaugg (CR84) 2011; 25 Wang, Jiang, Rue, Semenza (CR179) 1995; 92 Xie (CR168) 2014; 4 Hirschhaeuser, Sattler, Mueller-Klieser (CR43) 2011; 71 Locasale (CR94) 2011; 43 Maschek (CR25) 2004; 64 Walenta, Schroeder, Mueller-Klieser (CR45) 2004; 11 Draoui, Feron (CR194) 2011; 4 Fukuda (CR183) 2007; 129 Zadra, Batista, Loda (CR224) 2015; 13 Soriano, Miro, Mensa (CR156) 2005; 353 Chajes, Cambot, Moreau, Lenoir, Joulin (CR103) 2006; 66 Nielsen, Nordestgaard, Bojesen (CR110) 2012; 367 Sotgia (CR51) 2012; 7 Rani, Kumar (CR60) 2016; 59 Amend, Pienta (CR193) 2015; 6 Nisoli (CR171) 2005; 310 Mulvihill, Nomura (CR106) 2013; 92 Abreu, Peek (CR75) 2014; 146 Viale (CR13) 2014; 514 Caro (CR80) 2012; 22 Gorrini, Harris, Mak (CR169) 2013; 12 Wilson, Hay (CR188) 2011; 11 Paoli, Bosco, Camporesi, Mangar (CR76) 2015; 6 Mullen (CR35) 2011; 481 Grassian, Metallo, Coloff, Stephanopoulos, Brugge (CR68) 2011; 25 Hitosugi (CR219) 2012; 22 Tan (CR119) 2015; 21 Hatzivassiliou (CR63) 2005; 8 Kubatka, Kruzliak, Rotrekl, Jelinkova, Mladosievicova (CR109) 2014; 92 Pike, Smift, Croteau, Ferrick, Wu (CR82) 2011; 1807 Galluzzi (CR223) 2015; 34 Skrtic (CR159) 2011; 20 Colegio (CR47) 2013; 513 Fujiwara (CR213) 2013; 108 Bao (CR134) 2012; 5 Foretz, Guigas, Bertrand, Pollak, Viollet (CR135) 2014; 20 Sellers (CR214) 2015; 125 Sonveaux (CR7) 2008; 118 Prezant (CR154) 1993; 4 Ferreri (CR157) 2006; 98 Agrawal, Kumar, Srivastava, Mishra (CR99) 2003; 6 Scharfman (CR56) 2015; 347 Pellerin, Magistretti (CR55) 2012; 32 Gaglio (CR65) 2011; 7 Yuneva (CR191) 2012; 15 Clemente, Ursell, Parfrey, Knight (CR74) 2012; 148 Ye, Ma, Xiong, Guan (CR203) 2013; 23 Hensley, Wasti, DeBerardinis (CR34) 2013; 123 Martinez-Outschoorn, Lisanti, Sotgia (CR6) 2014; 25 Zhang (CR184) 2008; 283 Hamanaka, Chandel (CR87) 2012; 209 Marin-Valencia (CR30) 2012; 15 Martinez-Outschoorn, Sotgia, Lisanti (CR50) 2012; 15 Song (CR133) 2012; 2 Wang (CR216) 2013; 340 DeBerardinis, Cheng (CR29) 2009; 29 Hadad (CR129) 2011; 128 Beckmann, Herrmann (CR145) 2015; 348 Visentin, Zhao, Goldman (CR201) 2012; 26 Woyach (CR81) 2014; 370 Katajisto (CR120) 2015; 348 Takeuchi (CR197) 2005; 65 Le (CR48) 2010; 107 Marchiq, Pouyssegur (CR20) 2016; 94 Lai, Lee, Lee, Wang, Chen (CR31) 2005; 15 Galluzzi, Kepp, Vander Heiden, Kroemer (CR19) 2013; 12 Pfeiffer, Schuster, Bonhoeffer (CR3) 2001; 292 Semenza (CR59) 2012; 33 Hirayama (CR41) 2009; 69 Filipp (CR40) 2012; 25 Nieman (CR16) 2011; 17 Diehn (CR36) 2009; 458 Vander Heiden (CR23) 2010; 79 Chen (CR167) 2008; 4 Joyce, Fearon (CR46) 2015; 348 Zhai (CR92) 2015; 21 Farber, Diamond (CR200) 1948; 238 Gross (CR38) 2014; 13 Glunde, Bhujwalla, Ronen (CR108) 2011; 11 LeBleu (CR118) 2014; 16 Kim, Gao, Liu, Semenza, Dang (CR181) 2007; 27 Lamb (CR221) 2015; 6 Ooi, Gomperts (CR22) 2015; 21 Yan, Bigner, Velculescu, Parsons (CR142) 2009; 69 Sada, Lee, Katsu, Otsuki, Inoue (CR57) 2015; 347 TR Prezant (BFnrclinonc201660_CR154) 1993; 4 V Chajes (BFnrclinonc201660_CR103) 2006; 66 R Pieters (BFnrclinonc201660_CR89) 2008; 112 I Marchiq (BFnrclinonc201660_CR20) 2016; 94 HE Scharfman (BFnrclinonc201660_CR56) 2015; 347 M Cortes-Cros (BFnrclinonc201660_CR24) 2013; 110 F Wang (BFnrclinonc201660_CR216) 2013; 340 H Pelicano (BFnrclinonc201660_CR125) 2003; 278 JR Doherty (BFnrclinonc201660_CR49) 2014; 74 MI Gross (BFnrclinonc201660_CR38) 2014; 13 T Porstmann (BFnrclinonc201660_CR66) 2008; 8 F Pietrocola (BFnrclinonc201660_CR11) 2015; 21 BF Clem (BFnrclinonc201660_CR104) 2011; 30 L Zhai (BFnrclinonc201660_CR92) 2015; 21 JR Doherty (BFnrclinonc201660_CR10) 2013; 123 MT Abreu (BFnrclinonc201660_CR75) 2014; 146 JJ Kamphorst (BFnrclinonc201660_CR64) 2013; 110 M Hasmann (BFnrclinonc201660_CR172) 2003; 63 P Sonveaux (BFnrclinonc201660_CR7) 2008; 118 DC Wallace (BFnrclinonc201660_CR14) 2012; 12 G Wells (BFnrclinonc201660_CR178) 2015; 43 P Katajisto (BFnrclinonc201660_CR120) 2015; 348 HS Lai (BFnrclinonc201660_CR31) 2005; 15 MM Mulvihill (BFnrclinonc201660_CR106) 2013; 92 JA Woyach (BFnrclinonc201660_CR81) 2014; 370 PE Porporato (BFnrclinonc201660_CR176) 2014; 8 CA Wurm (BFnrclinonc201660_CR115) 2011; 108 H Zhang (BFnrclinonc201660_CR184) 2008; 283 P Papaldo (BFnrclinonc201660_CR28) 2003; 21 T Kimura (BFnrclinonc201660_CR199) 2013; 73 R Beckmann (BFnrclinonc201660_CR145) 2015; 348 A Amunts (BFnrclinonc201660_CR148) 2014; 343 W Luo (BFnrclinonc201660_CR182) 2011; 145 AP Carter (BFnrclinonc201660_CR151) 2000; 407 J Fan (BFnrclinonc201660_CR32) 2013; 9 KM Maslowski (BFnrclinonc201660_CR72) 2009; 461 F Sotgia (BFnrclinonc201660_CR51) 2012; 7 RJ DeBerardinis (BFnrclinonc201660_CR29) 2009; 29 JD Rabinowitz (BFnrclinonc201660_CR70) 2010; 330 A Paoli (BFnrclinonc201660_CR76) 2015; 6 DN Wilson (BFnrclinonc201660_CR150) 2014; 12 MG Vander Heiden (BFnrclinonc201660_CR2) 2009; 324 K Zaugg (BFnrclinonc201660_CR84) 2011; 25 T Hitosugi (BFnrclinonc201660_CR219) 2012; 22 G Hatzivassiliou (BFnrclinonc201660_CR63) 2005; 8 I Marin-Valencia (BFnrclinonc201660_CR30) 2012; 15 CS Ahn (BFnrclinonc201660_CR1) 2015; 3 BJ Chen (BFnrclinonc201660_CR190) 2014; 10 D Hanahan (BFnrclinonc201660_CR12) 2011; 144 T Kanno (BFnrclinonc201660_CR61) 1988; 173 E White (BFnrclinonc201660_CR195) 2012; 12 BS Dwarakanath (BFnrclinonc201660_CR27) 2009; 5 T Shlomi (BFnrclinonc201660_CR163) 2011; 7 JW Kim (BFnrclinonc201660_CR181) 2007; 27 F Bahrami (BFnrclinonc201660_CR160) 2012; 12 A Soriano (BFnrclinonc201660_CR156) 2005; 353 R Rani (BFnrclinonc201660_CR60) 2016; 59 ZE Stine (BFnrclinonc201660_CR97) 2015; 5 SK Parks (BFnrclinonc201660_CR79) 2013; 228 F Morais-Santos (BFnrclinonc201660_CR212) 2015; 6 M Foretz (BFnrclinonc201660_CR135) 2014; 20 A Viale (BFnrclinonc201660_CR13) 2014; 514 L Galluzzi (BFnrclinonc201660_CR19) 2013; 12 L Pellerin (BFnrclinonc201660_CR55) 2012; 32 R Possemato (BFnrclinonc201660_CR93) 2011; 476 K Birsoy (BFnrclinonc201660_CR131) 2014; 508 UE Martinez-Outschoorn (BFnrclinonc201660_CR6) 2014; 25 TS Pardee (BFnrclinonc201660_CR215) 2014; 20 B Li (BFnrclinonc201660_CR96) 2013; 19 G Maschek (BFnrclinonc201660_CR25) 2004; 64 M Peiris-Pages (BFnrclinonc201660_CR210) 2015; 22 JM Funes (BFnrclinonc201660_CR112) 2007; 104 A Le (BFnrclinonc201660_CR48) 2010; 107 AT Ooi (BFnrclinonc201660_CR22) 2015; 21 ES Burgos (BFnrclinonc201660_CR174) 2011; 18 WR Wilson (BFnrclinonc201660_CR188) 2011; 11 G Zadra (BFnrclinonc201660_CR224) 2015; 13 SM Jeon (BFnrclinonc201660_CR78) 2012; 485 S Fujiwara (BFnrclinonc201660_CR213) 2013; 108 M Visentin (BFnrclinonc201660_CR201) 2012; 26 MR Owen (BFnrclinonc201660_CR124) 2000; 348 RE Ley (BFnrclinonc201660_CR73) 2006; 444 M Bitner-Glindzicz (BFnrclinonc201660_CR155) 2009; 360 S Kordes (BFnrclinonc201660_CR136) 2015; 16 B Salani (BFnrclinonc201660_CR137) 2014; 21 Y Sun (BFnrclinonc201660_CR71) 2012; 18 CW Song (BFnrclinonc201660_CR133) 2012; 2 CJ Holubarsch (BFnrclinonc201660_CR85) 2007; 113 R Lamb (BFnrclinonc201660_CR121) 2015; 6 S Pavlides (BFnrclinonc201660_CR15) 2009; 8 IW Asterholm (BFnrclinonc201660_CR166) 2012; 15 JL Chen (BFnrclinonc201660_CR167) 2008; 4 M Pollak (BFnrclinonc201660_CR126) 2014; 20 S Walenta (BFnrclinonc201660_CR45) 2004; 11 S Sriskanthadevan (BFnrclinonc201660_CR111) 2015; 125 N Draoui (BFnrclinonc201660_CR194) 2011; 4 S Pavlides (BFnrclinonc201660_CR226) 2012; 16 SF Nielsen (BFnrclinonc201660_CR110) 2012; 367 LS Pike (BFnrclinonc201660_CR82) 2011; 1807 KM Nieman (BFnrclinonc201660_CR16) 2011; 17 J Fan (BFnrclinonc201660_CR100) 2014; 510 GL Semenza (BFnrclinonc201660_CR185) 2013; 123 E Pham (BFnrclinonc201660_CR222) 2015; 21 Y Xiang (BFnrclinonc201660_CR37) 2015; 125 AR Mullen (BFnrclinonc201660_CR35) 2011; 481 R Fukuda (BFnrclinonc201660_CR183) 2007; 129 OR Colegio (BFnrclinonc201660_CR47) 2013; 513 JW Locasale (BFnrclinonc201660_CR94) 2011; 43 K Glunde (BFnrclinonc201660_CR108) 2011; 11 ES Glazer (BFnrclinonc201660_CR91) 2010; 28 F Kruiswijk (BFnrclinonc201660_CR77) 2015; 16 A Carrer (BFnrclinonc201660_CR209) 2015; 34 T Fiaschi (BFnrclinonc201660_CR17) 2012; 72 D Sampath (BFnrclinonc201660_CR173) 2015; 151 J Yun (BFnrclinonc201660_CR175) 2015; 350 MG Vander Heiden (BFnrclinonc201660_CR23) 2010; 79 T Pfeiffer (BFnrclinonc201660_CR3) 2001; 292 G Chen (BFnrclinonc201660_CR132) 2012; 97 BJ Greber (BFnrclinonc201660_CR146) 2015; 348 SL Bowker (BFnrclinonc201660_CR127) 2006; 29 A Amunts (BFnrclinonc201660_CR147) 2015; 348 MO Yuneva (BFnrclinonc201660_CR191) 2012; 15 D Whitaker-Menezes (BFnrclinonc201660_CR8) 2011; 10 L Galluzzi (BFnrclinonc201660_CR223) 2015; 34 AJ Ferreri (BFnrclinonc201660_CR158) 2012; 30 JA Joyce (BFnrclinonc201660_CR46) 2015; 348 AJ Ferreri (BFnrclinonc201660_CR157) 2006; 98 BF Clem (BFnrclinonc201660_CR211) 2013; 12 F Vazquez (BFnrclinonc201660_CR117) 2013; 23 T Velasco-Hernandez (BFnrclinonc201660_CR186) 2014; 124 JM Curry (BFnrclinonc201660_CR114) 2013; 12 S Agrawal (BFnrclinonc201660_CR99) 2003; 6 M Skrtic (BFnrclinonc201660_CR159) 2011; 20 AP Halestrap (BFnrclinonc201660_CR54) 2013; 3 ZT Schug (BFnrclinonc201660_CR69) 2015; 27 RB Hamanaka (BFnrclinonc201660_CR87) 2012; 209 GL Wang (BFnrclinonc201660_CR179) 1995; 92 AR Diers (BFnrclinonc201660_CR62) 2012; 444 AS Tan (BFnrclinonc201660_CR119) 2015; 21 LA Sena (BFnrclinonc201660_CR164) 2012; 48 H Yan (BFnrclinonc201660_CR142) 2009; 69 AT Fathi (BFnrclinonc201660_CR143) 2015; 52 GL Semenza (BFnrclinonc201660_CR59) 2012; 33 D Rohle (BFnrclinonc201660_CR206) 2013; 340 GM DeNicola (BFnrclinonc201660_CR177) 2011; 475 F Chiarini (BFnrclinonc201660_CR198) 2015; 36 L Dang (BFnrclinonc201660_CR204) 2009; 462 ED Michelakis (BFnrclinonc201660_CR140) 2008; 99 LG Feun (BFnrclinonc201660_CR220) 2015; 18 JA Jara (BFnrclinonc201660_CR218) 2015; 101 N Sada (BFnrclinonc201660_CR57) 2015; 347 SR Amend (BFnrclinonc201660_CR193) 2015; 6 AR Grassian (BFnrclinonc201660_CR68) 2011; 25 D Zhang (BFnrclinonc201660_CR52) 2015; 10 P Kubatka (BFnrclinonc201660_CR109) 2014; 92 KM Bailey (BFnrclinonc201660_CR58) 2012; 65 DE Bauer (BFnrclinonc201660_CR102) 2005; 24 E Nisoli (BFnrclinonc201660_CR171) 2005; 310 UE Martinez-Outschoorn (BFnrclinonc201660_CR196) 2010; 9 JC Clemente (BFnrclinonc201660_CR74) 2012; 148 S Gehrke (BFnrclinonc201660_CR116) 2015; 21 UE Martinez-Outschoorn (BFnrclinonc201660_CR165) 2010; 9 R Flavin (BFnrclinonc201660_CR105) 2010; 6 E Cox (BFnrclinonc201660_CR4) 2001; 292 K Sellers (BFnrclinonc201660_CR214) 2015; 125 F Lo-Coco (BFnrclinonc201660_CR123) 2013; 369 F Bertolini (BFnrclinonc201660_CR86) 2015; 12 B Bao (BFnrclinonc201660_CR134) 2012; 5 M Jain (BFnrclinonc201660_CR101) 2012; 336 MY El-Mir (BFnrclinonc201660_CR217) 2000; 275 CD Britten (BFnrclinonc201660_CR138) 2000; 6 R Lamb (BFnrclinonc201660_CR122) 2015; 6 JA Menendez (BFnrclinonc201660_CR130) 2012; 11 PA Ascierto (BFnrclinonc201660_CR90) 2005; 23 R Polanski (BFnrclinonc201660_CR53) 2014; 20 XL Zu (BFnrclinonc201660_CR5) 2004; 313 D Moazed (BFnrclinonc201660_CR152) 1987; 327 D Gallego-Ortega (BFnrclinonc201660_CR107) 2011; 51 BFnrclinonc201660_CR153 G Deep (BFnrclinonc201660_CR21) 2013; 13 PM Wilson (BFnrclinonc201660_CR88) 2014; 11 M Diehn (BFnrclinonc201660_CR36) 2009; 458 JA Losman (BFnrclinonc201660_CR205) 2013; 339 GM DeNicola (BFnrclinonc201660_CR95) 2015; 47 M Talekar (BFnrclinonc201660_CR189) 2014; 14 T Valencia (BFnrclinonc201660_CR192) 2014; 26 N Goldin (BFnrclinonc201660_CR26) 2008; 27 F Weinberg (BFnrclinonc201660_CR39) 2010; 107 KM Kennedy (BFnrclinonc201660_CR44) 2013; 8 DJ Propper (BFnrclinonc201660_CR139) 1999; 10 VI Sayin (BFnrclinonc201660_CR225) 2014; 6 S Hadad (BFnrclinonc201660_CR129) 2011; 128 M Yang (BFnrclinonc201660_CR161) 2013; 123 FV Filipp (BFnrclinonc201660_CR40) 2012; 25 D Gaglio (BFnrclinonc201660_CR65) 2011; 7 AM Intlekofer (BFnrclinonc201660_CR208) 2015; 22 A Hirayama (BFnrclinonc201660_CR41) 2009; 69 H Zhang (BFnrclinonc201660_CR180) 2007; 11 S Farber (BFnrclinonc201660_CR200) 1948; 238 A Brown (BFnrclinonc201660_CR149) 2014; 346 V Fogal (BFnrclinonc201660_CR113) 2010; 30 J Fan (BFnrclinonc201660_CR98) 2015; 10 H Takeuchi (BFnrclinonc201660_CR197) 2005; 65 LK Boroughs (BFnrclinonc201660_CR18) 2015; 17 F Hirschhaeuser (BFnrclinonc201660_CR43) 2011; 71 J Xie (BFnrclinonc201660_CR168) 2014; 4 WG Kaelin Jr (BFnrclinonc201660_CR202) 2013; 153 K Duvel (BFnrclinonc201660_CR67) 2010; 39 X Fu (BFnrclinonc201660_CR141) 2015; 22 T Ogawa (BFnrclinonc201660_CR42) 2014; 118 CM Metallo (BFnrclinonc201660_CR33) 2011; 481 VS LeBleu (BFnrclinonc201660_CR118) 2014; 16 A Vazquez (BFnrclinonc201660_CR162) 2010; 4 R Lamb (BFnrclinonc201660_CR221) 2015; 6 UE Martinez-Outschoorn (BFnrclinonc201660_CR50) 2012; 15 B Chiavarina (BFnrclinonc201660_CR187) 2010; 9 P Caro (BFnrclinonc201660_CR80) 2012; 22 ML Goodwin (BFnrclinonc201660_CR9) 2014; 26 L Sagan (BFnrclinonc201660_CR144) 1967; 14 D Ye (BFnrclinonc201660_CR203) 2013; 23 CT Hensley (BFnrclinonc201660_CR34) 2013; 123 C Gorrini (BFnrclinonc201660_CR169) 2013; 12 IR Schlaepfer (BFnrclinonc201660_CR83) 2015; 6 HA Hirsch (BFnrclinonc201660_CR128) 2009; 69 E Nisoli (BFnrclinonc201660_CR170) 2003; 299 K Smolkova (BFnrclinonc201660_CR207) 2015; 65 22424233 - Cell. 2012 Mar 16;148(6):1258-70 26482881 - Nat Genet. 2015 Dec;47(12):1475-81 18281291 - J Biol Chem. 2008 Apr 18;283(16):10892-903 11283355 - Science. 2001 Apr 20;292(5516):504-7 25002027 - Cancer Cell. 2014 Jul 14;26(1):121-35 19196684 - N Engl J Med. 2009 Feb 5;360(6):640-2 14729604 - Cancer Res. 2004 Jan 1;64(1):31-4 14697210 - Biochem Biophys Res Commun. 2004 Jan 16;313(3):459-65 23079663 - Cancer Cell. 2012 Oct 16;22(4):547-60 23393090 - Science. 2013 Mar 29;339(6127):1621-5 24113830 - Nat Rev Drug Discov. 2013 Nov;12 (11):829-46 19996293 - Cancer Res. 2009 Dec 15;69(24):9157-9 23574725 - Cell Cycle. 2013 May 1;12(9):1371-84 22863786 - Nat Med. 2012 Sep;18(9):1359-68 25497227 - Trends Pharmacol Sci. 2015 Feb;36(2):124-35 21620138 - Cell. 2011 May 27;145(5):732-44 24486645 - Semin Cancer Biol. 2014 Apr;25:47-60 25712477 - EMBO J. 2015 Apr 1;34(7):856-80 21655990 - Breast Cancer Res Treat. 2011 Aug;128(3):783-94 23288916 - Cancer Res. 2013 Jan 1;73(1):3-7 21734707 - Nature. 2011 Jul 06;475(7354):106-9 23558169 - Science. 2013 May 3;340(6132):626-30 16443869 - Diabetes Care. 2006 Feb;29(2):254-8 23897900 - Clin Cancer Res. 2013 Nov 1;19(21):5835-41 17183309 - Nature. 2006 Dec 21;444(7122):1022-3 21760589 - Nature. 2011 Aug 18;476(7360):346-50 23841729 - N Engl J Med. 2013 Jul 11;369(2):111-21 25406093 - ACS Chem Biol. 2015 Feb 20;10 (2):510-6 25043024 - Nature. 2014 Sep 25;513(7519):559-63 24732946 - Nat Rev Clin Oncol. 2014 May;11(5):282-98 17319797 - Clin Sci (Lond). 2007 Aug;113(4):205-12 21035492 - Adv Enzyme Regul. 2011;51(1):183-94 22809961 - Cell Cycle. 2012 Aug 1;11(15):2782-92 19935646 - Nature. 2009 Dec 10;462(7274):739-44 23999438 - J Clin Invest. 2013 Sep;123(9):3652-8 25584894 - Cancer Cell. 2015 Jan 12;27(1):57-71 22027938 - J Cereb Blood Flow Metab. 2012 Jul;32(7):1152-66 16234528 - J Clin Oncol. 2005 Oct 20;23(30):7660-8 24477002 - Sci Transl Med. 2014 Jan 29;6(221):221ra15 22278418 - J Clin Endocrinol Metab. 2012 Apr;97(4):E510-20 24285728 - Cancer Res. 2014 Feb 1;74(3):908-20 24301801 - Mol Syst Biol. 2013 Dec 03;9:712 24287781 - Nat Rev Drug Discov. 2013 Dec;12(12):931-47 20814239 - Cell Cycle. 2010 Aug 15;9(16):3256-76 26541605 - Science. 2015 Dec 11;350(6266):1391-6 20100866 - Mol Cell Biol. 2010 Mar;30(6):1303-18 25565208 - Cell Metab. 2015 Jan 6;21(1):95-108 18762023 - Cell Metab. 2008 Sep;8(3):224-36 10617608 - J Biol Chem. 2000 Jan 7;275(1):223-8 20855962 - Cell Cycle. 2010 Sep 1;9(17):3515-33 20133848 - Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2037-42 21847114 - Mol Syst Biol. 2011 Aug 16;7:523 7689389 - Nat Genet. 1993 Jul;4(3):289-94 21423717 - PLoS Comput Biol. 2011 Mar;7(3):e1002018 22660331 - Nature. 2012 May 09;485(7400):661-5 25119024 - Nature. 2014 Oct 30;514(7524):628-32 22094260 - Cancer Cell. 2011 Nov 15;20(5):674-88 24277449 - Clin Cancer Res. 2014 Feb 15;20(4):926-37 11283359 - Science. 2001 Apr 20;292(5516):448-9 22458763 - Biochem J. 2012 Jun 15;444(3):561-71 17785433 - Mol Cell Biol. 2007 Nov;27(21):7381-93 27023846 - Annu Rev Biochem. 2016 Jun 2;85:103-32 21883043 - Antioxid Redox Signal. 2012 Jun 1;16(11):1264-84 17482131 - Cancer Cell. 2007 May;11(5):407-20 21517777 - Curr Med Chem. 2011;18(13):1947-61 22959024 - Adv Pharmacol. 2012;65:63-107 23142242 - Life Sci. 2013 Mar 19;92(8-9):492-7 22682223 - Cell Metab. 2012 Jun 6;15(6):827-37 26087400 - Oncotarget. 2015 Sep 8;6(26):22836-56 25792315 - Science. 2015 Mar 20;347(6228):1312-3 25956158 - Mol Cancer Res. 2015 Jul;13(7):1059-72 22520983 - Hematol Oncol Clin North Am. 2012 Jun;26(3):629-48, ix 21799113 - Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13546-51 26007236 - Int J Biochem Cell Biol. 2015 Aug;65:125-33 10509153 - Ann Oncol. 1999 Aug;10(8):923-7 25278503 - Science. 2014 Nov 7;346(6210):718-22 16306535 - N Engl J Med. 2005 Nov 24;353(21):2305-6 22846158 - Pigment Cell Melanoma Res. 2012 Nov;25(6):732-9 23999443 - J Clin Invest. 2013 Sep;123(9):3685-92 19923890 - Cell Cycle. 2009 Dec;8(23):3984-4001 25066121 - Cell Rep. 2014 Aug 7;8(3):754-66 22326218 - Cell Metab. 2012 Feb 8;15(2):157-70 22225869 - Cell Metab. 2012 Jan 4;15(1):4-5 25241037 - Nat Cell Biol. 2014 Oct;16(10 ):992-1003, 1-15 26111463 - Semin Hematol. 2015 Jul;52(3):165-71 23617249 - Curr Cancer Drug Targets. 2013 Jun;13(5):486-99 25456737 - Cell Metab. 2014 Dec 2;20(6):953-66 19033663 - J Clin Invest. 2008 Dec;118(12):3930-42 21127245 - Science. 2010 Dec 3;330(6009):1344-8 11541392 - J Theor Biol. 1967 Mar;14(3):255-74 25461508 - Curr Opin Biotechnol. 2015 Aug;34:23-9 22134189 - Cell Cycle. 2011 Dec 1;10(23):4047-64 24069390 - PLoS One. 2013 Sep 12;8(9):e75154 20864819 - Cell Cycle. 2010 Sep 1;9(17):3534-51 18766181 - Br J Cancer. 2008 Oct 7;99(7):989-94 25165100 - Clin Cancer Res. 2014 Oct 15;20(20):5255-64 21376230 - Cell. 2011 Mar 4;144(5):646-74 23674815 - Mol Cancer Ther. 2013 Aug;12(8):1461-70 26636492 - Cell Metab. 2015 Dec 1;22(6):956-8 16707454 - Cancer Res. 2006 May 15;66(10):5287-94 22802315 - J Clin Oncol. 2012 Aug 20;30(24):2988-94 26519060 - Clin Cancer Res. 2015 Dec 15;21(24):5427-33 24762115 - Expert Opin Biol Ther. 2014 Aug;14(8):1145-59 25774832 - Nat Cell Biol. 2015 Apr;17(4):351-9 16007201 - Oncogene. 2005 Sep 15;24(41):6314-22 20005212 - Biochem Pharmacol. 2010 Apr 15;79(8):1118-24 19460998 - Science. 2009 May 22;324(5930):1029-33 26382145 - Cancer Discov. 2015 Oct;5(10):1024-39 25524310 - Clin Cancer Res. 2015 Feb 15;21(4):808-18 24336183 - Nat Rev Microbiol. 2014 Jan;12(1):35-48 26067687 - Lancet Oncol. 2015 Jul;16(7):839-47 23321518 - Br J Cancer. 2013 Jan 15;108(1):170-8 16226706 - Cancer Cell. 2005 Oct;8(4):311-21 26212717 - Cell Metab. 2015 Aug 4;22(2):304-11 22070692 - Mini Rev Med Chem. 2012 Jan;12(1):44-52 28094266 - Nat Rev Clin Oncol. 2017 Feb;14 (2):113 26551711 - Biochem Soc Trans. 2015 Aug;43(4):674-9 22398146 - Trends Pharmacol Sci. 2012 Apr;33(4):207-14 17384149 - Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6223-8 25621173 - Cancer Metab. 2015 Jan 25;3(1):1 23267074 - Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):489-94 23001348 - Nat Rev Cancer. 2012 Oct;12(10):685-98 25837512 - Science. 2015 Apr 17;348(6232):303-8 24820099 - Sci Rep. 2014 May 13;4:4927 26323205 - Oncotarget. 2015 Sep 8;6(26):21892-905 20351325 - J Clin Oncol. 2010 May 1;28(13):2220-6 25732824 - Cell Rep. 2015 Mar 3;10 (8):1335-48 25792327 - Science. 2015 Mar 20;347(6228):1362-7 24927638 - Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Aug;118(2):218-25 26087309 - Oncotarget. 2015 Jun 10;6(16):14005-25 15894488 - Semin Cancer Biol. 2005 Aug;15(4):267-76 15833867 - Cancer Res. 2005 Apr 15;65(8):3336-46 26190651 - Cell Metab. 2015 Sep 1;22(3):508-15 3383424 - Clin Chim Acta. 1988 Mar 31;173(1):89-98 24805240 - Nature. 2014 Jun 12;510(7504):298-302 25332683 - Int J Biol Sci. 2014 Sep 13;10(10):1084-96 24406471 - Gastroenterology. 2014 May;146(6):1534-1546.e3 25838379 - Science. 2015 Apr 3;348(6230):95-8 19752085 - Cancer Res. 2009 Oct 1;69(19):7507-11 12853461 - J Biol Chem. 2003 Sep 26;278(39):37832-9 21606941 - Nat Rev Cancer. 2011 Jun;11(6):393-410 22101431 - Nature. 2011 Nov 20;481(7381):385-8 21852536 - Genes Dev. 2011 Aug 15;25(16):1716-33 22500211 - Sci Rep. 2012;2:362 17018784 - J Natl Cancer Inst. 2006 Oct 4;98(19):1375-82 26483297 - Nat Rev Clin Oncol. 2015 Dec;12(12):732-42 22850421 - Cancer Res. 2012 Oct 1;72(19):5130-40 23459996 - J Cell Physiol. 2013 Sep;228(9):1854-62 18860765 - N Engl J Med. 1948 Jun 3;238(23):787-93 23416000 - Cancer Cell. 2013 Mar 18;23 (3):287-301 24869598 - N Engl J Med. 2014 Jun 12;370(24):2286-94 25883344 - Science. 2015 Apr 17;348(6232):288-9 21692241 - Biochim Biophys Acta. 2011 Jun;1807(6):726-34 18805963 - Blood. 2008 Dec 15;112(13):4832-8 7539918 - Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5510-4 26203664 - Oncotarget. 2015 Aug 7;6(22):19177-89 25273809 - Endocr Relat Cancer. 2014;21(6):R461-71 22326219 - Cell Metab. 2012 Feb 8;15(2):171-85 23558173 - Science. 2013 May 3;340(6132):622-6 25220658 - Crit Rev Oncol Hematol. 2014 Dec;92(3):296-311 18408762 - Oncogene. 2008 Aug 7;27(34):4636-43 25631767 - Blood. 2015 Mar 26;125(13):2120-30 11014183 - Nature. 2000 Sep 21;407(6802):340-8 24670634 - Nature. 2014 Apr 3;508(7494):108-12 20009289 - J Cancer Res Ther. 2009 Sep;5 Suppl 1:S21-6 22534666 - Nat Rev Cancer. 2012 Apr 26;12(6):401-10 17418790 - Cell. 2007 Apr 6;129(1):111-22 14612543 - Cancer Res. 2003 Nov 1;63(21):7436-42 25607840 - J Clin Invest. 2015 Feb;125(2):687-98 10656430 - Clin Cancer Res. 2000 Jan;6(1):42-9 22628656 - Science. 2012 May 25;336(6084):1040-4 23518346 - Cancer Cell. 2013 Mar 18;23(3):274-6 25698989 - Front Psychol. 2015 Feb 02;6:27 22101433 - Nature. 2011 Nov 20;481(7381):380-4 10839993 - Biochem J. 2000 Jun 15;348 Pt 3:607-14 20421486 - Proc Natl Acad Sci U S A. 2010 May 11;107(19):8788-93 19194462 - Nature. 2009 Apr 9;458(7239):780-3 25474015 - Curr Opin Clin Nutr Metab Care. 2015 Jan;18(1):78-82 21423211 - Oncogene. 2011 Jul 28;30(30):3370-80 22330683 - J Exp Med. 2012 Feb 13;209(2):211-5 25838376 - Science. 2015 Apr 3;348(6230):74-80 24901568 - Nat Med. 2014 Jun;20(6):591-3 22077552 - Annu Rev Pathol. 2012;7:423-67 19865172 - Nature. 2009 Oct 29;461(7268):1282-6 25625193 - Oncotarget. 2015 Mar 10;6(7):4569-84 25837514 - Science. 2015 Apr 17;348(6232):340-3 22037646 - Nat Med. 2011 Oct 30;17(11):1498-503 2953976 - Nature. 1987 Jun 4-10;327(6121):389-94 20670887 - Mol Cell. 2010 Jul 30;39(2):171-83 25895024 - Oncotarget. 2015 ;6(12 ):9669-78 23153533 - Cancer Cell. 2012 Nov 13;22(5):585-600 12972521 - J Clin Oncol. 2003 Sep 15;21(18):3462-8 21804546 - Nat Genet. 2011 Jul 31;43(9):869-74 19458066 - Cancer Res. 2009 Jun 1;69(11):4918-25 25838393 - Clin Cancer Res. 2015 Jun 1;21(11):2440-4 19881548 - Oncogene. 2010 Jan 21;29(3):313-24 19057672 - PLoS Genet. 2008 Dec;4(12 ):e1000293 12574632 - Science. 2003 Feb 7;299(5608):896-9 20373869 - Future Oncol. 2010 Apr;6(4):551-62 15044825 - J Mol Microbiol Biotechnol. 2003;6(2):67-75 26122615 - Nat Rev Mol Cell Biol. 2015 Jul;16(7):393-405 26340601 - J Med Chem. 2016 Jan 28;59(2):487-96 26277279 - Pharmacol Res. 2015 Nov;101:102-8 23671091 - Proc Natl Acad Sci U S A. 2013 May 28;110(22):8882-7 16224023 - Science. 2 |
| References_xml | – volume: 69 start-page: 4918 year: 2009 end-page: 4925 ident: CR41 article-title: Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry publication-title: Cancer Res. – volume: 370 start-page: 2286 year: 2014 end-page: 2294 ident: CR81 article-title: Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib publication-title: N. Engl. J. Med. – volume: 21 start-page: 2440 year: 2015 end-page: 2444 ident: CR22 article-title: Molecular pathways: targeting cellular energy metabolism in cancer via inhibition of SLC2A1 and LDHA publication-title: Clin. Cancer Res. – volume: 6 start-page: 19177 year: 2015 end-page: 19189 ident: CR212 article-title: Targeting lactate transport suppresses breast tumour growth publication-title: Oncotarget – volume: 26 start-page: 629 year: 2012 end-page: 648 ident: CR201 article-title: The antifolates publication-title: Hematol. Oncol. Clin. North Am. – volume: 125 start-page: 2120 year: 2015 end-page: 2130 ident: CR111 article-title: AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress publication-title: Blood – volume: 99 start-page: 989 year: 2008 end-page: 994 ident: CR140 article-title: Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer publication-title: Br. J. Cancer – volume: 32 start-page: 1152 year: 2012 end-page: 1166 ident: CR55 article-title: Sweet sixteen for ANLS publication-title: J. Cereb. Blood Flow Metab. – volume: 23 start-page: 287 year: 2013 end-page: 301 ident: CR117 article-title: PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress publication-title: Cancer Cell – volume: 23 start-page: 274 year: 2013 end-page: 276 ident: CR203 article-title: -2-hydroxyglutarate as the key effector of mutations promoting oncogenesis publication-title: Cancer Cell – volume: 92 start-page: 5510 year: 1995 end-page: 5514 ident: CR179 article-title: Hypoxia-inducible factor 1 is a basic-helix-loop- helix-PAS heterodimer regulated by cellular O tension publication-title: Proc. Natl Acad. Sci. USA – volume: 10 start-page: 1084 year: 2014 end-page: 1096 ident: CR190 article-title: Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics publication-title: Int. J. Biol. Sci. – volume: 12 start-page: 1371 year: 2013 end-page: 1384 ident: CR114 article-title: Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer publication-title: Cell Cycle – volume: 15 start-page: 157 year: 2012 end-page: 170 ident: CR191 article-title: The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type publication-title: Cell Metab. – volume: 36 start-page: 124 year: 2015 end-page: 135 ident: CR198 article-title: Current treatment strategies for inhibiting mTOR in cancer publication-title: Trends Pharmacol. Sci. – volume: 275 start-page: 223 year: 2000 end-page: 228 ident: CR217 article-title: Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I publication-title: J. Biol. Chem. – volume: 72 start-page: 5130 year: 2012 end-page: 5140 ident: CR17 article-title: Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor–stroma interplay publication-title: Cancer Res. – volume: 65 start-page: 3336 year: 2005 end-page: 3346 ident: CR197 article-title: Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors publication-title: Cancer Res. – volume: 107 start-page: 2037 year: 2010 end-page: 2042 ident: CR48 article-title: Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression publication-title: Proc. Natl Acad. Sci. USA – volume: 39 start-page: 171 year: 2010 end-page: 183 ident: CR67 article-title: Activation of a metabolic gene regulatory network downstream of mTOR complex 1 publication-title: Mol. Cell – volume: 148 start-page: 1258 year: 2012 end-page: 1270 ident: CR74 article-title: The impact of the gut microbiota on human health: an integrative view publication-title: Cell – volume: 10 start-page: 510 year: 2015 end-page: 516 ident: CR98 article-title: Human phosphoglycerate dehydrogenase produces the oncometabolite d-2-hydroxyglutarate publication-title: ACS Chem. Biol. – volume: 462 start-page: 739 year: 2009 end-page: 744 ident: CR204 article-title: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate publication-title: Nature – volume: 123 start-page: 3685 year: 2013 end-page: 3692 ident: CR10 article-title: Targeting lactate metabolism for cancer therapeutics publication-title: J. Clin. Invest. – volume: 348 start-page: 74 year: 2015 end-page: 80 ident: CR46 article-title: T cell exclusion, immune privilege, and the tumor microenvironment publication-title: Science – volume: 458 start-page: 780 year: 2009 end-page: 783 ident: CR36 article-title: Association of reactive oxygen species levels and radioresistance in cancer stem cells publication-title: Nature – volume: 107 start-page: 8788 year: 2010 end-page: 8793 ident: CR39 article-title: Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity publication-title: Proc. Natl Acad. Sci. USA – volume: 367 start-page: 1792 year: 2012 end-page: 1802 ident: CR110 article-title: Statin use and reduced cancer-related mortality publication-title: N. Engl. J. Med. – volume: 59 start-page: 487 year: 2016 end-page: 496 ident: CR60 article-title: Recent update on human lactate dehydrogenase enzyme 5 ( LDH5) inhibitors: a promising approach for cancer chemotherapy publication-title: J. Med. Chem. – volume: 9 start-page: 712 year: 2013 ident: CR32 article-title: Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia publication-title: Mol. Syst. Biol. – volume: 27 start-page: 57 year: 2015 end-page: 71 ident: CR69 article-title: Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress publication-title: Cancer Cell – volume: 444 start-page: 1022 year: 2006 end-page: 1023 ident: CR73 article-title: Microbial ecology: human gut microbes associated with obesity publication-title: Nature – volume: 25 start-page: 47 year: 2014 end-page: 60 ident: CR6 article-title: Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth publication-title: Semin. Cancer Biol. – volume: 20 start-page: 953 year: 2014 end-page: 966 ident: CR135 article-title: Metformin: from mechanisms of action to therapies publication-title: Cell Metab. – volume: 69 start-page: 9157 year: 2009 end-page: 9159 ident: CR142 article-title: Mutant metabolic enzymes are at the origin of gliomas publication-title: Cancer Res. – volume: 25 start-page: 1041 year: 2011 end-page: 1051 ident: CR84 article-title: Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress publication-title: Genes Dev. – volume: 108 start-page: 170 year: 2013 end-page: 178 ident: CR213 article-title: PDK1 inhibition is a novel therapeutic target in multiple myeloma publication-title: Br. J. Cancer – volume: 6 start-page: 14005 year: 2015 end-page: 14025 ident: CR221 article-title: Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: implications for more effective radiation therapy publication-title: Oncotarget – volume: 22 start-page: 547 year: 2012 end-page: 560 ident: CR80 article-title: Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma publication-title: Cancer Cell – volume: 15 start-page: 267 year: 2005 end-page: 276 ident: CR31 article-title: Plasma free amino acid profile in cancer patients publication-title: Semin. Cancer Biol. – volume: 348 start-page: 303 year: 2015 end-page: 308 ident: CR146 article-title: The complete structure of the 55S mammalian mitochondrial ribosome publication-title: Science – volume: 22 start-page: 585 year: 2012 end-page: 600 ident: CR219 article-title: Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth publication-title: Cancer Cell – volume: 110 start-page: 8882 year: 2013 end-page: 8887 ident: CR64 article-title: Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids publication-title: Proc. Natl Acad. Sci. USA – volume: 8 start-page: 224 year: 2008 end-page: 236 ident: CR66 article-title: SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth publication-title: Cell Metab. – volume: 25 start-page: 732 year: 2012 end-page: 739 ident: CR40 article-title: Glutamine-fueled mitochondrial metabolism is decoupled from glycolysis in melanoma publication-title: Pigment Cell Melanoma Res. – volume: 10 start-page: 923 year: 1999 end-page: 927 ident: CR139 article-title: Phase I trial of the selective mitochondrial toxin MKT077 in chemo-resistant solid tumours publication-title: Ann. Oncol. – volume: 20 start-page: 674 year: 2011 end-page: 688 ident: CR159 article-title: Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia publication-title: Cancer Cell – volume: 11 start-page: 393 year: 2011 end-page: 410 ident: CR188 article-title: Targeting hypoxia in cancer therapy publication-title: Nat. Rev. Cancer – volume: 43 start-page: 674 year: 2015 end-page: 679 ident: CR178 article-title: Peptide and small molecule inhibitors of the Keap1–Nrf2 protein–protein interaction publication-title: Biochem. Soc. Trans. – volume: 10 start-page: 1335 year: 2015 end-page: 1348 ident: CR52 article-title: Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation publication-title: Cell Rep. – volume: 79 start-page: 1118 year: 2010 end-page: 1124 ident: CR23 article-title: Identification of small molecule inhibitors of pyruvate kinase M2 publication-title: Biochem. Pharmacol. – volume: 65 start-page: 125 year: 2015 end-page: 133 ident: CR207 article-title: Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells publication-title: Int. J. Biochem. Cell Biol. – volume: 65 start-page: 63 year: 2012 end-page: 107 ident: CR58 article-title: Targeting the metabolic microenvironment of tumors publication-title: Adv. Pharmacol. – volume: 21 start-page: R461 year: 2014 end-page: R471 ident: CR137 article-title: Metformin, cancer and glucose metabolism publication-title: Endocr. Relat. Cancer – volume: 101 start-page: 102 year: 2015 end-page: 108 ident: CR218 article-title: Metformin and cancer: between the bioenergetic disturbances and the antifolate activity publication-title: Pharmacol. Res. – volume: 30 start-page: 1303 year: 2010 end-page: 1318 ident: CR113 article-title: Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation publication-title: Mol. Cell. Biol. – volume: 20 start-page: 591 year: 2014 end-page: 593 ident: CR126 article-title: Overcoming drug development bottlenecks with repurposing: repurposing biguanides to target energy metabolism for cancer treatment publication-title: Nat. Med. – volume: 69 start-page: 7507 year: 2009 end-page: 7511 ident: CR128 article-title: Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission publication-title: Cancer Res. – volume: 21 start-page: 805 year: 2015 end-page: 821 ident: CR11 article-title: Acetyl coenzyme A: a central metabolite and second messenger publication-title: Cell Metab. – volume: 292 start-page: 448 year: 2001 end-page: 449 ident: CR4 article-title: The advantages of togetherness publication-title: Science – volume: 92 start-page: 296 year: 2014 end-page: 311 ident: CR109 article-title: Statins in oncological research: from experimental studies to clinical practice publication-title: Crit. Rev. Oncol. Hematol. – volume: 16 start-page: 992 year: 2014 end-page: 1003 ident: CR118 article-title: PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis publication-title: Nat. Cell Biol. – volume: 17 start-page: 1498 year: 2011 end-page: 1503 ident: CR16 article-title: Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth publication-title: Nat. Med. – volume: 15 start-page: 827 year: 2012 end-page: 837 ident: CR30 article-title: Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain publication-title: Cell Metab. – volume: 11 start-page: 407 year: 2007 end-page: 420 ident: CR180 article-title: HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity publication-title: Cancer Cell – volume: 22 start-page: 956 year: 2015 end-page: 958 ident: CR210 article-title: Metastasis and oxidative stress: are antioxidants a metabolic driver of progression? publication-title: Cell Metab. – volume: 238 start-page: 787 year: 1948 end-page: 793 ident: CR200 article-title: Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid publication-title: N. Engl. J. Med. – volume: 340 start-page: 626 year: 2013 end-page: 630 ident: CR206 article-title: An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells publication-title: Science – volume: 6 start-page: 22836 year: 2015 end-page: 22856 ident: CR83 article-title: Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation publication-title: Oncotarget – volume: 21 start-page: 95 year: 2015 end-page: 108 ident: CR116 article-title: PINK1 and Parkin control localized translation of respiratory chain component mRNAs on mitochondria outer membrane publication-title: Cell Metab. – volume: 34 start-page: 23 year: 2015 end-page: 29 ident: CR209 article-title: Metabolism and epigenetics: a link cancer cells exploit publication-title: Curr. Opin. Biotechnol. – volume: 8 start-page: 754 year: 2014 end-page: 766 ident: CR176 article-title: A mitochondrial switch promotes tumor metastasis publication-title: Cell Rep. – volume: 63 start-page: 7436 year: 2003 end-page: 7442 ident: CR172 article-title: FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis publication-title: Cancer Res. – volume: 6 start-page: 9669 year: 2015 end-page: 9678 ident: CR193 article-title: Ecology meets cancer biology: the cancer swamp promotes the lethal cancer phenotype publication-title: Oncotarget – volume: 348 start-page: 607 year: 2000 end-page: 614 ident: CR124 article-title: Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain publication-title: Biochem. J. – volume: 353 start-page: 2305 year: 2005 end-page: 2306 ident: CR156 article-title: Mitochondrial toxicity associated with linezolid publication-title: N. Engl. J. Med. – volume: 146 start-page: 1534 year: 2014 end-page: 1546.e1533 ident: CR75 article-title: Gastrointestinal malignancy and the microbiome publication-title: Gastroenterology – volume: 347 start-page: 1362 year: 2015 end-page: 1367 ident: CR57 article-title: Targeting LDH enzymes with a stiripentol analog to treat epilepsy publication-title: Science – volume: 7 start-page: 523 year: 2011 ident: CR65 article-title: Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth publication-title: Mol. Syst. Biol. – volume: 112 start-page: 4832 year: 2008 end-page: 4838 ident: CR89 article-title: Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial publication-title: Blood – volume: 125 start-page: 2293 year: 2015 end-page: 2306 ident: CR37 article-title: Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis publication-title: J. Clin. Invest. – volume: 29 start-page: 254 year: 2006 end-page: 258 ident: CR127 article-title: Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin publication-title: Diabetes Care – volume: 5 start-page: 1024 year: 2015 end-page: 1039 ident: CR97 article-title: MYC, metabolism and cancer publication-title: Cancer Discov. – volume: 327 start-page: 389 year: 1987 end-page: 394 ident: CR152 article-title: Interaction of antibiotics with functional sites in 16S ribosomal RNA publication-title: Nature – volume: 28 start-page: 2220 year: 2010 end-page: 2226 ident: CR91 article-title: Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma publication-title: J. Clin. Oncol. – volume: 22 start-page: 304 year: 2015 end-page: 311 ident: CR208 article-title: Hypoxia induces production of L-2-hydroxyglutarate publication-title: Cell Metab. – volume: 12 start-page: 1461 year: 2013 end-page: 1470 ident: CR211 article-title: Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer publication-title: Mol. Cancer Ther. – volume: 11 start-page: 2782 year: 2012 end-page: 2792 ident: CR130 article-title: Metformin is synthetically lethal with glucose withdrawal in cancer cells publication-title: Cell Cycle – volume: 74 start-page: 908 year: 2014 end-page: 920 ident: CR49 article-title: Blocking lactate export by inhibiting the Myc target MCT1 disables glycolysis and glutathione synthesis publication-title: Cancer Res. – volume: 13 start-page: 486 year: 2013 end-page: 499 ident: CR21 article-title: Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy publication-title: Curr. Cancer Drug Targets – volume: 1807 start-page: 726 year: 2011 end-page: 734 ident: CR82 article-title: Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells publication-title: Biochim. Biophys. Acta – volume: 173 start-page: 89 year: 1988 end-page: 98 ident: CR61 article-title: Lactate dehydrogenase M-subunit deficiency: a new type of hereditary exertional myopathy publication-title: Clin. Chim. Acta – volume: 24 start-page: 6314 year: 2005 end-page: 6322 ident: CR102 article-title: ATP citrate lyase is an important component of cell growth and transformation publication-title: Oncogene – volume: 4 start-page: 4927 year: 2014 ident: CR168 article-title: Beyond Warburg effect — dual metabolic nature of cancer cells publication-title: Sci. Rep. – volume: 209 start-page: 211 year: 2012 end-page: 215 ident: CR87 article-title: Targeting glucose metabolism for cancer therapy publication-title: J. Exp. Med. – volume: 16 start-page: 839 year: 2015 end-page: 847 ident: CR136 article-title: Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial publication-title: Lancet Oncol. – volume: 8 start-page: 311 year: 2005 end-page: 321 ident: CR63 article-title: ATP citrate lyase inhibition can suppress tumor cell growth publication-title: Cancer Cell – volume: 15 start-page: 4 year: 2012 end-page: 5 ident: CR50 article-title: Power surge: supporting cells 'fuel' cancer cell mitochondria publication-title: Cell Metab. – volume: 12 start-page: 44 year: 2012 end-page: 52 ident: CR160 article-title: Tetracyclines: drugs with huge therapeutic potential publication-title: Mini Rev. Med. Chem. – volume: 348 start-page: 288 year: 2015 end-page: 289 ident: CR145 article-title: Mitoribosome oddities publication-title: Science – volume: 6 start-page: 551 year: 2010 end-page: 562 ident: CR105 article-title: Fatty acid synthase as a potential therapeutic target in cancer publication-title: Future Oncol. – volume: 20 start-page: 926 year: 2014 end-page: 937 ident: CR53 article-title: Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer publication-title: Clin. Cancer Res. – volume: 6 start-page: 27 year: 2015 ident: CR76 article-title: Ketosis, ketogenic diet and food intake control: a complex relationship publication-title: Front. Psychol. – volume: 485 start-page: 661 year: 2012 end-page: 665 ident: CR78 article-title: AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress publication-title: Nature – volume: 16 start-page: 1264 year: 2012 end-page: 1284 ident: CR226 article-title: Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis publication-title: Antioxid. Redox Signal. – volume: 71 start-page: 6921 year: 2011 end-page: 6925 ident: CR43 article-title: Lactate: a metabolic key player in cancer publication-title: Cancer Res. – volume: 18 start-page: 1359 year: 2012 end-page: 1368 ident: CR71 article-title: Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B publication-title: Nat. Med. – volume: 20 start-page: 5255 year: 2014 end-page: 5264 ident: CR215 article-title: A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies publication-title: Clin. Cancer Res. – volume: 15 start-page: 171 year: 2012 end-page: 185 ident: CR166 article-title: Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1 publication-title: Cell Metab. – volume: 299 start-page: 896 year: 2003 end-page: 899 ident: CR170 article-title: Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide publication-title: Science – volume: 113 start-page: 205 year: 2007 end-page: 212 ident: CR85 article-title: A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study publication-title: Clin. Sci. (Lond.) – volume: 97 start-page: E510 year: 2012 end-page: E520 ident: CR132 article-title: Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents publication-title: J. Clin. Endocrinol. Metab. – volume: 30 start-page: 3370 year: 2011 end-page: 3380 ident: CR104 article-title: A novel small molecule antagonist of choline kinase-alpha that simultaneously suppresses MAPK and PI3K/AKT signaling publication-title: Oncogene – volume: 12 start-page: 685 year: 2012 end-page: 698 ident: CR14 article-title: Mitochondria and cancer publication-title: Nat. Rev.Cancer – volume: 4 start-page: e1000293 year: 2008 ident: CR167 article-title: The genomic analysis of lactic acidosis and acidosis response in human cancers publication-title: PLoS Genet. – volume: 12 start-page: 829 year: 2013 end-page: 846 ident: CR19 article-title: Metabolic targets for cancer therapy publication-title: Nat. Rev. Drug Discov. – volume: 339 start-page: 1621 year: 2013 end-page: 1625 ident: CR205 article-title: ( )-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible publication-title: Science – volume: 73 start-page: 3 year: 2013 end-page: 7 ident: CR199 article-title: Chloroquine in cancer therapy: a double-edged sword of autophagy publication-title: Cancer Res. – volume: 461 start-page: 1282 year: 2009 end-page: 1286 ident: CR72 article-title: Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 publication-title: Nature – volume: 2 start-page: 362 year: 2012 ident: CR133 article-title: Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells publication-title: Sci. Rep. – volume: 346 start-page: 718 year: 2014 end-page: 722 ident: CR149 article-title: Structure of the large ribosomal subunit from human mitochondria publication-title: Science – volume: 129 start-page: 111 year: 2007 end-page: 122 ident: CR183 article-title: HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells publication-title: Cell – volume: 9 start-page: 3534 year: 2010 end-page: 3551 ident: CR187 article-title: HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: autophagy drives compartment-specific oncogenesis publication-title: Cell Cycle – volume: 444 start-page: 561 year: 2012 end-page: 571 ident: CR62 article-title: Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition publication-title: Biochem. J. – volume: 153 start-page: 56 year: 2013 end-page: 69 ident: CR202 article-title: Influence of metabolism on epigenetics and disease publication-title: Cell – volume: 33 start-page: 207 year: 2012 end-page: 214 ident: CR59 article-title: Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy publication-title: Trends Pharmacol. Sci. – volume: 123 start-page: 3664 year: 2013 end-page: 3671 ident: CR185 article-title: HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations publication-title: J. Clin. Invest. – ident: CR153 – volume: 407 start-page: 340 year: 2000 end-page: 348 ident: CR151 article-title: Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics publication-title: Nature – volume: 8 start-page: 3984 year: 2009 end-page: 4001 ident: CR15 article-title: The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma publication-title: Cell Cycle – volume: 510 start-page: 298 year: 2014 end-page: 302 ident: CR100 article-title: Quantitative flux analysis reveals folate-dependent NADPH production publication-title: Nature – volume: 8 start-page: e75154 year: 2013 ident: CR44 article-title: Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer publication-title: PLoS ONE – volume: 30 start-page: 2988 year: 2012 end-page: 2994 ident: CR158 article-title: eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial publication-title: J. Clin. Oncol. – volume: 26 start-page: 121 year: 2014 end-page: 135 ident: CR192 article-title: Metabolic reprogramming of stromal fibroblasts through p62–mTORC1 signaling promotes inflammation and tumorigenesis publication-title: Cancer Cell – volume: 94 start-page: 155 year: 2016 end-page: 171 ident: CR20 article-title: Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H symporters publication-title: J. Mol. Med. (Berl.) – volume: 21 start-page: 81 year: 2015 end-page: 94 ident: CR119 article-title: Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA publication-title: Cell Metab. – volume: 347 start-page: 1312 year: 2015 end-page: 1313 ident: CR56 article-title: Metabolic control of epilepsy publication-title: Science – volume: 330 start-page: 1344 year: 2010 end-page: 1348 ident: CR70 article-title: Autophagy and metabolism publication-title: Science – volume: 11 start-page: 2195 year: 2004 end-page: 2204 ident: CR45 article-title: Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology publication-title: Curr. Med. Chem. – volume: 369 start-page: 111 year: 2013 end-page: 121 ident: CR123 article-title: Retinoic acid and arsenic trioxide for acute promyelocytic leukemia publication-title: N. Engl. J. Med. – volume: 25 start-page: 1716 year: 2011 end-page: 1733 ident: CR68 article-title: Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation publication-title: Genes Dev. – volume: 10 start-page: 4047 year: 2011 end-page: 4064 ident: CR8 article-title: Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells : visualizing the therapeutic effects of metformin in tumor tissue publication-title: Cell Cycle – volume: 12 start-page: 401 year: 2012 end-page: 410 ident: CR195 article-title: Deconvoluting the context-dependent role for autophagy in cancer publication-title: Nat. Rev. Cancer – volume: 22 start-page: 508 year: 2015 end-page: 515 ident: CR141 article-title: 2-hydroxyglutarate inhibits ATP synthase and mTOR signaling publication-title: Cell Metab. – volume: 3 start-page: 1 year: 2015 ident: CR1 article-title: Mitochondria as biosynthetic factories for cancer proliferation publication-title: Cancer Metab. – volume: 481 start-page: 385 year: 2011 end-page: 388 ident: CR35 article-title: Reductive carboxylation supports growth in tumour cells with defective mitochondria publication-title: Nature – volume: 11 start-page: 835 year: 2011 end-page: 848 ident: CR108 article-title: Choline metabolism in malignant transformation publication-title: Nat. Rev. Cancer – volume: 27 start-page: 7381 year: 2007 end-page: 7393 ident: CR181 article-title: Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1 publication-title: Mol. Cell. Biol. – volume: 21 start-page: 5427 year: 2015 end-page: 5433 ident: CR92 article-title: Molecular pathways: targeting IDO1 and other tryptophan dioxygenases for cancer immunotherapy publication-title: Clin. Cancer Res. – volume: 9 start-page: 3256 year: 2010 end-page: 3276 ident: CR165 article-title: Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells publication-title: Cell Cycle – volume: 12 start-page: 732 year: 2015 end-page: 742 ident: CR86 article-title: Drug repurposing in oncology — patient and health systems opportunities publication-title: Nat. Rev. Clin. Oncol. – volume: 324 start-page: 1029 year: 2009 end-page: 1033 ident: CR2 article-title: Understanding the Warburg effect: the metabolic requirements of cell proliferation publication-title: Science – volume: 123 start-page: 3678 year: 2013 end-page: 3684 ident: CR34 article-title: Glutamine and cancer: cell biology, physiology, and clinical opportunities publication-title: J. Clin. Invest. – volume: 336 start-page: 1040 year: 2012 end-page: 1044 ident: CR101 article-title: Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation publication-title: Science – volume: 51 start-page: 183 year: 2011 end-page: 194 ident: CR107 article-title: Involvement of human choline kinase alpha and beta in carcinogenesis: a different role in lipid metabolism and biological functions publication-title: Adv. Enzyme Regul. – volume: 26 start-page: 851 year: 2014 end-page: 862 ident: CR9 article-title: Modeling alveolar soft part sarcomagenesis in the mouse: a role for lactate in the tumor microenvironment publication-title: Cancer Cell – volume: 481 start-page: 380 year: 2011 end-page: 384 ident: CR33 article-title: Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia publication-title: Nature – volume: 92 start-page: 492 year: 2013 end-page: 497 ident: CR106 article-title: Therapeutic potential of monoacylglycerol lipase inhibitors publication-title: Life Sci. – volume: 7 start-page: e1002018 year: 2011 ident: CR163 article-title: Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing the Warburg effect publication-title: PLoS Comput. Biol. – volume: 21 start-page: 3462 year: 2003 end-page: 3468 ident: CR28 article-title: Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide publication-title: J. Clin. Oncol. – volume: 13 start-page: 1059 year: 2015 end-page: 1072 ident: CR224 article-title: Dissecting the dual role of AMPK in cancer: from experimental to human studies publication-title: Mol. Cancer Res. – volume: 348 start-page: 340 year: 2015 end-page: 343 ident: CR120 article-title: Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness publication-title: Science – volume: 125 start-page: 687 year: 2015 end-page: 698 ident: CR214 article-title: Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation publication-title: J. Clin. Invest. – volume: 17 start-page: 351 year: 2015 end-page: 359 ident: CR18 article-title: Metabolic pathways promoting cancer cell survival and growth publication-title: Nat. Cell Biol. – volume: 3 start-page: 1611 year: 2013 end-page: 1643 ident: CR54 article-title: Monocarboxylic acid transport publication-title: Compr. Physiol. – volume: 5 start-page: 355 year: 2012 end-page: 364 ident: CR134 article-title: Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells publication-title: Cancer Prev. Res. (Phila.) – volume: 14 start-page: 1145 year: 2014 end-page: 1159 ident: CR189 article-title: Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery publication-title: Expert Opin. Biol. Ther. – volume: 98 start-page: 1375 year: 2006 end-page: 1382 ident: CR157 article-title: Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial publication-title: J. Natl Cancer Inst. – volume: 110 start-page: 489 year: 2013 end-page: 494 ident: CR24 article-title: M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth publication-title: Proc. Natl Acad. Sci. USA – volume: 23 start-page: 7660 year: 2005 end-page: 7668 ident: CR90 article-title: Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies publication-title: J. Clin. Oncol. – volume: 43 start-page: 869 year: 2011 end-page: 874 ident: CR94 article-title: Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis publication-title: Nat. Genet. – volume: 151 start-page: 16 year: 2015 end-page: 31 ident: CR173 article-title: Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer publication-title: Pharmacol. Ther. – volume: 11 start-page: 282 year: 2014 end-page: 298 ident: CR88 article-title: Standing the test of time: targeting thymidylate biosynthesis in cancer therapy publication-title: Nat. Rev. Clin. Oncol. – volume: 6 start-page: 21892 year: 2015 end-page: 21905 ident: CR122 article-title: Dissecting tumor metabolic heterogeneity: telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells publication-title: Oncotarget – volume: 124 start-page: 3597 year: 2014 end-page: 3607 ident: CR186 article-title: HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia publication-title: Blood – volume: 19 start-page: 5835 year: 2013 end-page: 5841 ident: CR96 article-title: Molecular pathways: targeting MYC-induced metabolic reprogramming and oncogenic stress in cancer publication-title: Clin. Cancer Res. – volume: 5 start-page: S21 issue: Suppl. 1 year: 2009 end-page: S26 ident: CR27 article-title: Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects publication-title: J. Cancer Res. Ther. – volume: 6 start-page: 221ra215 year: 2014 ident: CR225 article-title: Antioxidants accelerate lung cancer progression in mice publication-title: Sci. Transl. Med. – volume: 34 start-page: 856 year: 2015 end-page: 880 ident: CR223 article-title: Autophagy in malignant transformation and cancer progression publication-title: EMBO J. – volume: 360 start-page: 640 year: 2009 end-page: 642 ident: CR155 article-title: Prevalence of mitochondrial 1555A→G mutation in European children publication-title: N. Engl. J. Med. – volume: 123 start-page: 3652 year: 2013 end-page: 3658 ident: CR161 article-title: Oncometabolites: linking altered metabolism with cancer publication-title: J. Clin. Invest. – volume: 64 start-page: 31 year: 2004 end-page: 34 ident: CR25 article-title: 2-deoxy-d-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers publication-title: Cancer Res. – volume: 278 start-page: 37832 year: 2003 end-page: 37839 ident: CR125 article-title: Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism publication-title: J. Biol. Chem. – volume: 4 start-page: 727 year: 2011 end-page: 732 ident: CR194 article-title: Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments publication-title: Dis. Model. Mech. – volume: 9 start-page: 3515 year: 2010 end-page: 3533 ident: CR196 article-title: Autophagy in cancer associated fibroblasts promotes tumor cell survival: role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment publication-title: Cell Cycle – volume: 118 start-page: 218 year: 2014 end-page: 225 ident: CR42 article-title: Glucose and glutamine metabolism in oral squamous cell carcinoma: insight from a quantitative metabolomic approach publication-title: Oral Surg. Oral Med. Oral Pathol. Oral Radiol. – volume: 228 start-page: 1854 year: 2013 end-page: 1862 ident: CR79 article-title: Hypoxia promotes tumor cell survival in acidic conditions by preserving ATP levels publication-title: J. Cell. Physiol. – volume: 16 start-page: 393 year: 2015 end-page: 405 ident: CR77 article-title: p53 in survival, death and metabolic health: a lifeguard with a licence to kill publication-title: Nat. Rev. Mol. Cell Biol. – volume: 340 start-page: 622 year: 2013 end-page: 626 ident: CR216 article-title: Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation publication-title: Science – volume: 18 start-page: 78 year: 2015 end-page: 82 ident: CR220 article-title: Arginine deprivation in cancer therapy publication-title: Curr. Opin. Clin. Nutr. Metab. Care – volume: 47 start-page: 1475 year: 2015 end-page: 1481 ident: CR95 article-title: NRF2 regulates serine biosynthesis in non-small cell lung cancer publication-title: Nat. Genet. – volume: 310 start-page: 314 year: 2005 end-page: 317 ident: CR171 article-title: Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS publication-title: Science – volume: 108 start-page: 13546 year: 2011 end-page: 13551 ident: CR115 article-title: Nanoscale distribution of mitochondrial import receptor Tom20 is adjusted to cellular conditions and exhibits an inner-cellular gradient publication-title: Proc. Natl Acad. Sci. USA – volume: 21 start-page: 808 year: 2015 end-page: 818 ident: CR222 article-title: Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer publication-title: Clin. Cancer Res. – volume: 7 start-page: 423 year: 2012 end-page: 467 ident: CR51 article-title: Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms publication-title: Annu. Rev. Pathol. – volume: 29 start-page: 313 year: 2009 end-page: 324 ident: CR29 article-title: Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer publication-title: Oncogene – volume: 513 start-page: 559 year: 2013 end-page: 563 ident: CR47 article-title: Functional polarization of tumour-associated macrophages by tumour-derived lactic acid publication-title: Nature – volume: 118 start-page: 3930 year: 2008 end-page: 3942 ident: CR7 article-title: Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice publication-title: J. Clin. Invest. – volume: 283 start-page: 10892 year: 2008 end-page: 10903 ident: CR184 article-title: Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia publication-title: J. Biol. Chem. – volume: 6 start-page: 4569 year: 2015 end-page: 4584 ident: CR121 article-title: Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease publication-title: Oncotarget – volume: 313 start-page: 459 year: 2004 end-page: 465 ident: CR5 article-title: Cancer metabolism: facts, fantasy, and fiction publication-title: Biochem. Biophys. Res. Commun. – volume: 343 start-page: 1485 year: 2014 end-page: 1489 ident: CR148 article-title: Structure of the yeast mitochondrial large ribosomal subunit publication-title: Science – volume: 508 start-page: 108 year: 2014 end-page: 112 ident: CR131 article-title: Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides publication-title: Nature – volume: 18 start-page: 1947 year: 2011 end-page: 1961 ident: CR174 article-title: NAMPT in regulated NAD biosynthesis and its pivotal role in human metabolism publication-title: Curr. Med. Chem. – volume: 348 start-page: 95 year: 2015 end-page: 98 ident: CR147 article-title: The structure of the human mitochondrial ribosome publication-title: Science – volume: 104 start-page: 6223 year: 2007 end-page: 6228 ident: CR112 article-title: Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production publication-title: Proc. Natl Acad. Sci. USA – volume: 12 start-page: 35 year: 2014 end-page: 48 ident: CR150 article-title: Ribosome-targeting antibiotics and mechanisms of bacterial resistance publication-title: Nat. Rev. Microbiol. – volume: 6 start-page: 67 year: 2003 end-page: 75 ident: CR99 article-title: Cloning, expression, activity and folding studies of serine hydroxymethyltransferase: a target enzyme for cancer chemotherapy publication-title: J. Mol. Microbiol. Biotechnol. – volume: 48 start-page: 158 year: 2012 end-page: 167 ident: CR164 article-title: Physiological roles of mitochondrial reactive oxygen species publication-title: Mol. Cell – volume: 13 start-page: 890 year: 2014 end-page: 901 ident: CR38 article-title: Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer publication-title: Mol. Cancer Ther. – volume: 4 start-page: 58 year: 2010 ident: CR162 article-title: Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited publication-title: BMC Syst. Biol. – volume: 66 start-page: 5287 year: 2006 end-page: 5294 ident: CR103 article-title: Acetyl-CoA carboxylase α is essential to breast cancer cell survival publication-title: Cancer Res. – volume: 475 start-page: 106 year: 2011 end-page: 109 ident: CR177 article-title: Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis publication-title: Nature – volume: 27 start-page: 4636 year: 2008 end-page: 4643 ident: CR26 article-title: Methyl jasmonate binds to and detaches mitochondria-bound hexokinase publication-title: Oncogene – volume: 52 start-page: 165 year: 2015 end-page: 171 ident: CR143 article-title: Biochemical, epigenetic and metabolic approaches to target IDH mutations in acute myeloid leukemia publication-title: Semin Hematol. – volume: 14 start-page: 255 year: 1967 end-page: 274 ident: CR144 article-title: On the origin of mitosing cells publication-title: J. Theor. Biol. – volume: 350 start-page: 1391 year: 2015 end-page: 1396 ident: CR175 article-title: Vitamin C selectively kills and mutant colorectal cancer cells by targeting GAPDH publication-title: Science – volume: 145 start-page: 732 year: 2011 end-page: 744 ident: CR182 article-title: Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1 publication-title: Cell – volume: 4 start-page: 289 year: 1993 end-page: 294 ident: CR154 article-title: Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness publication-title: Nat. Genet. – volume: 128 start-page: 783 year: 2011 end-page: 794 ident: CR129 article-title: Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial publication-title: Breast Cancer Res. Treat. – volume: 292 start-page: 504 year: 2001 end-page: 507 ident: CR3 article-title: Cooperation and competition in the evolution of ATP-producing pathways publication-title: Science – volume: 514 start-page: 628 year: 2014 end-page: 632 ident: CR13 article-title: Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function publication-title: Nature – volume: 476 start-page: 346 year: 2011 end-page: 350 ident: CR93 article-title: Functional genomics reveal that the serine synthesis pathway is essential in breast cancer publication-title: Nature – volume: 144 start-page: 646 year: 2011 end-page: 674 ident: CR12 article-title: Hallmarks of cancer: the next generation publication-title: Cell – volume: 6 start-page: 42 year: 2000 end-page: 49 ident: CR138 article-title: A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077 publication-title: Clin. Cancer Res. – volume: 12 start-page: 931 year: 2013 end-page: 947 ident: CR169 article-title: Modulation of oxidative stress as an anticancer strategy publication-title: Nat. Rev. Drug Discov. – volume: 10 start-page: 510 year: 2015 ident: BFnrclinonc201660_CR98 publication-title: ACS Chem. Biol. doi: 10.1021/cb500683c – volume: 21 start-page: 808 year: 2015 ident: BFnrclinonc201660_CR222 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-14-2810 – volume: 23 start-page: 274 year: 2013 ident: BFnrclinonc201660_CR203 publication-title: Cancer Cell doi: 10.1016/j.ccr.2013.03.005 – volume: 462 start-page: 739 year: 2009 ident: BFnrclinonc201660_CR204 publication-title: Nature doi: 10.1038/nature08617 – volume: 101 start-page: 102 year: 2015 ident: BFnrclinonc201660_CR218 publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2015.06.014 – volume: 118 start-page: 218 year: 2014 ident: BFnrclinonc201660_CR42 publication-title: Oral Surg. Oral Med. Oral Pathol. Oral Radiol. doi: 10.1016/j.oooo.2014.04.003 – volume: 12 start-page: 1371 year: 2013 ident: BFnrclinonc201660_CR114 publication-title: Cell Cycle doi: 10.4161/cc.24092 – ident: BFnrclinonc201660_CR153 doi: 10.1146/annurevbiochem060815014343 – volume: 65 start-page: 125 year: 2015 ident: BFnrclinonc201660_CR207 publication-title: Int. J. Biochem. Cell Biol. doi: 10.1016/j.biocel.2015.05.012 – volume: 66 start-page: 5287 year: 2006 ident: BFnrclinonc201660_CR103 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-05-1489 – volume: 4 start-page: e1000293 year: 2008 ident: BFnrclinonc201660_CR167 publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1000293 – volume: 10 start-page: 1084 year: 2014 ident: BFnrclinonc201660_CR190 publication-title: Int. J. Biol. Sci. doi: 10.7150/ijbs.10190 – volume: 29 start-page: 254 year: 2006 ident: BFnrclinonc201660_CR127 publication-title: Diabetes Care doi: 10.2337/diacare.29.02.06.dc05-1558 – volume: 4 start-page: 4927 year: 2014 ident: BFnrclinonc201660_CR168 publication-title: Sci. Rep. doi: 10.1038/srep04927 – volume: 22 start-page: 508 year: 2015 ident: BFnrclinonc201660_CR141 publication-title: Cell Metab. doi: 10.1016/j.cmet.2015.06.009 – volume: 8 start-page: e75154 year: 2013 ident: BFnrclinonc201660_CR44 publication-title: PLoS ONE doi: 10.1371/journal.pone.0075154 – volume: 10 start-page: 923 year: 1999 ident: BFnrclinonc201660_CR139 publication-title: Ann. Oncol. doi: 10.1023/A:1008336904585 – volume: 47 start-page: 1475 year: 2015 ident: BFnrclinonc201660_CR95 publication-title: Nat. Genet. doi: 10.1038/ng.3421 – volume: 327 start-page: 389 year: 1987 ident: BFnrclinonc201660_CR152 publication-title: Nature doi: 10.1038/327389a0 – volume: 369 start-page: 111 year: 2013 ident: BFnrclinonc201660_CR123 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1300874 – volume: 13 start-page: 890 year: 2014 ident: BFnrclinonc201660_CR38 publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-13-0870 – volume: 69 start-page: 7507 year: 2009 ident: BFnrclinonc201660_CR128 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-2994 – volume: 15 start-page: 267 year: 2005 ident: BFnrclinonc201660_CR31 publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2005.04.003 – volume: 107 start-page: 2037 year: 2010 ident: BFnrclinonc201660_CR48 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0914433107 – volume: 360 start-page: 640 year: 2009 ident: BFnrclinonc201660_CR155 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc0806396 – volume: 125 start-page: 687 year: 2015 ident: BFnrclinonc201660_CR214 publication-title: J. Clin. Invest. doi: 10.1172/JCI72873 – volume: 1807 start-page: 726 year: 2011 ident: BFnrclinonc201660_CR82 publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbabio.2010.10.022 – volume: 17 start-page: 351 year: 2015 ident: BFnrclinonc201660_CR18 publication-title: Nat. Cell Biol. doi: 10.1038/ncb3124 – volume: 25 start-page: 1041 year: 2011 ident: BFnrclinonc201660_CR84 publication-title: Genes Dev. doi: 10.1101/gad.1987211 – volume: 13 start-page: 486 year: 2013 ident: BFnrclinonc201660_CR21 publication-title: Curr. Cancer Drug Targets doi: 10.2174/15680096113139990041 – volume: 330 start-page: 1344 year: 2010 ident: BFnrclinonc201660_CR70 publication-title: Science doi: 10.1126/science.1193497 – volume: 52 start-page: 165 year: 2015 ident: BFnrclinonc201660_CR143 publication-title: Semin Hematol. doi: 10.1053/j.seminhematol.2015.03.002 – volume: 21 start-page: 2440 year: 2015 ident: BFnrclinonc201660_CR22 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-14-1209 – volume: 19 start-page: 5835 year: 2013 ident: BFnrclinonc201660_CR96 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-12-3629 – volume: 123 start-page: 3664 year: 2013 ident: BFnrclinonc201660_CR185 publication-title: J. Clin. Invest. doi: 10.1172/JCI67230 – volume: 485 start-page: 661 year: 2012 ident: BFnrclinonc201660_CR78 publication-title: Nature doi: 10.1038/nature11066 – volume: 18 start-page: 78 year: 2015 ident: BFnrclinonc201660_CR220 publication-title: Curr. Opin. Clin. Nutr. Metab. Care doi: 10.1097/MCO.0000000000000122 – volume: 21 start-page: R461 year: 2014 ident: BFnrclinonc201660_CR137 publication-title: Endocr. Relat. Cancer doi: 10.1530/ERC-14-0284 – volume: 347 start-page: 1362 year: 2015 ident: BFnrclinonc201660_CR57 publication-title: Science doi: 10.1126/science.aaa1299 – volume: 336 start-page: 1040 year: 2012 ident: BFnrclinonc201660_CR101 publication-title: Science doi: 10.1126/science.1218595 – volume: 15 start-page: 4 year: 2012 ident: BFnrclinonc201660_CR50 publication-title: Cell Metab. doi: 10.1016/j.cmet.2011.12.011 – volume: 407 start-page: 340 year: 2000 ident: BFnrclinonc201660_CR151 publication-title: Nature doi: 10.1038/35030019 – volume: 7 start-page: e1002018 year: 2011 ident: BFnrclinonc201660_CR163 publication-title: PLoS Comput. Biol. doi: 10.1371/journal.pcbi.1002018 – volume: 72 start-page: 5130 year: 2012 ident: BFnrclinonc201660_CR17 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-1949 – volume: 69 start-page: 4918 year: 2009 ident: BFnrclinonc201660_CR41 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-4806 – volume: 65 start-page: 63 year: 2012 ident: BFnrclinonc201660_CR58 publication-title: Adv. Pharmacol. doi: 10.1016/B978-0-12-397927-8.00004-X – volume: 324 start-page: 1029 year: 2009 ident: BFnrclinonc201660_CR2 publication-title: Science doi: 10.1126/science.1160809 – volume: 16 start-page: 1264 year: 2012 ident: BFnrclinonc201660_CR226 publication-title: Antioxid. Redox Signal. doi: 10.1089/ars.2011.4243 – volume: 23 start-page: 287 year: 2013 ident: BFnrclinonc201660_CR117 publication-title: Cancer Cell doi: 10.1016/j.ccr.2012.11.020 – volume: 22 start-page: 585 year: 2012 ident: BFnrclinonc201660_CR219 publication-title: Cancer Cell doi: 10.1016/j.ccr.2012.09.020 – volume: 11 start-page: 2195 year: 2004 ident: BFnrclinonc201660_CR45 publication-title: Curr. Med. Chem. doi: 10.2174/0929867043364711 – volume: 71 start-page: 6921 year: 2011 ident: BFnrclinonc201660_CR43 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-11-1457 – volume: 25 start-page: 1716 year: 2011 ident: BFnrclinonc201660_CR68 publication-title: Genes Dev. doi: 10.1101/gad.16771811 – volume: 18 start-page: 1359 year: 2012 ident: BFnrclinonc201660_CR71 publication-title: Nat. Med. doi: 10.1038/nm.2890 – volume: 27 start-page: 4636 year: 2008 ident: BFnrclinonc201660_CR26 publication-title: Oncogene doi: 10.1038/onc.2008.108 – volume: 20 start-page: 591 year: 2014 ident: BFnrclinonc201660_CR126 publication-title: Nat. Med. doi: 10.1038/nm.3596 – volume: 15 start-page: 157 year: 2012 ident: BFnrclinonc201660_CR191 publication-title: Cell Metab. doi: 10.1016/j.cmet.2011.12.015 – volume: 30 start-page: 3370 year: 2011 ident: BFnrclinonc201660_CR104 publication-title: Oncogene doi: 10.1038/onc.2011.51 – volume: 348 start-page: 95 year: 2015 ident: BFnrclinonc201660_CR147 publication-title: Science doi: 10.1126/science.aaa1193 – volume: 123 start-page: 3678 year: 2013 ident: BFnrclinonc201660_CR34 publication-title: J. Clin. Invest. doi: 10.1172/JCI69600 – volume: 59 start-page: 487 year: 2016 ident: BFnrclinonc201660_CR60 publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b00168 – volume: 173 start-page: 89 year: 1988 ident: BFnrclinonc201660_CR61 publication-title: Clin. Chim. Acta doi: 10.1016/0009-8981(88)90359-2 – volume: 15 start-page: 171 year: 2012 ident: BFnrclinonc201660_CR166 publication-title: Cell Metab. doi: 10.1016/j.cmet.2012.01.004 – volume: 6 start-page: 221ra215 year: 2014 ident: BFnrclinonc201660_CR225 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3007653 – volume: 10 start-page: 4047 year: 2011 ident: BFnrclinonc201660_CR8 publication-title: Cell Cycle doi: 10.4161/cc.10.23.18151 – volume: 118 start-page: 3930 year: 2008 ident: BFnrclinonc201660_CR7 publication-title: J. Clin. Invest. – volume: 353 start-page: 2305 year: 2005 ident: BFnrclinonc201660_CR156 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM200511243532123 – volume: 8 start-page: 224 year: 2008 ident: BFnrclinonc201660_CR66 publication-title: Cell Metab. doi: 10.1016/j.cmet.2008.07.007 – volume: 6 start-page: 27 year: 2015 ident: BFnrclinonc201660_CR76 publication-title: Front. Psychol. doi: 10.3389/fpsyg.2015.00027 – volume: 12 start-page: 931 year: 2013 ident: BFnrclinonc201660_CR169 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4002 – volume: 299 start-page: 896 year: 2003 ident: BFnrclinonc201660_CR170 publication-title: Science doi: 10.1126/science.1079368 – volume: 23 start-page: 7660 year: 2005 ident: BFnrclinonc201660_CR90 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2005.02.0933 – volume: 12 start-page: 44 year: 2012 ident: BFnrclinonc201660_CR160 publication-title: Mini Rev. Med. Chem. doi: 10.2174/138955712798868977 – volume: 458 start-page: 780 year: 2009 ident: BFnrclinonc201660_CR36 publication-title: Nature doi: 10.1038/nature07733 – volume: 350 start-page: 1391 year: 2015 ident: BFnrclinonc201660_CR175 publication-title: Science doi: 10.1126/science.aaa5004 – volume: 27 start-page: 7381 year: 2007 ident: BFnrclinonc201660_CR181 publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.00440-07 – volume: 25 start-page: 47 year: 2014 ident: BFnrclinonc201660_CR6 publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2014.01.005 – volume: 125 start-page: 2293 year: 2015 ident: BFnrclinonc201660_CR37 publication-title: J. Clin. Invest. doi: 10.1172/JCI75836 – volume: 32 start-page: 1152 year: 2012 ident: BFnrclinonc201660_CR55 publication-title: J. Cereb. Blood Flow Metab. doi: 10.1038/jcbfm.2011.149 – volume: 9 start-page: 3256 year: 2010 ident: BFnrclinonc201660_CR165 publication-title: Cell Cycle – volume: 99 start-page: 989 year: 2008 ident: BFnrclinonc201660_CR140 publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6604554 – volume: 9 start-page: 3534 year: 2010 ident: BFnrclinonc201660_CR187 publication-title: Cell Cycle doi: 10.4161/cc.9.17.12908 – volume: 34 start-page: 23 year: 2015 ident: BFnrclinonc201660_CR209 publication-title: Curr. Opin. Biotechnol. doi: 10.1016/j.copbio.2014.11.012 – volume: 209 start-page: 211 year: 2012 ident: BFnrclinonc201660_CR87 publication-title: J. Exp. Med. doi: 10.1084/jem.20120162 – volume: 110 start-page: 8882 year: 2013 ident: BFnrclinonc201660_CR64 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1307237110 – volume: 151 start-page: 16 year: 2015 ident: BFnrclinonc201660_CR173 publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2015.02.004 – volume: 8 start-page: 3984 year: 2009 ident: BFnrclinonc201660_CR15 publication-title: Cell Cycle doi: 10.4161/cc.8.23.10238 – volume: 129 start-page: 111 year: 2007 ident: BFnrclinonc201660_CR183 publication-title: Cell doi: 10.1016/j.cell.2007.01.047 – volume: 20 start-page: 926 year: 2014 ident: BFnrclinonc201660_CR53 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-13-2270 – volume: 6 start-page: 21892 year: 2015 ident: BFnrclinonc201660_CR122 publication-title: Oncotarget doi: 10.18632/oncotarget.5260 – volume: 12 start-page: 401 year: 2012 ident: BFnrclinonc201660_CR195 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3262 – volume: 343 start-page: 1485 year: 2014 ident: BFnrclinonc201660_CR148 publication-title: Science doi: 10.1126/science.1249410 – volume: 310 start-page: 314 year: 2005 ident: BFnrclinonc201660_CR171 publication-title: Science doi: 10.1126/science.1117728 – volume: 21 start-page: 3462 year: 2003 ident: BFnrclinonc201660_CR28 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2003.03.034 – volume: 10 start-page: 1335 year: 2015 ident: BFnrclinonc201660_CR52 publication-title: Cell Rep. doi: 10.1016/j.celrep.2015.02.006 – volume: 508 start-page: 108 year: 2014 ident: BFnrclinonc201660_CR131 publication-title: Nature doi: 10.1038/nature13110 – volume: 444 start-page: 1022 year: 2006 ident: BFnrclinonc201660_CR73 publication-title: Nature doi: 10.1038/4441022a – volume: 74 start-page: 908 year: 2014 ident: BFnrclinonc201660_CR49 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-13-2034 – volume: 64 start-page: 31 year: 2004 ident: BFnrclinonc201660_CR25 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-03-3294 – volume: 24 start-page: 6314 year: 2005 ident: BFnrclinonc201660_CR102 publication-title: Oncogene doi: 10.1038/sj.onc.1208773 – volume: 69 start-page: 9157 year: 2009 ident: BFnrclinonc201660_CR142 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-2650 – volume: 27 start-page: 57 year: 2015 ident: BFnrclinonc201660_CR69 publication-title: Cancer Cell doi: 10.1016/j.ccell.2014.12.002 – volume: 30 start-page: 1303 year: 2010 ident: BFnrclinonc201660_CR113 publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.01101-09 – volume: 313 start-page: 459 year: 2004 ident: BFnrclinonc201660_CR5 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2003.11.136 – volume: 348 start-page: 340 year: 2015 ident: BFnrclinonc201660_CR120 publication-title: Science doi: 10.1126/science.1260384 – volume: 2 start-page: 362 year: 2012 ident: BFnrclinonc201660_CR133 publication-title: Sci. Rep. doi: 10.1038/srep00362 – volume: 367 start-page: 1792 year: 2012 ident: BFnrclinonc201660_CR110 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1201735 – volume: 11 start-page: 2782 year: 2012 ident: BFnrclinonc201660_CR130 publication-title: Cell Cycle doi: 10.4161/cc.20948 – volume: 348 start-page: 288 year: 2015 ident: BFnrclinonc201660_CR145 publication-title: Science doi: 10.1126/science.aab1054 – volume: 9 start-page: 712 year: 2013 ident: BFnrclinonc201660_CR32 publication-title: Mol. Syst. Biol. doi: 10.1038/msb.2013.65 – volume: 510 start-page: 298 year: 2014 ident: BFnrclinonc201660_CR100 publication-title: Nature doi: 10.1038/nature13236 – volume: 20 start-page: 674 year: 2011 ident: BFnrclinonc201660_CR159 publication-title: Cancer Cell doi: 10.1016/j.ccr.2011.10.015 – volume: 6 start-page: 4569 year: 2015 ident: BFnrclinonc201660_CR121 publication-title: Oncotarget doi: 10.18632/oncotarget.3174 – volume: 153 start-page: 56 year: 2013 ident: BFnrclinonc201660_CR202 publication-title: Cell doi: 10.1016/j.cell.2013.03.004 – volume: 16 start-page: 992 year: 2014 ident: BFnrclinonc201660_CR118 publication-title: Nat. Cell Biol. doi: 10.1038/ncb3039 – volume: 94 start-page: 155 year: 2016 ident: BFnrclinonc201660_CR20 publication-title: J. Mol. Med. (Berl.) doi: 10.1007/s00109-015-1307-x – volume: 340 start-page: 622 year: 2013 ident: BFnrclinonc201660_CR216 publication-title: Science doi: 10.1126/science.1234769 – volume: 12 start-page: 829 year: 2013 ident: BFnrclinonc201660_CR19 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4145 – volume: 275 start-page: 223 year: 2000 ident: BFnrclinonc201660_CR217 publication-title: J. Biol. Chem. doi: 10.1074/jbc.275.1.223 – volume: 148 start-page: 1258 year: 2012 ident: BFnrclinonc201660_CR74 publication-title: Cell doi: 10.1016/j.cell.2012.01.035 – volume: 65 start-page: 3336 year: 2005 ident: BFnrclinonc201660_CR197 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-04-3640 – volume: 26 start-page: 121 year: 2014 ident: BFnrclinonc201660_CR192 publication-title: Cancer Cell doi: 10.1016/j.ccr.2014.05.004 – volume: 123 start-page: 3685 year: 2013 ident: BFnrclinonc201660_CR10 publication-title: J. Clin. Invest. doi: 10.1172/JCI69741 – volume: 346 start-page: 718 year: 2014 ident: BFnrclinonc201660_CR149 publication-title: Science doi: 10.1126/science.1258026 – volume: 63 start-page: 7436 year: 2003 ident: BFnrclinonc201660_CR172 publication-title: Cancer Res. – volume: 347 start-page: 1312 year: 2015 ident: BFnrclinonc201660_CR56 publication-title: Science doi: 10.1126/science.aaa9607 – volume: 34 start-page: 856 year: 2015 ident: BFnrclinonc201660_CR223 publication-title: EMBO J. doi: 10.15252/embj.201490784 – volume: 16 start-page: 393 year: 2015 ident: BFnrclinonc201660_CR77 publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm4007 – volume: 476 start-page: 346 year: 2011 ident: BFnrclinonc201660_CR93 publication-title: Nature doi: 10.1038/nature10350 – volume: 18 start-page: 1947 year: 2011 ident: BFnrclinonc201660_CR174 publication-title: Curr. Med. Chem. doi: 10.2174/092986711795590101 – volume: 125 start-page: 2120 year: 2015 ident: BFnrclinonc201660_CR111 publication-title: Blood doi: 10.1182/blood-2014-08-594408 – volume: 98 start-page: 1375 year: 2006 ident: BFnrclinonc201660_CR157 publication-title: J. Natl Cancer Inst. doi: 10.1093/jnci/djj373 – volume: 20 start-page: 5255 year: 2014 ident: BFnrclinonc201660_CR215 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-14-1019 – volume: 22 start-page: 304 year: 2015 ident: BFnrclinonc201660_CR208 publication-title: Cell Metab. doi: 10.1016/j.cmet.2015.06.023 – volume: 13 start-page: 1059 year: 2015 ident: BFnrclinonc201660_CR224 publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-15-0068 – volume: 25 start-page: 732 year: 2012 ident: BFnrclinonc201660_CR40 publication-title: Pigment Cell Melanoma Res. doi: 10.1111/pcmr.12000 – volume: 144 start-page: 646 year: 2011 ident: BFnrclinonc201660_CR12 publication-title: Cell doi: 10.1016/j.cell.2011.02.013 – volume: 444 start-page: 561 year: 2012 ident: BFnrclinonc201660_CR62 publication-title: Biochem. J. doi: 10.1042/BJ20120294 – volume: 4 start-page: 58 year: 2010 ident: BFnrclinonc201660_CR162 publication-title: BMC Syst. Biol. doi: 10.1186/1752-0509-4-58 – volume: 92 start-page: 5510 year: 1995 ident: BFnrclinonc201660_CR179 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.92.12.5510 – volume: 11 start-page: 407 year: 2007 ident: BFnrclinonc201660_CR180 publication-title: Cancer Cell doi: 10.1016/j.ccr.2007.04.001 – volume: 12 start-page: 732 year: 2015 ident: BFnrclinonc201660_CR86 publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/nrclinonc.2015.169 – volume: 73 start-page: 3 year: 2013 ident: BFnrclinonc201660_CR199 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-2464 – volume: 7 start-page: 423 year: 2012 ident: BFnrclinonc201660_CR51 publication-title: Annu. Rev. Pathol. doi: 10.1146/annurev-pathol-011811-120856 – volume: 51 start-page: 183 year: 2011 ident: BFnrclinonc201660_CR107 publication-title: Adv. Enzyme Regul. doi: 10.1016/j.advenzreg.2010.09.010 – volume: 6 start-page: 14005 year: 2015 ident: BFnrclinonc201660_CR221 publication-title: Oncotarget doi: 10.18632/oncotarget.4159 – volume: 6 start-page: 551 year: 2010 ident: BFnrclinonc201660_CR105 publication-title: Future Oncol. doi: 10.2217/fon.10.11 – volume: 79 start-page: 1118 year: 2010 ident: BFnrclinonc201660_CR23 publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2009.12.003 – volume: 461 start-page: 1282 year: 2009 ident: BFnrclinonc201660_CR72 publication-title: Nature doi: 10.1038/nature08530 – volume: 6 start-page: 22836 year: 2015 ident: BFnrclinonc201660_CR83 publication-title: Oncotarget doi: 10.18632/oncotarget.4479 – volume: 278 start-page: 37832 year: 2003 ident: BFnrclinonc201660_CR125 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M301546200 – volume: 21 start-page: 5427 year: 2015 ident: BFnrclinonc201660_CR92 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-15-0420 – volume: 3 start-page: 1611 year: 2013 ident: BFnrclinonc201660_CR54 publication-title: Compr. Physiol. doi: 10.1002/cphy.c130008 – volume: 108 start-page: 13546 year: 2011 ident: BFnrclinonc201660_CR115 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1107553108 – volume: 22 start-page: 956 year: 2015 ident: BFnrclinonc201660_CR210 publication-title: Cell Metab. doi: 10.1016/j.cmet.2015.11.008 – volume: 11 start-page: 282 year: 2014 ident: BFnrclinonc201660_CR88 publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/nrclinonc.2014.51 – volume: 5 start-page: 355 year: 2012 ident: BFnrclinonc201660_CR134 publication-title: Cancer Prev. Res. (Phila.) doi: 10.1158/1940-6207.CAPR-11-0299 – volume: 6 start-page: 42 year: 2000 ident: BFnrclinonc201660_CR138 publication-title: Clin. Cancer Res. – volume: 6 start-page: 19177 year: 2015 ident: BFnrclinonc201660_CR212 publication-title: Oncotarget doi: 10.18632/oncotarget.3910 – volume: 21 start-page: 81 year: 2015 ident: BFnrclinonc201660_CR119 publication-title: Cell Metab. doi: 10.1016/j.cmet.2014.12.003 – volume: 11 start-page: 393 year: 2011 ident: BFnrclinonc201660_CR188 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3064 – volume: 20 start-page: 953 year: 2014 ident: BFnrclinonc201660_CR135 publication-title: Cell Metab. doi: 10.1016/j.cmet.2014.09.018 – volume: 113 start-page: 205 year: 2007 ident: BFnrclinonc201660_CR85 publication-title: Clin. Sci. (Lond.) doi: 10.1042/CS20060307 – volume: 17 start-page: 1498 year: 2011 ident: BFnrclinonc201660_CR16 publication-title: Nat. Med. doi: 10.1038/nm.2492 – volume: 228 start-page: 1854 year: 2013 ident: BFnrclinonc201660_CR79 publication-title: J. Cell. Physiol. doi: 10.1002/jcp.24346 – volume: 238 start-page: 787 year: 1948 ident: BFnrclinonc201660_CR200 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM194806032382301 – volume: 124 start-page: 3597 year: 2014 ident: BFnrclinonc201660_CR186 publication-title: Blood doi: 10.1182/blood-2014-04-567065 – volume: 370 start-page: 2286 year: 2014 ident: BFnrclinonc201660_CR81 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1400029 – volume: 513 start-page: 559 year: 2013 ident: BFnrclinonc201660_CR47 publication-title: Nature doi: 10.1038/nature13490 – volume: 12 start-page: 1461 year: 2013 ident: BFnrclinonc201660_CR211 publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-13-0097 – volume: 514 start-page: 628 year: 2014 ident: BFnrclinonc201660_CR13 publication-title: Nature doi: 10.1038/nature13611 – volume: 9 start-page: 3515 year: 2010 ident: BFnrclinonc201660_CR196 publication-title: Cell Cycle doi: 10.4161/cc.9.17.12928 – volume: 43 start-page: 674 year: 2015 ident: BFnrclinonc201660_CR178 publication-title: Biochem. Soc. Trans. doi: 10.1042/BST20150051 – volume: 292 start-page: 448 year: 2001 ident: BFnrclinonc201660_CR4 publication-title: Science doi: 10.1126/science.1060456 – volume: 339 start-page: 1621 year: 2013 ident: BFnrclinonc201660_CR205 publication-title: Science doi: 10.1126/science.1231677 – volume: 16 start-page: 839 year: 2015 ident: BFnrclinonc201660_CR136 publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(15)00027-3 – volume: 15 start-page: 827 year: 2012 ident: BFnrclinonc201660_CR30 publication-title: Cell Metab. doi: 10.1016/j.cmet.2012.05.001 – volume: 14 start-page: 255 year: 1967 ident: BFnrclinonc201660_CR144 publication-title: J. Theor. Biol. doi: 10.1016/0022-5193(67)90079-3 – volume: 292 start-page: 504 year: 2001 ident: BFnrclinonc201660_CR3 publication-title: Science doi: 10.1126/science.1058079 – volume: 30 start-page: 2988 year: 2012 ident: BFnrclinonc201660_CR158 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2011.41.4466 – volume: 348 start-page: 303 year: 2015 ident: BFnrclinonc201660_CR146 publication-title: Science doi: 10.1126/science.aaa3872 – volume: 481 start-page: 380 year: 2011 ident: BFnrclinonc201660_CR33 publication-title: Nature doi: 10.1038/nature10602 – volume: 11 start-page: 835 year: 2011 ident: BFnrclinonc201660_CR108 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3162 – volume: 43 start-page: 869 year: 2011 ident: BFnrclinonc201660_CR94 publication-title: Nat. Genet. doi: 10.1038/ng.890 – volume: 348 start-page: 74 year: 2015 ident: BFnrclinonc201660_CR46 publication-title: Science doi: 10.1126/science.aaa6204 – volume: 8 start-page: 311 year: 2005 ident: BFnrclinonc201660_CR63 publication-title: Cancer Cell doi: 10.1016/j.ccr.2005.09.008 – volume: 92 start-page: 296 year: 2014 ident: BFnrclinonc201660_CR109 publication-title: Crit. Rev. Oncol. Hematol. doi: 10.1016/j.critrevonc.2014.08.002 – volume: 145 start-page: 732 year: 2011 ident: BFnrclinonc201660_CR182 publication-title: Cell doi: 10.1016/j.cell.2011.03.054 – volume: 12 start-page: 35 year: 2014 ident: BFnrclinonc201660_CR150 publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro3155 – volume: 92 start-page: 492 year: 2013 ident: BFnrclinonc201660_CR106 publication-title: Life Sci. doi: 10.1016/j.lfs.2012.10.025 – volume: 21 start-page: 805 year: 2015 ident: BFnrclinonc201660_CR11 publication-title: Cell Metab. doi: 10.1016/j.cmet.2015.05.014 – volume: 110 start-page: 489 year: 2013 ident: BFnrclinonc201660_CR24 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1212780110 – volume: 26 start-page: 629 year: 2012 ident: BFnrclinonc201660_CR201 publication-title: Hematol. Oncol. Clin. North Am. doi: 10.1016/j.hoc.2012.02.002 – volume: 39 start-page: 171 year: 2010 ident: BFnrclinonc201660_CR67 publication-title: Mol. Cell doi: 10.1016/j.molcel.2010.06.022 – volume: 12 start-page: 685 year: 2012 ident: BFnrclinonc201660_CR14 publication-title: Nat. Rev.Cancer doi: 10.1038/nrc3365 – volume: 22 start-page: 547 year: 2012 ident: BFnrclinonc201660_CR80 publication-title: Cancer Cell doi: 10.1016/j.ccr.2012.08.014 – volume: 283 start-page: 10892 year: 2008 ident: BFnrclinonc201660_CR184 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M800102200 – volume: 29 start-page: 313 year: 2009 ident: BFnrclinonc201660_CR29 publication-title: Oncogene doi: 10.1038/onc.2009.358 – volume: 123 start-page: 3652 year: 2013 ident: BFnrclinonc201660_CR161 publication-title: J. Clin. Invest. doi: 10.1172/JCI67228 – volume: 146 start-page: 1534 year: 2014 ident: BFnrclinonc201660_CR75 publication-title: Gastroenterology doi: 10.1053/j.gastro.2014.01.001 – volume: 48 start-page: 158 year: 2012 ident: BFnrclinonc201660_CR164 publication-title: Mol. Cell doi: 10.1016/j.molcel.2012.09.025 – volume: 14 start-page: 1145 year: 2014 ident: BFnrclinonc201660_CR189 publication-title: Expert Opin. Biol. Ther. doi: 10.1517/14712598.2014.912270 – volume: 33 start-page: 207 year: 2012 ident: BFnrclinonc201660_CR59 publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2012.01.005 – volume: 5 start-page: 1024 year: 2015 ident: BFnrclinonc201660_CR97 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-15-0507 – volume: 340 start-page: 626 year: 2013 ident: BFnrclinonc201660_CR206 publication-title: Science doi: 10.1126/science.1236062 – volume: 481 start-page: 385 year: 2011 ident: BFnrclinonc201660_CR35 publication-title: Nature doi: 10.1038/nature10642 – volume: 108 start-page: 170 year: 2013 ident: BFnrclinonc201660_CR213 publication-title: Br. J. Cancer doi: 10.1038/bjc.2012.527 – volume: 4 start-page: 289 year: 1993 ident: BFnrclinonc201660_CR154 publication-title: Nat. Genet. doi: 10.1038/ng0793-289 – volume: 6 start-page: 9669 year: 2015 ident: BFnrclinonc201660_CR193 publication-title: Oncotarget doi: 10.18632/oncotarget.3430 – volume: 107 start-page: 8788 year: 2010 ident: BFnrclinonc201660_CR39 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1003428107 – volume: 8 start-page: 754 year: 2014 ident: BFnrclinonc201660_CR176 publication-title: Cell Rep. doi: 10.1016/j.celrep.2014.06.043 – volume: 348 start-page: 607 year: 2000 ident: BFnrclinonc201660_CR124 publication-title: Biochem. J. doi: 10.1042/bj3480607 – volume: 97 start-page: E510 year: 2012 ident: BFnrclinonc201660_CR132 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2011-1754 – volume: 28 start-page: 2220 year: 2010 ident: BFnrclinonc201660_CR91 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2009.26.7765 – volume: 3 start-page: 1 year: 2015 ident: BFnrclinonc201660_CR1 publication-title: Cancer Metab. doi: 10.1186/s40170-015-0128-2 – volume: 128 start-page: 783 year: 2011 ident: BFnrclinonc201660_CR129 publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-011-1612-1 – volume: 5 start-page: S21 issue: Suppl. 1 year: 2009 ident: BFnrclinonc201660_CR27 publication-title: J. Cancer Res. Ther. doi: 10.4103/0973-1482.55136 – volume: 36 start-page: 124 year: 2015 ident: BFnrclinonc201660_CR198 publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2014.11.004 – volume: 475 start-page: 106 year: 2011 ident: BFnrclinonc201660_CR177 publication-title: Nature doi: 10.1038/nature10189 – volume: 112 start-page: 4832 year: 2008 ident: BFnrclinonc201660_CR89 publication-title: Blood doi: 10.1182/blood-2008-04-149443 – volume: 26 start-page: 851 year: 2014 ident: BFnrclinonc201660_CR9 publication-title: Cancer Cell doi: 10.1016/j.ccell.2014.10.003 – volume: 6 start-page: 67 year: 2003 ident: BFnrclinonc201660_CR99 publication-title: J. Mol. Microbiol. Biotechnol. doi: 10.1159/000076737 – volume: 21 start-page: 95 year: 2015 ident: BFnrclinonc201660_CR116 publication-title: Cell Metab. doi: 10.1016/j.cmet.2014.12.007 – volume: 7 start-page: 523 year: 2011 ident: BFnrclinonc201660_CR65 publication-title: Mol. Syst. Biol. doi: 10.1038/msb.2011.56 – volume: 4 start-page: 727 year: 2011 ident: BFnrclinonc201660_CR194 publication-title: Dis. Model. Mech. doi: 10.1242/dmm.007724 – volume: 104 start-page: 6223 year: 2007 ident: BFnrclinonc201660_CR112 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0700690104 – reference: 24477002 - Sci Transl Med. 2014 Jan 29;6(221):221ra15 – reference: 25474015 - Curr Opin Clin Nutr Metab Care. 2015 Jan;18(1):78-82 – reference: 23001348 - Nat Rev Cancer. 2012 Oct;12(10):685-98 – reference: 23617249 - Curr Cancer Drug Targets. 2013 Jun;13(5):486-99 – reference: 25625193 - Oncotarget. 2015 Mar 10;6(7):4569-84 – reference: 17319797 - Clin Sci (Lond). 2007 Aug;113(4):205-12 – reference: 20855962 - Cell Cycle. 2010 Sep 1;9(17):3515-33 – reference: 10509153 - Ann Oncol. 1999 Aug;10(8):923-7 – reference: 23153533 - Cancer Cell. 2012 Nov 13;22(5):585-600 – reference: 24069390 - PLoS One. 2013 Sep 12;8(9):e75154 – reference: 26111463 - Semin Hematol. 2015 Jul;52(3):165-71 – reference: 22458763 - Biochem J. 2012 Jun 15;444(3):561-71 – reference: 26340601 - J Med Chem. 2016 Jan 28;59(2):487-96 – reference: 22846158 - Pigment Cell Melanoma Res. 2012 Nov;25(6):732-9 – reference: 18281291 - J Biol Chem. 2008 Apr 18;283(16):10892-903 – reference: 25838379 - Science. 2015 Apr 3;348(6230):95-8 – reference: 23321518 - Br J Cancer. 2013 Jan 15;108(1):170-8 – reference: 21035492 - Adv Enzyme Regul. 2011;51(1):183-94 – reference: 22424233 - Cell. 2012 Mar 16;148(6):1258-70 – reference: 17482131 - Cancer Cell. 2007 May;11(5):407-20 – reference: 11014183 - Nature. 2000 Sep 21;407(6802):340-8 – reference: 19460998 - Science. 2009 May 22;324(5930):1029-33 – reference: 16224023 - Science. 2005 Oct 14;310(5746):314-7 – reference: 22027938 - J Cereb Blood Flow Metab. 2012 Jul;32(7):1152-66 – reference: 18766181 - Br J Cancer. 2008 Oct 7;99(7):989-94 – reference: 7539918 - Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5510-4 – reference: 15833867 - Cancer Res. 2005 Apr 15;65(8):3336-46 – reference: 23142242 - Life Sci. 2013 Mar 19;92(8-9):492-7 – reference: 25712477 - EMBO J. 2015 Apr 1;34(7):856-80 – reference: 22959024 - Adv Pharmacol. 2012;65:63-107 – reference: 22134189 - Cell Cycle. 2011 Dec 1;10(23):4047-64 – reference: 24265240 - Compr Physiol. 2013 Oct;3(4):1611-43 – reference: 26212717 - Cell Metab. 2015 Aug 4;22(2):304-11 – reference: 26087309 - Oncotarget. 2015 Jun 10;6(16):14005-25 – reference: 12972521 - J Clin Oncol. 2003 Sep 15;21(18):3462-8 – reference: 18805963 - Blood. 2008 Dec 15;112(13):4832-8 – reference: 22077552 - Annu Rev Pathol. 2012;7:423-67 – reference: 19033663 - J Clin Invest. 2008 Dec;118(12):3930-42 – reference: 25565207 - Cell Metab. 2015 Jan 6;21(1):81-94 – reference: 19194462 - Nature. 2009 Apr 9;458(7239):780-3 – reference: 22850421 - Cancer Res. 2012 Oct 1;72(19):5130-40 – reference: 26099350 - J Mol Med (Berl). 2016 Feb;94(2):155-71 – reference: 25273809 - Endocr Relat Cancer. 2014;21(6):R461-71 – reference: 25002027 - Cancer Cell. 2014 Jul 14;26(1):121-35 – reference: 26203664 - Oncotarget. 2015 Aug 7;6(22):19177-89 – reference: 22500211 - Sci Rep. 2012;2:362 – reference: 23841729 - N Engl J Med. 2013 Jul 11;369(2):111-21 – reference: 23671091 - Proc Natl Acad Sci U S A. 2013 May 28;110(22):8882-7 – reference: 23558173 - Science. 2013 May 3;340(6132):622-6 – reference: 25837514 - Science. 2015 Apr 17;348(6232):340-3 – reference: 21517777 - Curr Med Chem. 2011;18(13):1947-61 – reference: 22398146 - Trends Pharmacol Sci. 2012 Apr;33(4):207-14 – reference: 22534666 - Nat Rev Cancer. 2012 Apr 26;12(6):401-10 – reference: 25565208 - Cell Metab. 2015 Jan 6;21(1):95-108 – reference: 22326218 - Cell Metab. 2012 Feb 8;15(2):157-70 – reference: 22330683 - J Exp Med. 2012 Feb 13;209(2):211-5 – reference: 15044825 - J Mol Microbiol Biotechnol. 2003;6(2):67-75 – reference: 23897900 - Clin Cancer Res. 2013 Nov 1;19(21):5835-41 – reference: 17418790 - Cell. 2007 Apr 6;129(1):111-22 – reference: 20864819 - Cell Cycle. 2010 Sep 1;9(17):3534-51 – reference: 19458066 - Cancer Res. 2009 Jun 1;69(11):4918-25 – reference: 25497227 - Trends Pharmacol Sci. 2015 Feb;36(2):124-35 – reference: 25165100 - Clin Cancer Res. 2014 Oct 15;20(20):5255-64 – reference: 21423717 - PLoS Comput Biol. 2011 Mar;7(3):e1002018 – reference: 24927638 - Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Aug;118(2):218-25 – reference: 26039447 - Cell Metab. 2015 Jun 2;21(6):805-21 – reference: 16707454 - Cancer Res. 2006 May 15;66(10):5287-94 – reference: 19923890 - Cell Cycle. 2009 Dec;8(23):3984-4001 – reference: 24277449 - Clin Cancer Res. 2014 Feb 15;20(4):926-37 – reference: 28094266 - Nat Rev Clin Oncol. 2017 Feb;14 (2):113 – reference: 19865172 - Nature. 2009 Oct 29;461(7268):1282-6 – reference: 24820099 - Sci Rep. 2014 May 13;4:4927 – reference: 24301801 - Mol Syst Biol. 2013 Dec 03;9:712 – reference: 24406471 - Gastroenterology. 2014 May;146(6):1534-1546.e3 – reference: 26087400 - Oncotarget. 2015 Sep 8;6(26):22836-56 – reference: 19752085 - Cancer Res. 2009 Oct 1;69(19):7507-11 – reference: 25792315 - Science. 2015 Mar 20;347(6228):1312-3 – reference: 24285728 - Cancer Res. 2014 Feb 1;74(3):908-20 – reference: 25278503 - Science. 2014 Nov 7;346(6210):718-22 – reference: 21734707 - Nature. 2011 Jul 06;475(7354):106-9 – reference: 20005212 - Biochem Pharmacol. 2010 Apr 15;79(8):1118-24 – reference: 23518346 - Cancer Cell. 2013 Mar 18;23(3):274-6 – reference: 16234528 - J Clin Oncol. 2005 Oct 20;23(30):7660-8 – reference: 21423211 - Oncogene. 2011 Jul 28;30(30):3370-80 – reference: 25332683 - Int J Biol Sci. 2014 Sep 13;10(10):1084-96 – reference: 23674815 - Mol Cancer Ther. 2013 Aug;12(8):1461-70 – reference: 21620138 - Cell. 2011 May 27;145(5):732-44 – reference: 21852536 - Genes Dev. 2011 Aug 15;25(16):1716-33 – reference: 25792327 - Science. 2015 Mar 20;347(6228):1362-7 – reference: 26007236 - Int J Biochem Cell Biol. 2015 Aug;65:125-33 – reference: 24732946 - Nat Rev Clin Oncol. 2014 May;11(5):282-98 – reference: 24901568 - Nat Med. 2014 Jun;20(6):591-3 – reference: 20373869 - Future Oncol. 2010 Apr;6(4):551-62 – reference: 21127245 - Science. 2010 Dec 3;330(6009):1344-8 – reference: 23558169 - Science. 2013 May 3;340(6132):626-30 – reference: 16306535 - N Engl J Med. 2005 Nov 24;353(21):2305-6 – reference: 21760589 - Nature. 2011 Aug 18;476(7360):346-50 – reference: 22089420 - Nat Rev Cancer. 2011 Nov 17;11(12):835-48 – reference: 22101431 - Nature. 2011 Nov 20;481(7381):385-8 – reference: 11541392 - J Theor Biol. 1967 Mar;14(3):255-74 – reference: 23288916 - Cancer Res. 2013 Jan 1;73(1):3-7 – reference: 23393090 - Science. 2013 Mar 29;339(6127):1621-5 – reference: 25524310 - Clin Cancer Res. 2015 Feb 15;21(4):808-18 – reference: 17183309 - Nature. 2006 Dec 21;444(7122):1022-3 – reference: 24287781 - Nat Rev Drug Discov. 2013 Dec;12(12):931-47 – reference: 24675956 - Science. 2014 Mar 28;343(6178):1485-9 – reference: 25883344 - Science. 2015 Apr 17;348(6232):288-9 – reference: 25698989 - Front Psychol. 2015 Feb 02;6:27 – reference: 24805240 - Nature. 2014 Jun 12;510(7504):298-302 – reference: 26323205 - Oncotarget. 2015 Sep 8;6(26):21892-905 – reference: 19881548 - Oncogene. 2010 Jan 21;29(3):313-24 – reference: 16226706 - Cancer Cell. 2005 Oct;8(4):311-21 – reference: 26482881 - Nat Genet. 2015 Dec;47(12):1475-81 – reference: 22101433 - Nature. 2011 Nov 20;481(7381):380-4 – reference: 25915584 - J Clin Invest. 2015 Jun;125(6):2293-306 – reference: 22520983 - Hematol Oncol Clin North Am. 2012 Jun;26(3):629-48, ix – reference: 22682223 - Cell Metab. 2012 Jun 6;15(6):827-37 – reference: 22094260 - Cancer Cell. 2011 Nov 15;20(5):674-88 – reference: 18860765 - N Engl J Med. 1948 Jun 3;238(23):787-93 – reference: 26067687 - Lancet Oncol. 2015 Jul;16(7):839-47 – reference: 22628656 - Science. 2012 May 25;336(6084):1040-4 – reference: 15894488 - Semin Cancer Biol. 2005 Aug;15(4):267-76 – reference: 24523301 - Mol Cancer Ther. 2014 Apr;13(4):890-901 – reference: 10656430 - Clin Cancer Res. 2000 Jan;6(1):42-9 – reference: 24113830 - Nat Rev Drug Discov. 2013 Nov;12 (11):829-46 – reference: 23459996 - J Cell Physiol. 2013 Sep;228(9):1854-62 – reference: 24762115 - Expert Opin Biol Ther. 2014 Aug;14(8):1145-59 – reference: 25241037 - Nat Cell Biol. 2014 Oct;16(10 ):992-1003, 1-15 – reference: 20133848 - Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2037-42 – reference: 26122615 - Nat Rev Mol Cell Biol. 2015 Jul;16(7):393-405 – reference: 26277279 - Pharmacol Res. 2015 Nov;101:102-8 – reference: 24336183 - Nat Rev Microbiol. 2014 Jan;12(1):35-48 – reference: 19196684 - N Engl J Med. 2009 Feb 5;360(6):640-2 – reference: 20100866 - Mol Cell Biol. 2010 Mar;30(6):1303-18 – reference: 17018784 - J Natl Cancer Inst. 2006 Oct 4;98(19):1375-82 – reference: 25267197 - Blood. 2014 Dec 4;124(24):3597-607 – reference: 21376230 - Cell. 2011 Mar 4;144(5):646-74 – reference: 25709099 - Pharmacol Ther. 2015 Jul;151:16-31 – reference: 10839993 - Biochem J. 2000 Jun 15;348 Pt 3:607-14 – reference: 26190651 - Cell Metab. 2015 Sep 1;22(3):508-15 – reference: 23999440 - J Clin Invest. 2013 Sep;123(9):3664-71 – reference: 25631767 - Blood. 2015 Mar 26;125(13):2120-30 – reference: 26551711 - Biochem Soc Trans. 2015 Aug;43(4):674-9 – reference: 7689389 - Nat Genet. 1993 Jul;4(3):289-94 – reference: 25043024 - Nature. 2014 Sep 25;513(7519):559-63 – reference: 19935646 - Nature. 2009 Dec 10;462(7274):739-44 – reference: 23999442 - J Clin Invest. 2013 Sep;123(9):3678-84 – reference: 3383424 - Clin Chim Acta. 1988 Mar 31;173(1):89-98 – reference: 19057672 - PLoS Genet. 2008 Dec;4(12 ):e1000293 – reference: 22863786 - Nat Med. 2012 Sep;18(9):1359-68 – reference: 22070692 - Mini Rev Med Chem. 2012 Jan;12(1):44-52 – reference: 12853461 - J Biol Chem. 2003 Sep 26;278(39):37832-9 – reference: 25895024 - Oncotarget. 2015 ;6(12 ):9669-78 – reference: 23574725 - Cell Cycle. 2013 May 1;12(9):1371-84 – reference: 2953976 - Nature. 1987 Jun 4-10;327(6121):389-94 – reference: 19996293 - Cancer Res. 2009 Dec 15;69(24):9157-9 – reference: 25621173 - Cancer Metab. 2015 Jan 25;3(1):1 – reference: 11283355 - Science. 2001 Apr 20;292(5516):504-7 – reference: 22809961 - Cell Cycle. 2012 Aug 1;11(15):2782-92 – reference: 22802315 - J Clin Oncol. 2012 Aug 20;30(24):2988-94 – reference: 21692241 - Biochim Biophys Acta. 2011 Jun;1807(6):726-34 – reference: 18408762 - Oncogene. 2008 Aug 7;27(34):4636-43 – reference: 17384149 - Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6223-8 – reference: 22065843 - Dis Model Mech. 2011 Nov;4(6):727-32 – reference: 26541605 - Science. 2015 Dec 11;350(6266):1391-6 – reference: 25066121 - Cell Rep. 2014 Aug 7;8(3):754-66 – reference: 21883043 - Antioxid Redox Signal. 2012 Jun 1;16(11):1264-84 – reference: 25774832 - Nat Cell Biol. 2015 Apr;17(4):351-9 – reference: 23267074 - Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):489-94 – reference: 25461508 - Curr Opin Biotechnol. 2015 Aug;34:23-9 – reference: 21576264 - Genes Dev. 2011 May 15;25(10 ):1041-51 – reference: 21655990 - Breast Cancer Res Treat. 2011 Aug;128(3):783-94 – reference: 22278418 - J Clin Endocrinol Metab. 2012 Apr;97(4):E510-20 – reference: 14729604 - Cancer Res. 2004 Jan 1;64(1):31-4 – reference: 21606941 - Nat Rev Cancer. 2011 Jun;11(6):393-410 – reference: 10617608 - J Biol Chem. 2000 Jan 7;275(1):223-8 – reference: 20814239 - Cell Cycle. 2010 Aug 15;9(16):3256-76 – reference: 23999443 - J Clin Invest. 2013 Sep;123(9):3685-92 – reference: 25838393 - Clin Cancer Res. 2015 Jun 1;21(11):2440-4 – reference: 20421486 - Proc Natl Acad Sci U S A. 2010 May 11;107(19):8788-93 – reference: 20459610 - BMC Syst Biol. 2010 May 06;4:58 – reference: 22326219 - Cell Metab. 2012 Feb 8;15(2):171-85 – reference: 25956158 - Mol Cancer Res. 2015 Jul;13(7):1059-72 – reference: 15279558 - Curr Med Chem. 2004 Aug;11(16):2195-204 – reference: 25453902 - Cancer Cell. 2014 Dec 8;26(6):851-62 – reference: 25406093 - ACS Chem Biol. 2015 Feb 20;10 (2):510-6 – reference: 20670887 - Mol Cell. 2010 Jul 30;39(2):171-83 – reference: 25838376 - Science. 2015 Apr 3;348(6230):74-80 – reference: 23416000 - Cancer Cell. 2013 Mar 18;23 (3):287-301 – reference: 22084445 - Cancer Res. 2011 Nov 15;71(22):6921-5 – reference: 22660331 - Nature. 2012 May 09;485(7400):661-5 – reference: 22225869 - Cell Metab. 2012 Jan 4;15(1):4-5 – reference: 25220658 - Crit Rev Oncol Hematol. 2014 Dec;92(3):296-311 – reference: 27023846 - Annu Rev Biochem. 2016 Jun 2;85:103-32 – reference: 23540690 - Cell. 2013 Mar 28;153(1):56-69 – reference: 23079663 - Cancer Cell. 2012 Oct 16;22(4):547-60 – reference: 14612543 - Cancer Res. 2003 Nov 1;63(21):7436-42 – reference: 25584894 - Cancer Cell. 2015 Jan 12;27(1):57-71 – reference: 23102266 - Mol Cell. 2012 Oct 26;48(2):158-67 – reference: 25607840 - J Clin Invest. 2015 Feb;125(2):687-98 – reference: 21847114 - Mol Syst Biol. 2011 Aug 16;7:523 – reference: 26382145 - Cancer Discov. 2015 Oct;5(10):1024-39 – reference: 26636492 - Cell Metab. 2015 Dec 1;22(6):956-8 – reference: 16443869 - Diabetes Care. 2006 Feb;29(2):254-8 – reference: 26483297 - Nat Rev Clin Oncol. 2015 Dec;12(12):732-42 – reference: 20009289 - J Cancer Res Ther. 2009 Sep;5 Suppl 1:S21-6 – reference: 24869598 - N Engl J Med. 2014 Jun 12;370(24):2286-94 – reference: 26519060 - Clin Cancer Res. 2015 Dec 15;21(24):5427-33 – reference: 25119024 - Nature. 2014 Oct 30;514(7524):628-32 – reference: 25732824 - Cell Rep. 2015 Mar 3;10 (8):1335-48 – reference: 14697210 - Biochem Biophys Res Commun. 2004 Jan 16;313(3):459-65 – reference: 22037646 - Nat Med. 2011 Oct 30;17(11):1498-503 – reference: 20351325 - J Clin Oncol. 2010 May 1;28(13):2220-6 – reference: 24670634 - Nature. 2014 Apr 3;508(7494):108-12 – reference: 11283359 - Science. 2001 Apr 20;292(5516):448-9 – reference: 24486645 - Semin Cancer Biol. 2014 Apr;25:47-60 – reference: 23999438 - J Clin Invest. 2013 Sep;123(9):3652-8 – reference: 25837512 - Science. 2015 Apr 17;348(6232):303-8 – reference: 16007201 - Oncogene. 2005 Sep 15;24(41):6314-22 – reference: 25456737 - Cell Metab. 2014 Dec 2;20(6):953-66 – reference: 21799113 - Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13546-51 – reference: 23134381 - N Engl J Med. 2012 Nov 8;367(19):1792-802 – reference: 18762023 - Cell Metab. 2008 Sep;8(3):224-36 – reference: 12574632 - Science. 2003 Feb 7;299(5608):896-9 – reference: 22086681 - Cancer Prev Res (Phila). 2012 Mar;5(3):355-64 – reference: 21804546 - Nat Genet. 2011 Jul 31;43(9):869-74 – reference: 17785433 - Mol Cell Biol. 2007 Nov;27(21):7381-93 |
| SSID | ssj0066473 |
| Score | 2.6761048 |
| SecondaryResourceType | review_article |
| Snippet | Key Points
The metabolic ecology of tumours enables component cells to generate ATP, maintain redox balance, and undertake biosynthesis, which in turn support... Awareness that the metabolic phenotype of cells within tumours is heterogeneous - and distinct from that of their normal counterparts - is growing. In general,... Awareness that the metabolic phenotype of cells within tumours is heterogeneous -- and distinct from that of their normal counterparts -- is growing. In... |
| SourceID | proquest gale pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 11 |
| SubjectTerms | 692/420/755 692/699/67/1059/153 692/699/67/2327 692/699/67/2329 692/699/67/327 Acetyl Coenzyme A - metabolism Adaptation, Physiological Amino Acids - metabolism Antineoplastic Agents - therapeutic use Antioxidants - metabolism Autophagy - physiology Blood Glucose - metabolism Cancer cells Cell metabolism Energy Metabolism - drug effects Epigenomics Fatty Acids - metabolism Genetic Heterogeneity Glutamic Acid - metabolism Glutamine - metabolism Growth Health aspects Humans Innovations Ketone Bodies - metabolism Lactic Acid - metabolism Lipids - biosynthesis Medicine & Public Health Mitochondria - drug effects Mitochondrial Ribosomes - drug effects Molecular targeted therapy Neoplasms - drug therapy Neoplasms - metabolism Nucleic Acids - biosynthesis Oncology Oxidative Stress - drug effects Pyruvic Acid - metabolism review-article TOR Serine-Threonine Kinases - antagonists & inhibitors Transcription Factors - metabolism Tumor Microenvironment |
| Title | Cancer metabolism: a therapeutic perspective |
| URI | https://link.springer.com/article/10.1038/nrclinonc.2016.60 https://www.ncbi.nlm.nih.gov/pubmed/27141887 https://www.proquest.com/docview/1849359510 https://www.proquest.com/docview/1826677604 https://www.proquest.com/docview/1855072747 |
| Volume | 14 |
| WOSCitedRecordID | wos000391344000004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1759-4782 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0066473 issn: 1759-4774 databaseCode: M7P dateStart: 20041101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1759-4782 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0066473 issn: 1759-4774 databaseCode: 7X7 dateStart: 20090401 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1759-4782 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0066473 issn: 1759-4774 databaseCode: 7RV dateStart: 20090401 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1759-4782 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0066473 issn: 1759-4774 databaseCode: BENPR dateStart: 20090401 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-xDaG98A0LjBIkJCQgzK5d2-UFjWkTD1BVE0x9sxx_SJO2trQdfz8-10nbSfSFFytSzonju_Nd7nw_A7w1jhnuRLeiVPgqXolKUR8qUfewGIErl4C0L77LwUCNRv1hDrjN87bKZk1MC7WbWIyRH8U_kVRESsmX6e8KT43C7Go-QmMH9hAlgaWte8NmJRaCpwxztJD9ikc_p8lqMnU0nmHl4WSMKIZUfEoIlSu7dHt1XjNPt_KlyQydPfjfD3gI97MDWh4vJeYR3PHjx3DvR06xP4GPJygHs_LaL6J8XF3Orz-Xplwr0yqnq_rMp_Dr7PTnybcqH6lQ2ejKLCprlGecqcgfYuJ_dF8oVRPm6-A5cZ7UEuMbQVnSDYEGHp2tWgjnQjDOhJ5jz2A3zpo_gLJ2IsjAogy4GnHCTHQEiQx1fK5xtu8LIM2EapvxxvHYiyud8t5M6ZYHGnmgBSngfdtlugTb2Eb8Grmkl_WiraLqYy45pk97tIB3iQJVNb7ZmlxxEMePoFcblIcblFHF7ObthqU6q_hcr_hZwJv2NvbEbWtjP7lBmuj_SCkI30aDkHIYHCjg-VLK2o_vSsppNAMFfGjEbm0A_5qZF9uH-xL2u-ibpDjSIewuZjf-Fdy1fxaX81kHduT5BbYjmVrVgb2vp4PheSfp1l92iCjX |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwED-NgYAXvj8CgwUJhASEOYlru0gITYNp07qKhw31zTixLU3a2tJ2IP4p_kbunI-2k-jbHniL5Itzyf1yHz7fGeClsbnhVmRJmgqX4JVIVOp8IooOFSNwZUMj7W892e-rwaD7dQ3-NLUwtK2y0YlBUdtRSWvkWxiJhCLSlH0a_0jo1CjKrjZHaFSwOHC_f2HINv24_xnl-yrLdr8c7ewl9akCSYnWfJaURrmc5wpZZAZDya5QqmC5K7zjzDpWSArxvSpZ5n3qOfobhRDWem-s8R2b47xX4CrqcUlbyOSgDfCE4CGjjRa5m3D0q5osaq62hhOqdBwNqWtiKt6HjphzO3jRGiyYwwv52WD2dm__bx_sDtyqHex4u_oj7sKaG96D64f1FoL78G6HcD6Jz9wM8X96Mj37EJt4oQwtHs_rTx_A8aXw-hDWUUruMcSFFV76HDFuC-qDZtDRZdIXOK-xZddFwBoB6rLup07HepzqkNfPlW5lrknmWrAI3rS3jKtmIquINwkVuqqHbRWR3uaSU3q4k0bwOlCQKsInl6auqED-qanXEuXGEiWqkHJ5uIGQrlXYVM_xE8GLdpjupG15Qzc6Jxr076QUjK-ioZZ5tPgRwaMK1e3LZzLlKZq5CN42MF9g4F9f5slqdjfhxt7RYU_39vsHT-FmRn5YWDPbgPXZ5Nw9g2vlz9nJdPI8_L0xfL9s9P8FN0WEug |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwED-NgSZe-GYEBgsSCAnI6iSu7SIhNG1UTNuqPsC0N-PEtjRpa0vbgfjX-Ou4c5J-TKJve-Atks_Jxffz3dnnOwO8MjY33IosSVPhEnwSiUqdT0TRpmQErmwopH1yJHs9dXra6a_BnyYXho5VNjoxKGo7LGmPvIUrkZBEmrKWr49F9Pe7n0Y_ErpBiiKtzXUaFUQO3e9fuHybfDzYR1m_zrLu5697X5L6hoGkRMs-TUqjXM5zhewyg8vKjlCqYLkrvOPMOlZIWu57VbLM-9Rz9D0KIaz13ljj2zbH996Am5KLoBSOZb-xAkLwEN1G69xJOPpYTUQ1V63BmLIehwOqoJiKnVAdc24Tr1qGBdN4JVYbTGD37v88ePfgTu14x7vVTLkPa27wADaO66MFD-H9HuF_HF-4Kc6L87PJxYfYxAvpafFonpf6CL5dC6-PYR0l5p5AXFjhpc8R-7ag-mgGHWAmfYHvNbbsuAhYI0xd1nXW6bqPcx3i_bnSM_lrkr8WLIK3sy6jqsjIKuJtQoiu8mRnCkrvcskpbNxOI3gTKEhF4ZdLU2daIP9U7GuJcmuJElVLudzcwEnXqm2i51iK4OWsmXrScb2BG14SDfp9UgrGV9FQKT3aFIlgs0L47OczmfIUzV8E7xrILzDwr5F5uprdbdhA0Oujg97hM7idkXsWttK2YH06vnTP4Vb5c3o2Gb8IEzmG79cN_r8GdY2J |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cancer+metabolism%3A+a+therapeutic+perspective&rft.jtitle=Nature+reviews.+Clinical+oncology&rft.au=Peiris-Pag%C3%A9s%2C+Maria&rft.au=Lisanti%2C+Michael+P&rft.au=Martinez-Outschoorn%2C+Ubaldo+E&rft.au=Pestell%2C+Richard+G&rft.date=2017-01-01&rft.pub=Nature+Publishing+Group&rft.issn=1759-4774&rft.volume=14&rft.issue=1&rft.spage=11&rft_id=info:doi/10.1038%2Fnrclinonc.2016.60&rft.externalDBID=n%2Fa&rft.externalDocID=A474028951 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1759-4774&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1759-4774&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1759-4774&client=summon |